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Summary 1
Summary 
 
 
Annually, Mycobacterium tuberculosis is responsible for nearly two million deaths 
worldwide. Part of its success lies in its ability to survive and replicate in macrophages, but 
the molecular mechanisms allowing it to do so are not yet understood. Once activated, 
macrophages produce reactive oxygen (ROI) and nitrogen (RNI) species, which amongst 
other targets damage DNA. M. tuberculosis seems to be superbly adapted to these 
unfavourable conditions, which demand efficient mechanisms to ensure genome stability.  
 
Mycobacteria are naturally devoid of the highly conserved mismatch repair (MMR) system, a 
crucial mechanism for mutation avoidance. Other DNA repair strategies, such as 
recombinational repair, base excision repair (BER), or nucleotide excision repair (NER), may 
compensate for some of the functions accomplished by the MMR system. In this study, the 
role of the NER pathway in mycobacteria was investigated. The bacterial NER pathway 
consists of the UvrABC endonuclease enzyme complex and a helicase named UvrD. 
Knockout mutants in the excinuclease component (uvrA or uvrB, respectively) and in the 
helicase (uvrD) were constructed in M. tuberculosis and in M. smegmatis. In addition, double 
mutants lacking both components were generated. Analyses of the NER mutants revealed that 
the mycobacterial NER system repairs a wide range of mutagenic DNA alterations and is an 
important defence mechanism against oxidative and nitrosative damage. In a gene conversion 
assay, the capability of M. smegmatis NER mutants to recognise and subsequently reject 
different base-pairing errors was assessed. Inactivation of uvrB and uvrD increased marker 
integration frequencies to various extents, with in part – and dependent on the mismatch 
studied - synergistic effects in the combined uvrB / uvrD mutant. Our results imply that NER 
and particularly the helicase UvrD in part compensate for the lack of MMR in mycobacteria. 
We also found that the helicase component UvrD is essential for long-term survival of M. 
tuberculosis in vitro and in vivo.  
 
Besides DNA repair, other mechanisms contribute to ensuring genome integrity. DNA 
binding proteins that establish chromosome architecture presumably are involved in 
stabilising the bacterial genome during persistence and to accomplish proper cell division 
during reactivation. SMC (structural maintenance of chromosomes) proteins play fundamental 
roles in various aspects of chromosome organisation and dynamics, including repair of DNA 
damage. Mutant strains of M. smegmatis and M. tuberculosis defective in SMC were 
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constructed. Surprisingly, inactivation of smc did not result in a recognizable phenotype. This 
is in contrast to data on smc null mutants in other species. Our observations suggest that the 
maintenance of mycobacterial chromosome organisation differs from that of described 
models. 
 
Taken together, our observations provide evidence that despite the lack of a MMR system, 
mycobacteria possess efficient defence mechanisms against DNA damage. We found that the 
NER system has a fundamental role in mutation avoidance and that the helicase UvrD has an 
additional role besides participation in NER. In addition, our data suggest unique mechanisms 
for chromosome organisation and partitioning in mycobacteria. Overall, the obtained findings 
indicate that mechanisms that govern genome stability in mycobacteria differ significantly 
from those of described model species.  
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Zusammenfassung 
 
 
Jedes Jahr ist das Bakterium Mycobacterium tuberculosis für weltweit fast zwei Millionen 
Todesfälle verantwortlich. Diese Bilanz liegt zum Teil darin begründet, dass das Bakterium in 
Makrophagen überleben und sich replizieren kann, wobei die molekularen Mechanismen für 
diese Fähigkeit noch nicht aufgeklärt sind. Aktivierte Makrophagen bilden reaktive 
Sauerstoff- (engl. reactive oxygen species, ROI) und Stickstoffmoleküle (engl. reactive 
nitrogen species, RNI), die unter anderem DNA-Schäden hervorrufen. Mycobacterium 
tuberculosis scheint hervorragend an diese Bedingungen angepasst zu sein, welche effiziente 
Mechanismen zur Sicherung der Genomstabilität erfordern.  
 
Mykobakterien fehlt das äusserst konservierte Basenfehlpaarungsreparatursystem (engl. 
mismatch repair, MMR), welches ein wichtiger Mechanismus zur Vermeidung von 
Mutationen ist. Es wird vermutet, dass andere DNA-Reparaturstrategien, wie Reparatur durch 
homologe Rekombination, Basenexzisionsreparatur (engl. base excision repair, BER) oder 
Nukleotidexzisionsreparatur (engl. nucleotide excision repair, NER) manche Funktionen des 
MMR übernehmen könnten. In dieser Arbeit wurde die Funktion des NER in Mykobakterien 
untersucht. Der bakterielle Nukleotidexzisionsreparaturweg besteht aus dem UvrABC 
Endonukleaseenzymkomplex und der Helikase UvrD. Die Exzinukleasekomponente uvrA 
bzw. uvrB sowie die Helikase uvrD von Mycobacterium tuberculosis und Mycobacterium 
smegmatis wurden durch gezielten Genaustausch inaktiviert. Zusätzlich wurden 
Doppelmutanten generiert, denen beide Komponenten fehlen.  
Die Charakterisierung der NER Mutanten zeigte, dass das mykobakterielle NER-System viele 
Arten von mutagenen DNA-Veränderungen reparieren kann und einen wichtigen 
Abwehrmechanismus gegen oxidative und nitrosative DNA-Schäden darstellt. In einem 
Genkonversionsassay wurde untersucht, ob die M. smegmatis NER-Mutanten verschiedene 
Basenfehlpaarungen erkennen und aussondern können. Verlust von uvrB und uvrD führte zu 
signifikant erhöhten Genkonversionsfrequenzen, sowie teilweise – abhängig von der 
untersuchten Basenfehlpaarung – zu einem synergistischen Effekt bei der uvrB / uvrD 
Doppelmutante. Unsere Ergebnisse zeigen, dass das NER- System und besonders die Helikase 
UvrD dazu beitragen, das Fehlen des MMR-Systems in Mykobakterien zu kompensieren. 
Ausserdem konnten wir in vitro und in vivo zeigen, dass die Helikase UvrD essentiell für die 
Persistenz von M. tuberculosis ist.  
Zusammenfassung 4
Neben der DNA-Reparatur sind weitere Mechanismen an der Gewährleistung der 
Genomintegrität beteiligt. Es wird angenommen, dass Chromosomenstrukturproteine 
wesentlich dazu beitragen, dass das Genom während der Persistenz stabilisiert wird und dass 
die Zellteilung während der Reaktivierung korrekt verläuft. SMC (structural maintenance of 
chromosomes) Proteine haben grundlegende Funktionen in vielen Aspekten der 
Chromosomenorganisation und Chromosomendynamik. Mycobacterium smegmatis und 
Mycobacterium tuberculosis smc Mutanten wurden durch gezielten Genaustausch generiert. 
Erstaunlicherweise prägten die smc Mutanten keinen ersichtlichen Phänotyp aus. Dieses 
Ergebnis steht im Gegensatz zu bisher beschriebenen smc Mutanten in anderen Organismen. 
Unsere Beobachtungen deuten darauf hin, dass die mykobakterielle Chromosomorganisation 
von beschriebenen Modellen abweicht.  
 
Die Ergebnisse dieser Arbeit lassen sich wie folgt zusammenfassen. Obwohl Mykobakterien 
das MMR-System fehlt, verfügen sie über effiziente Abwehrmechanismen zur Vermeidung 
von DNA-Schäden. Das NER-System hat eine bedeutende Funktion in der Vermeidung von 
Mutationen und die Helikase UvrD hat neben der Beteiligung im NER-System weitere 
Funktionen. Des Weiteren weisen unsere Beobachtungen auf aussergewöhnliche 
Mechanismen der Chromosomenorganisation und Chromosomenteilung in Mykobakterien 
hin. Die Resultate zeigen, dass die Mechanismen zur Erhaltung der Genomstabilität in 
Mykobakterien signifikant von denen in bisher beschriebenen Modellorganismen abweichen.  
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Abbreviations 
 
 
BER       base excision repair 
bp       basepair 
CFU       colony forming units 
kbp       Kilobasepairs 
kDa       Kilodalton 
KO       knockout 
NER       nucleotide excision repair 
NHEJ       nonhomologous end-joining 
MBC       minimal bactericidal concentration 
MDR-TB      multidrug –resistant M. tuberculosis 
MIC       minimal inhibitory concentration 
MMC       mitomycin C 
MMR       mismatch repair 
OD       optical density 
ORF       open reading frame 
RNI       reactive nitrogen intermediates 
ROI       reactive oxygen intermediates 
sco        single cross-over 
SMC       structural maintenance of chromosomes 
TB        tuberculosis 
TBH       tert-butylhydroperoxide 
UV-C       short wavelength UV light 
wt       wildtype 
XDR-TB      extensively drug-resistant M. tuberculosis 
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1 Introduction 
 
 
1.1  Mycobacterium tuberculosis and disease 
 
With more than eight million new cases each year, tuberculosis (TB) remains a global health 
problem. The World Health Organisation (WHO) estimates that approximately 1.6 million 
deaths per year are tuberculosis-related. More than 90 percent of TB cases and 98 percent of 
TB deaths occur in the developing world (data from “Tuberculosis facts- Handout 2007” 
published on www.who.int). TB is a chronic, contagious disease, which is caused by the 
members of the Mycobacterium tuberculosis complex. 
The Mycobacterium tuberculosis complex includes the closely related organisms 
M. tuberculosis, M. africanum, M. bovis, M. bovis BCG, M. caprae, M. pinnipedii, M. microti 
and M. canettii (Brosch et al., 2002). Despite their close genetic similarity, these organisms 
differ significantly with regard to epidemiology, pathogenicity, and host spectrum. 
M. tuberculosis is considered the principal cause of TB in humans. Most people infected with 
M. tuberculosis contain the initial infection and develop latent, asymptomatic TB. Following 
primary infection, M. tuberculosis can persist for decades within the human body and is able 
to cause active disease at a later date. It has been estimated that one-third of the world’s 
population, amounting to around 2 billion people, is latently infected (Dye et al., 2005).  
In spite of the fact that potent antitubercular drugs are available, the course of therapy requires 
a treatment period of at least six months and is rather complex in cases of drug resistant TB 
(Böttger, 2006; Furin, 2007; Shah et al., 2007). The long duration of treatment is thought to 
result from bacteria shifting into a non-replicating or dormant state in the host which renders 
the bacteria tolerant to antibiotic killing (Wayne and Hayes, 1996). HIV infection, which 
weakens the immune system and allows reactivation of latent TB infection, as well as the 
emergence of multidrug-resistant TB (MDR-TB), pose a serious threat to TB control (Böttger 
and Springer, 2008). Resistance to anti-TB drugs primarily arises due to poorly managed TB 
care. As a result of incorrect drug prescribing practices, poor quality drugs and patient non-
adherence, extensively drug-resistant (XDR) M. tuberculosis strains have evolved during the 
last years (Shah et al., 2007). As XDR M. tuberculosis strains are resistant to the most 
powerful first-line and second-line drugs, patients are left with treatment options that are less 
effective resulting in unfortunate treatment outcomes. The emergence of multidrug resistance 
in M. tuberculosis constitutes an alarming trend. Consistent with the genetic isolation of this 
organism, acquisition of novel transmissible genetic elements by horizontal gene transfer is 
extremely rare, if found at all (Fleischmann et al., 2002; Hirsh et al., 2004). In fact, all known 
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resistance mechanisms of M. tuberculosis are due to spontaneous mutations in chromosomal 
genes (Böttger, 1994; Finken et al., 1993; Meier et al., 1996; Ramaswamy and Musser, 1998). 
One key factor to pathogenesis is the ability of M. tuberculosis to persist albeit the host 
immune response. Following initial infection, the bacteria survive and replicate within 
macrophages, normally part of the host’s defence system (Kaufmann, 2001). The bacilli are 
exposed to changing host environments, e.g. nutritional deprivation, hypoxia, reactive 
nitrogen and oxygen species. It is assumed that the bacteria are exposed to nitric oxygen 
during latent infection, as inhibition of inducible nitric oxide synthase in mouse models of 
latency leads to reactivation of bacterial replication (Flynn et al., 1998). Nitric oxygen 
generates reactive species capable of damaging bacterial cell components. Reactive oxygen 
intermediates (ROI) and reactive nitrogen intermediates (RNI) can damage lipids, proteins 
and DNA (Chan et al., 1992).  
Elevated mutation rates can promote adaptation to fluctuating living conditions. Mutator 
strains are characterised by an increased spontaneous mutation rate due to defects in genes 
involved in DNA repair or error avoidance systems. While a mutator phenotype may be a 
driving force in adaptive evolution, intact DNA repair is essential during persistent infection. 
If not repaired, DNA damage in a haploid microorganism may cause extinction, either 
immediately, by blocking chromosome replication, or on a longer time scale, by accumulation 
of unfavourable mutations. Hence, the survival of species depends on a balance between 
genome stability and the requirement for mutation to allow adaptation to novel environmental 
conditions. In general, the selective advantage of a high mutation rate is transient and 
maintenance of genomic integrity is essential for long-term survival of the population 
(Warner and Mizrahi, 2006). Thus, it can be reasoned that DNA repair mechanisms play a 
crucial role in long-term survival of M. tuberculosis in the host.  
 
 
1.2
1.2.1 
  Role of DNA repair in genome stability 
 
Common principles in DNA repair 
DNA repair mechanisms are well conserved from bacteria to humans, due to their importance 
in maintaining genome integrity. All living organisms are equipped with DNA repair systems 
that can cope with a wide variety of DNA lesions. The proteins involved in DNA repair can 
be grouped into the following major functional categories: damage reversal, excision repair 
and repair of DNA double-strand breaks (Friedberg, 2005). 
Introduction  9
Damage reversal 
Direct repair systems reverse the mutagenic event. Repair by direct reversal mechanisms are 
extremely specific to the type of damage incurred (Mishina et al., 2006; Sancar, 2003). To 
circumvent the necessity of individual repair pathways for each of the numerous types of 
DNA alterations, cells are endowed with more general repair systems (Friedberg, 2005). 
 
Excision repair 
Multiple distinct mechanisms exist for excising damaged parts of the DNA, termed nucleotide 
excision repair (NER), base excision repair (BER) and mismatch repair (MMR). The principle 
of all three mechanisms involves splicing out the damaged region and inserting new bases to 
fill the gap (Friedberg, 2005). 
 
The nucleotide excision repair system displays a broad substrate specifity: NER recognises all 
lesions that generate bulky distortions in the conformation of the DNA double helix, e.g. UV-
induced photolesions (e.g. pyrimidine dimers), intrastrand-crosslinks and large chemical 
adducts in the DNA formed through exposure to genotoxic agents (Batty and Wood, 2000). 
Eukaryotes and prokaryotes share the basic mechanism although the proteins involved are 
different (Batty and Wood, 2000). The process of nucleotide excision repair in bacteria is 
mediated by the UvrABC endonuclease enzyme complex and a helicase named UvrD. The 
process of NER begins with the binding of a complex of an UvrA dimer and one UvrB protein 
to the DNA, scanning for damage in an ATP-dependent manner. On encountering damage, 
the UvrA dimer dissociates and UvrC is recruited. The UvrBC complex holds an excinuclease 
activity and cuts the DNA several bases upstream and downstream of the damage. After 
replacing UvrC, UvrD removes the excised DNA strand with the altered base. Subsequently, 
the resulting gap is filled in by polymerase and the nick is sealed by ligase I (Sancar, 1996). 
A common type of DNA damage is base damage, which is usually corrected by BER, 
involving the action of DNA-glycosylases. These enzymes specifically recognise damaged 
bases and cleave the glycosidic bond between the damaged base and the deoxyribose 
backbone. Removal of the base by DNA-glycosylases results in apurinic or apyrimidinic (AP) 
sites. The AP-sites are further processed by AP-endonucleases, which excise the remaining 
sugar backbone. Subsequently, an undamaged nucleotide is inserted into the resulting gap by 
DNA polymerase I and sealed through the action of a ligase (David et al., 2007; Huffman et 
al., 2005). 
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MMR removes incorrect bases incorporated during DNA replication (Iyer et al., 2006). In 
prokaryotes, this repair mechanism is based on the activity of the MMR proteins MutS, MutL, 
MutH and of the helicase UvrD. The repair process is initiated by binding of MutS to 
mismatched base pairs with subsequent recruitment of MutL. This complex activates MutH, 
which binds to the DNA and cleaves the strand 5’ to a GATC site. Subsequently, the segment 
from the cleavage site to the mismatch is removed by UvrD. The gap is filled by DNA 
polymerase I and sealed by DNA ligase (Kunkel and Erie, 2005). Correction of the replication 
error requires that the MMR enzymes specifically recognise the newly synthesised strand. In 
E. coli, this is achieved by methylation of all adenines that occur within GATC sequences 
(Schlagman et al., 1986). Immediately after DNA replication, the newly synthesised strand is 
not methylated yet and could thus be specifically recognised by the MMR machinery. MMR 
proteins were first identified by genetic analyses of Escherichia coli mutator mutants. 
Inactivation of mutS or mutL genes increases spontaneous mutation by a factor of 50-100, and 
is the most common cause of an increased spontaneous mutation rate in E. coli (LeClerc et al., 
1996).  
 
Repair of DNA double-strand breaks 
In addition to the various modes of base damage that can arise, cells may experience breakage 
of one or both chains of the DNA duplex (Friedberg, 2005). The main mechanism for 
repairing double-strand breaks is homologous recombination repair. This repair pathway takes 
advantage of the fact that each molecule has an identical copy present in the cell following 
replication. Damage to one DNA molecule can therefore be repaired using its identical copy 
as a template without loss of any genetic information (Ishino et al., 2006; Wyman et al., 
2004). An alternative mechanism, called nonhomologous end-joining (NHEJ) joins broken 
chromosome ends independently of homologous sequences at the price of error incorporation 
(Burma et al., 2006). 
 
SOS response 
Most bacteria respond to DNA damage by inducing a multitude of genes involved in repair 
and control of cell division. This so-called SOS-response is regulated by the global repressor 
protein LexA, and depends on the action of a functional recA gene product (Cox et al., 2000). 
In a recA mutant strain, genes regulated by LexA are no longer DNA damage inducible 
(Schlacher et al., 2006).  
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DNA damage tolerance 
Besides the DNA damage repair strategies detailed above, cells have evolved a mechanism to 
tolerate damage. Among the genes that are induced during the SOS response are low-fidelity 
or “mutator” polymerases, which are able to bypass DNA lesions. However, the benefit of 
overcoming the replication block is contrasted by the introduction of mutations in the newly 
synthesised sequence (Goodman, 2002; Nohmi, 2006). 
 
 
1.2.2 DNA repair in mycobacteria  
In silico genome analyses of mycobacterial genomes, i.e. M. tuberculosis (Cole et al., 1998; 
Mizrahi and Andersen, 1998), M. leprae (Cole et al., 2001), M. bovis (Garnier et al., 2003), 
M. avium, M. paratuberculosis and M. smegmatis (The Institute for Genome Research; 
http://www.tigr.org) indicate the presence of genes coding for enzymes involved in damage 
reversal, NER, BER, recombinational repair, NHEJ and SOS repair. However, mycobacteria 
are devoid of the otherwise highly conserved MMR proteins MutS and MutL (Mizrahi and 
Andersen, 1998).  
 
Biological evidence for the lack of a classical mismatch repair function in mycobacteria was 
provided by testing mononucleotide repeat instability in M. smegmatis. M. smegmatis 
generated frameshifts with a much higher rate than general mutations, indicating the absence 
of a replication-associated mononucleotide repeat stabilizing function. However, despite the 
decisive role of MMR in ensuring accuracy of DNA replication and recombination, 
mycobacteria do not show the high mutation rates typical for mutants lacking MMR (Springer 
et al., 2004). In addition, M. tuberculosis is able to resist extensive periods of exposure to ROI 
and RNI during persistent infection, which amongst other targets damage DNA (Zahrt and 
Deretic, 2002). Taken together, these observations indicate that mycobacteria possess efficient 
mechanisms to maintain genome integrity. Most likely, other DNA repair pathways have to 
compensate for MMR deficiency. 
 
The most frequent types of DNA damage resulting from exposure to RNI and ROI are thought 
to be alterations in DNA bases and deoxyribose damages (Demple and Harrison, 1994), which 
are subject to repair by excision repair pathways like BER and NER. However, the role of 
excision repair pathways in the pathogenesis and persistence of mycobacteria is not yet fully 
understood. Little progress has been made so far in understanding the role of BER in 
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mycobacteria. Using a strategy based on high-throughput screening of a transposon library, 
several BER enzymes have been identified to be essential for growth in vivo, implying a role 
in virulence (Sassetti et al., 2003; Sassetti and Rubin, 2003). Furthermore, in silico analyses 
suggest that mycobacteria possess at least ten different DNA glycosylases, although the in 
vivo role of most of these homologues in BER remains uncertain (Mizrahi and Andersen, 
1998). Research on the uracil DNA glycosylase (Ung) of M. smegmatis suggests an important 
role in mutation prevention and tolerance to nitrosative stress. Survival of the M. smegmatis 
ung mutant in a macrophage infection model was significantly impaired compared to the 
wildtype, alluding to a role of BER in mycobacterial pathogenicity (Venkatesh et al., 2003). 
Involvement of NER in resistance of M. tuberculosis against nitrosative and oxidative stress 
has been reasoned by a study that employed a transposon mutagenesis strategy as well. In a 
screen for mutants that became hypersusceptible to acidified nitrite, transposon mutations in 
the uvrB gene of M. tuberculosis have been identified. Further analyses in a mouse model of 
infection revealed a reduced capacity of these mutants to resist ROI and RNI in vivo, 
indicating a role of NER in M. tuberculosis persistence (Darwin and Nathan, 2005).  
 
Intracellular M. tuberculosis is exposed to a variety of DNA damaging agents and experiences 
an accumulation of mutations and double-strand breaks, in particular during the latent phase. 
Repair of double-strand breaks is an essential process in maintaining genome integrity and is 
a prerequisite for resuscitation from dormancy (Stephanou et al., 2007). DNA double-strand 
breaks can be repaired either by homologous recombination or by NHEJ. The homologous 
recombination repair pathway is not required for survival of M. tuberculosis in a mouse model 
of acute infection (Sander et al., 2001a), which led to the assumption that NHEJ might 
provide a possible alternative for repair of double-strand breaks during persistence. Proteins 
involved in that pathway have been characterised recently in M. tuberculosis. These in vitro 
analyses demonstrated a functional role of mycobacterial Ku, Ligase D and Ligase C in the 
error-prone repair of double-strand breaks (Gong et al., 2005; Pitcher et al., 2007). 
Interestingly, recent investigations revealed that NHEJ of M. smegmatis is specifically 
required for the repair of DNA double-strand breaks in late stationary phase (Stephanou et al., 
2007). However, the in vivo role of the NHEJ repair pathway in pathogenesis and persistence 
of M. tuberculosis remains yet to be elucidated. 
 
Taken together, these findings indicate that mycobacteria are endowed with a variety of repair 
pathways that might functionally substitute for each other. The possible redundancy of repair 
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mechanisms is corroborated by studies on the mycobacterial SOS repair system. Analysis of 
the regulation of recA gene expression revealed that two mechanisms exist for the induction 
of gene expression following DNA damage in M. tuberculosis. Whereas one of these depends 
on RecA and LexA in the known manner of the classical SOS response, the other mechanism 
is independent of both of these proteins and induction occurs in the absence of RecA (Davis et 
al., 2002). Interestingly, most of the genes with known or predicted functions in DNA repair 
do not depend on RecA function for induction (Rand et al., 2003). These observations point 
towards the existence of an alternative gene regulation mechanism in response to DNA 
damage in M. tuberculosis. 
 
In summary, the mycobacterial DNA repair system differs in several aspects from that of 
described model species. Further investigations on the mechanisms that maintain genome 
integrity in mycobacteria might provide fundamental new insights, not the least with respect 
to dormancy and the development of drugs for the treatment of the latent state.  
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1.2.3 Nucleoid structure and maintenance of genome integrity  
A common principle to provide and maintain chromosome structure comprises condensation 
of the DNA into a structure called the nucleoid. Diverse DNA binding proteins are associated 
with the nucleoid and take part in chromosome organisation to assist in diverse and complex 
processes such as replication, recombination, repair, modification and DNA transcription. 
Among these proteins are the SMC (structural maintenance of chromosomes) proteins that are 
conserved from prokaryotes to eukaryotes (Cobbe and Heck, 2000; Cobbe and Heck, 2004; 
Soppa, 2001). The SMC family proteins are large proteins in the range between 110-170 kDa 
and share common principles in domain organisation: globular N- and C-terminal domains 
which are connected by two long coiled coil domains, separated by a globular hinge domain of 
approximately 150 amino acids in length (Hirano, 2005).  
Eukaryotes possess at least six distinct SMCs that function in chromosome condensation, 
sister chromatid cohesion, DNA repair and dosage compensation (Jessberger, 2002; Losada 
and Hirano, 2005). Genetic and biochemical evidence suggests that eukaryotic SMCs are also 
involved in the repair of double-strand breaks (Lehmann, 2005).  
In contrast to the preserved multiple SMC proteins in eukaryotes, most bacteria possess only a 
single SMC (Soppa, 2001). SMC proteins from Bacillus subtilis or Caulobacter crescentus 
appear to have functions that resemble those of eukaryotic SMCs. The proteins are not 
essential but null mutations of SMC result in anucleate cell (“titan cells”) and aberrant 
nucleoid formation, i.e. decondensed chromosomes (Britton et al., 1998; Jensen and Shapiro, 
1999; Volkov et al., 2003). Furthermore, deletion of SMC leads to increased susceptibility to 
DNA damaging agents, indicating a role of prokaryotic SMCs in DNA repair (Dervyn et al., 
2004).  
Little is known about mycobacterial SMCs. In silico analyses revealed that all mycobacterial 
genomes that have been sequenced so far harbour a single SMC homologue. It is even present 
in M. leprae, a bacterium that has lost various gene functions during reductive genomic 
evolution (Cole et al., 2001).  
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2  Aim of this study 
 
 
2.1 Role of NER in mycobacteria 
 
As part of its intracellular lifestyle, M. tuberculosis encounters various adverse conditions, 
which demand efficient mechanisms to maintain genome integrity. Mycobacteria are devoid 
of the highly conserved MMR system, which is fundamental to prevent mutations during 
replication. The finding that mycobacteria exhibit a general mutation rate that is comparable 
to that of MMR proficient species suggests that mycobacteria use alternative DNA repair 
systems to compensate for the lack of MMR. Towards this aim, we investigated the genetics 
and function of the mycobacterial NER pathway. NER knockout mutants were constructed in 
M. smegmatis using allelic replacement techniques. M. smegmatis, like M. tuberculosis, lacks 
the MutSLH based mismatch repair system (www.tigr.org). M. smegmatis has a full set of 
homologues for the UvrABCD (NER) pathway; strains containing deletions in the 
excinuclease component uvrB and in the helicase component uvrD were examined. To 
evaluate the significance of the results obtained in M. smegmatis, i.e. to assess whether NER 
is also important in the persistence of the relevant pathogen in vivo, strains deficient in the 
NER excinuclease part uvrA and in the NER helicase uvrD were constructed in M. 
tuberculosis and studied in in vivo infection experiments.  
 
 
2.2 Role of DNA repair in M. tuberculosis pathogenesis 
 
To gain insight into the role of DNA repair mechanisms in the pathogenesis of 
M. tuberculosis infection, we set out to generate M. tuberculosis strains with multiple 
deficiencies in DNA repair pathways. We intended to construct these mutants successively, 
starting with single mutants, followed by double and triple mutants.  
In particular, we aimed to construct strains lacking NER and recombinational repair. To 
inactivate the recombinational repair pathway, the gene encoding for RecA was targeted for 
deletion in NER mutant strains using allelic replacement techniques. 
A second gene with significant homology to uvrD, annotated as uvrD2, is present in the        
M. tuberculosis genome. To assess the degree of functional redundancy of these two genes, 
we set out to construct mutants lacking uvrD and its homologue uvrD2. 
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2.3 Role of SMC in mycobacteria 
 
Little is known about chromosome stability, organisation, and partitioning in mycobacteria. 
Mycobacterium tuberculosis displays the ability to persist for decades in its host during latent 
infection. It is an issue of high interest to investigate how the bacterium manages to stabilise 
its genome during persistence and how it accomplishes proper cell division during 
reactivation. As detailed in section 1.3.3, SMC plays a major role in maintaining chromosome 
stability in various organisms and it was also found to be involved in the repair of DNA 
double-strand breaks. Functional SMC may therefore be crucial for maintenance of genome 
integrity during mycobacterial dormancy and may have a decisive role during reactivation. To 
investigate the role of SMC in mycobacteria, we generated and analysed M. smegmatis and M. 
tuberculosis mutants deficient in SMC. 
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3 Materials and Methods 
 
 
All chemicals were purchased from Sigma-Aldrich or Fluka if not specially indicated. 
Molecular methods were performed according to standard protocols (Sambrook, 1989). 
 
 
 
3.1  Bacterial strains, growth conditions and conservation 
 
E. coli strain XL1 blue (Stratagene) was used for cloning and propagation of plasmids. 
Bacterial cultures were grown in Luria Bertani (LB) medium at 37°C for 14-20 h.  
 
Cultures of M. smegmatis  SMR5 (Sander et al., 1995) and M. smegmatis SMR5 rrnB (Sander 
et al., 1996), both derivatives of M. smegmatis mc2 155, were grown either in LB-Tween 80 
or in 7H9 medium at 37°C for 2-3 days. M. smegmatis SMR5 rrnB harbours only a single 
functional rRNA operon which is a prerequisite for the assays applied in this study.  
 
M. tuberculosis H37Rv #1424, a derivative of M. tuberculosis H37Rv (Raynaud et al., 2002), 
was grown in OADC enriched Middlebrook 7H9 medium at 37°C for 3 weeks in settling 
cultures.  
 
The above-mentioned parental strains of M. tuberculosis and M. smegmatis carry a rpsL 
mutation conferring streptomycin resistance. 
 
When appropriate, antibiotics were added at the following concentrations: 
 
Ampicillin   100 µg/ml medium 
Hygromycin  100 µg/ml medium 
Kanamycin  50 µg/ml medium  
Gentamicin  5 µg/ml medium 
Streptomycin  100 µg/ml medium 
Apramycin  20 µg/ml medium 
Clarithromycin 50 µg/ml medium 
 
 
E. coli were frozen and stored at –80°C in LB medium containing 10% glycerol. 
Mycobacteria were stored at –80°C using freezing medium for mycobacteria. 
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3.2 Growth media 
 
Luria-Bertani Broth (LB)   1% (w/v) BactoTM Tryptone, Difco  
      0.5% (w/v) BactoTM Yeast Extract, Difco  
      1% (w/v) sodium chloride 
LB-Tween     LB + 0.05% (v/v)Tween  
LB-Agar  LB + 1.5% (w/v) Bacto-agar, BBL 
Middlebrook 7H9    0.47 % (w/v) Middlebrook 7H9 broth, Difco
      0.2% (v/v) glycerol, Merck 
      0.05% (v/v) Tween  
Middlebrook 7H9 OADC enriched  0.47 % (w/v) Middlebrook 7H9 broth, Difco
      0.2% (v/v) glycerol, Merck 
      0.05% (v/v) Tween  
      Middlebrook OADC (oleic acid albumin dextrose)  
      enrichment, Difco  
Middlebrook 7H10-Agar Middlebrook 7H10 agar, Difco 
 0.4% (v/v) glycerol, Merck 
Middlebrook 7H10-Agar OADC enriched Middlebrook 7H10 agar, Difco 
 0.4% (v/v) glycerol, Merck 
      Middlebrook OADC (oleic acid albumin dextrose) 
      enrichment, Difco  
Mueller-Hinton agar / 5% sheep blood 2.0 g/l meat infusion            
17.5 g/l casein hydrolysate, 1.5 g/l starch, 
 65 ml sheep blood, 14.0 g/l agar-agar  
Freezing medium for mycobacteria   2.6 g Middlebrook 7H9 broth, (Difco),  
      113 g saccharose, 2.22 ml glycerol, 
      dist. water (1000 ml) 
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3.3 
3.3.1 
3.3.2 
3.3.3 
Buffers and solutions 
 
General 
EB-buffer    10 mM Tris/HCl, pH 8.5 
DNA loading buffer (6x)  15 % (w/v) Ficoll Type 400 
     0.25 % (w/v) Bromphenolblue/ Xylenecyanol 
PBS (phosphate buffer saline) 220 mM NaCl, 150 mM Na2HPO4  
     130 mM KH2PO4, pH 7.4 
Physiological NaCl-solution  0.9 g NaCl, dist. water (1000 ml) 
SDS     10 % SDS (w/v) 
TAE-buffer (50 x)    2 M Tris base, pH 8, 0.1 M EDTA 
TE-buffer     10 mM Tris/HCl, pH 7.5, 1 mM EDTA  
Southern blot  
HCl solution   0.25 M HCl 
Denaturation solution  1.5 M NaCl, 0.5 M NaOH 
Neutralization solution 0.5 M Tris Base, 3 M NaCl, pH 7.5 
20 x SSC   3 M NaCl, 0.3 M sodium citrate, pH 7.0 
Wash buffer   0.1 M maleic acid, 0.15 M NaCl, 0.3% (v/v) Tween20 
Maleic acid buffer  0.1 M maleic acid, 0.15 M NaCl, pH 7.5 
Detection buffer  0.1 M NaCl, 2 M Tris-base, pH 9.5 
Hybridization solution 0.05 M SDS, 50% formamide (v/v), 25% 20 x SSC (v/v),  
    5% 1 M NaPO4 pH 7.0 (v/v), 0.003 M N-lauroylsarcosine, 
    20% (v/v) 10x blocking solution 
Blocking solution  10% blocking solution (10 x), 90% maleic acid buffer 
Stripping buffer  0.2 M NaOH, 0.1% (v/v) SDS 
Assays: Stock solutions 
Rifampicin: 20 mg/ml in dimethylsulfoxide (DMSO)  
Mitomycin C: 0.2 mg/ml in water 
tert-Butyl-hydroperoxide: 70 % solution in water  
Sodium nitrite: 3 M solution in water 
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3.4 Primers and plasmids used in this study 
 
Table 1: Primers (f = forward primers, r = reverse primers) 
 Restriction site  Gene specific  Tm Function 
 
1f GGAATTCCATATG NdeI
 
GTGAGGACGCCTACGAC 
 
56°C  
1r GGAAGATCT
BglII
GGTGAACGTGATGGCCAG 58°C  
 
Amplification of upstream 
region of  
M. smegmatis uvrD1 
2f GGAAGATCT
BglII
GCAGGAACTCATCGACTGGCG 68°C  
2r TGCATGCAT
NsiI
GATCGCGTCGGGCACCTTC 68°C  
Amplification of downstream 
region of  
M. smegmatis uvrD1 
3f GGAATTCCATATG
NdeI
GGCCGAGTACGGCCAGTC 58°C  
3r GGAAGATCT
BglII
GCGCCATCACGAGCGTG 58°C  
Amplification of upstream 
region of  
M. smegmatis uvrB 
4f GGAAGATCT
BglII
GAGTCGGTCGAGATCGGTGG 66°C  
4r TGCATGCAT
NsiI
CGTCATGTGCGCCAGCCGC 66°C  
Amplification of downstream 
region of  
M. smegmatis uvrB 
5f GGAATTCCATATG
NdeI
CGACACCGTCCTGCCG 56°C 
5r GGAAGATCT
BglII
CGTCTCGGCCTGATTGG 56°C 
Amplification of upstream 
region of  
M. smegmatis smc 
6f GGAAGATCT
BglII
CACCGCGCTCAACAACC 56°C 
6r TGCATGCAT
NsiI
GGCACCTTCTGTCACCG 56°C 
Amplification of downstream 
region of  
M. smegmatis smc 
7f GGAATTCCATATG
NdeI
GAACTGGCATGACAACGCACG 66°C  
7r GGAAGATCT
BglII
CACGGCGAACTTGCTGTCCAG 66°C  
Amplification of upstream 
region of  
M. tuberculosis uvrD2 
8f GGAAGATCT
BglII
GACGTGTGCAGCCGACG 58°C  
8r TGCATGCAT
NsiI
CCAGGTCGAGGTCTTCC 56°C  
Amplification of downstream 
region of  
M. tuberculosis uvrD2 
9f GGAATTCCATATG 
NdeI
CCCTCAAGTCGGGCACCAC 64°C 
9r CTAGCTAGC
NheI
CCATCGTGTCGAGTTTGCGCA 66°C 
Amplification of upstream 
region of  
M. tuberculosis smc 
10f GCTAGC
NheI
GACGAGGTGAACACGCTGAG 64°C 
10r CCATGG
NcoI
CAGCGCAGCGATGACGACC 64°C 
Amplification of downstream 
region of  
M. tuberculosis smc 
 
 
 
 
 
 
 
 
Materials and Methods 21
Table 2: Sequencing Primers 
T7     5’-TAA TAC GAC TCA CTA TAG GG-3’  
SP6      5’-ATT TAG GTG ACA CTA TAG-3’  
pMCS5 MCS SmaI Æ NdeI  5’-TAC GTA GGT ACC GAG CTC-3’  
5’ pMCS5-122    5’–GTT TTC CCA GTC ACG ACG-3’  
Hyg  # 692R:    5’-GTT CTCGGT GGT G-3’   
Hyg # 834F:    5’-CAC GGG ACC AAC ATC TTC G-3’  
5’ rpsL out    5’-TGT CGT CCA TGA CGC CGG TC-3’  
3’ rpsL out     5’-GCA GGG TGT CAA GAA CCG-3’ 
 
 
 
Table 3: Plasmids 
Parental vectors for cloning 
 
pGEM®-T Easy 
pBluescript II KS (-) 
pBluescript-rpsL 
pUC4K 
pML10 
ptrpA1-rpsL 
pMCS5 
pMCS5-rpsL 
pMCS5-rpsL-hyg 
pMV 361 
 
 
(Promega)  
(Stratagene)  
(Sander et al., 2001a) 
(Pharmacia)  
(Labes et al., 1990)  
(Sander et al., 2001b) 
(Stratagene) 
(Rezwan, 2006) 
(this study)  
(Stover et al., 1991) 
Suicide vectors for generation of knockout mutants 
 
puvrD-rpsL-2-II 
puvrA::aph-rpsL 
precA-hyg 
pMCS5-rpsL-hyg-uvrD2 
pMCS5-rpsL-smc-hyg 
pMCS5-rpsL-hyg-uvrD (sm) 
pMCS5-rpsL-hyg-uvrB (sm) 
pMCS5-rpsL- smc (sm)-hyg 
 
 
 
 
Disruption of M. tuberculosis uvrD 
Disruption of M. tuberculosis uvrA 
Disruption of M. tuberculosis recA 
Disruption of M. tuberculosis uvrD2 
Disruption of M. tuberculosis smc 
Disruption of M. smegmatis uvrD 
Disruption of M. smegmatis uvrB 
Disruption of M. smegmatis smc 
 
(this study)  
(this study) 
(Sander et al., 2001a) 
(this study)  
(this study)  
(this study)  
(this study)  
(this study)  
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Integrative vectors for complementation of knockout mutants 
 
pMV361-uvrD                                      Complementation of M. tuberculosis uvrD 
 
 
(this study) 
 
 
Recombination substrates containing a rrnA fragment 
All vectors contain a mutated rrnA fragment which confers antibiotic resistance (denoted in parentheses) upon 
recombination with the chromosomal wildtype rrnA gene. Numbers indicate the rrnA position of the mutated 
nucleotide. 
 
pMV361ΔKan-Gm-rRNA A 2059 C (Clarithromycin) 
pMV361ΔKan-Gm-rRNA A 2059 G (Clarithromycin) 
pMV361ΔKan-Gm-rRNA A 2058 C (Clarithromycin) 
pMV361ΔKan-Gm-rRNA A 2058 G (Clarithromycin) 
pMV361ΔKan-Gm-rRNA G 1491 A (Apramycin) 
pMV361ΔKan-Gm-rRNA G 1491 C (Apramycin) 
pMV361ΔKan-Gm-rRNA G 1491 T (Apramycin) 
 
(Pfister et al., 2004) 
(Pfister et al., 2003) 
(Pfister et al., 2004) 
(Pfister et al., 2004) 
(Pfister et al., 2005) 
(Pfister et al., 2005) 
(Pfister et al., 2005) 
 
 
 
 
 
3.5 
3.5.1 
Preparation of competent bacteria and transformation 
 
Escherichia coli  
An overnight culture of E. coli strain XL-1 blue was inoculated into one litre of LB medium 
and cultivated at 37°C until OD600 reached 0.5-0.6. To prepare electrocompetent bacteria, 
cells were collected by centrifugation at 5000 x g at 4°C for 15 min and washed twice with an 
equal volume ice-chilled 1 mM HEPES (pH 7.0). The washing procedure was repeated twice 
with an equal volume of 10% glycerol. Finally, bacteria were resuspended in 5-10 ml of 10% 
glycerol. The suspension was divided into 40 µl aliquots, frozen in liquid nitrogen and stored 
at –80°C until use.  
For electroporation, 40 µl of competent bacteria were mixed with 2 µl of precipitated ligation 
reaction or 0.1 µg of supercoiled plasmid DNA (transformation control), respectively, and 
kept on ice for 5 min. Electroporation was performed in 0.1 cm cuvettes with a single pulse 
[1.8 kV, 2 µF, 200 Ω (Gene Pulser XcellTM, BioRad)]. Bacteria were immediately 
resuspended in 1 ml of LB medium and incubated at 37°C for 1 h. Transformants were 
selected by plating 100 µl of electroporated bacteria on LB agar plates containing an 
appropriate antibiotic. Plates were incubated at 37°C for 14-20 h. 
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3.5.2 
3.5.3 
Mycobacterium smegmatis 
M. smegmatis strains were cultivated in LB-Tween medium. When an OD600 of 0.6-0.8 was 
achieved, bacteria were incubated on ice for 30 minutes. Subsequently, the bacteria were 
collected by centrifugation at 5000 x g at 4°C for 15 min, washed several times with ice-
chilled 10% glycerol and finally resuspended in 5 ml glycerol. The suspension was divided 
into 410 µl aliquots, frozen in liquid nitrogen and stored at -80°C until use.  
For electroporation, competent bacteria were thawed on ice and washed once with ice-chilled 
10% glycerol. Subsequently, 100 µl competent bacteria were mixed with 1 µg of plasmid 
DNA and placed on ice for 10 min. Electroporation was performed in 0.4 cm cuvettes with a 
single pulse [2.5 kV, 25 µF, 1000 Ω (Gene Pulser XcellTM, BioRad)]. Bacteria were 
immediately resuspended in 1 ml of LB-Tween 80 medium and incubated at 37°C for 3 h. 
Electroporated bacteria were selected by plating 100 µl on LB agar plates containing an 
appropriate antibiotic. Plates were incubated at 37°C for 3-4 days. 
 
Mycobacterium tuberculosis 
M. tuberculosis strains were cultivated in Middlebrook 7H9 medium enriched with OADC. 
When an OD600 of 0.7-1.0 was achieved, glycine (2 M) was added (final concentration 1.5%) 
to increase transformation efficiency. After incubation for additional 20-24 h, the bacteria 
were harvested by centrifugation, washed several times with 10% glycerol, and bacteria were 
finally resuspended in a volume of 5 ml glycerol. For electroporation, 400 µl of competent 
cells were mixed with 1 µg of supercoiled plasmid DNA and electroporated (Gene pulser II, 
Bio-Rad) with following settings: 2.5 kV, 1000 Ω, 25 µF. After electroporation, cells were 
resuspended in 4 ml of 7H9-OADC and incubated for 24 h at 37°C. Following incubation, 
appropriate dilutions were plated on selective agar. Plates were incubated at 37°C for 3-6 
weeks. 
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3.6 
3.7 
3.8 
DNA manipulations and isolation of plasmids 
 
Standard techniques were used for DNA manipulation. The restriction endonucleases and 
DNA modifying enzymes were purchased from MBI Fermentas, Roche and Amersham. 
PCR was performed in a DNA thermal cycler (Tpersonal, Biometra) with triple master PCR 
system (Eppendorf) or GC rich system (Roche) according to the manufacturers’ protocols.  
All initial cloning procedures were performed with E. coli XL1-Blue. Plasmids were prepared 
with a NucleoSpin®Plasmid preparation kit (Macherey-Nagel) or PureYieldTM Plasmid 
Midiprep system (Promega) according to the manufacturers’ recommendations. Plasmid 
DNA was dissolved in water in concentrations of 500 to 1,000 ng/µl. 
 
 
DNA sequencing 
 
Plasmid DNA was extracted as described in section 3.6. The ABI Dye Terminator Cycle 
Sequencing Kit was used for sequencing on an ABI Prism 310 Genetic Analyzer (Applied 
Biosystems) following the supplier’s instruction. Sequence analyses were performed using 
sequence analysis software ABI Prism 310 collection, Sequencing Analysis Version 3.4.1. 
 
 
Isolation of genomic DNA 
 
Bacteria were grown for 3-5 days (M. smegmatis) or 3-4 weeks (M. tuberculosis). Bacteria 
were resuspended in 340 µl TE buffer and heat inactivated at 80°C for 20 min. After cooling 
down to room temperature, 2 µl 20 % Tween 80 and 10 µl lysozyme (80 mg/ml, Roche) were 
added, followed by incubation at 37°C / 300 rpm for 2 hours. After addition of 20 µl 20 % 
SDS and 20 µl proteinase K (2 mg/ml, Roche), samples were incubated at 50°C for 1 hour. 
Phenol / chloroform / isoamylalcohol extraction was performed by adding 400 µl of a 
(25/24/1) mixture with subsequent centrifugation at 16,000 g at 4°C for 20 min and transfer of 
the supernatant into a 1.5 ml tube. 8 µl 5 M NaCl and 2.5 volumes (1 ml) of ethanol were 
added and the solution was incubated at -20°C overnight. After centrifugation of the samples 
at 13,000 rpm at 4°C for 20 min, the pellet was washed twice with 70 % ethanol, dried under 
vacuum and resuspended in 100 µl EB buffer. 
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3.9 
3.10 
 Southern blot 
 
For Southern blot analyses, 200 ng of genomic DNA was digested with appropriate restriction 
enzymes, separated by agarose gel electrophoresis, and treated according to standard 
protocols. DNA was transferred to a positively charged nylon membrane (Roche) by vacuum 
blotting using a VacuBlot System (Biometra). Subsequently, the DNA was cross-linked to the 
membrane by UV- irradiation (UV–Stratalinker, Stratagene). DNA was hybridised to a 
digoxigenin (DIG)-labelled probe, washed under stringent conditions, and detected with an 
anti-digoxigenin antibody coupled with horseradish peroxidase (Roche). 
 
Labelling of probes 
Templates were excised from the corresponding vectors with appropriate restriction nucleases 
that create fragments with a size of 200-1000 bp. Nucleic acid probes were generated by 
labelling with digoxigenin (DIG) according to the manufacturer’s recommendation.  
 
 
  Gene disruption in M. tuberculosis and M. smegmatis 
 
To generate M. tuberculosis and M. smegmatis knockout mutants, allelic replacement 
techniques (deletion mutagenesis) were applied using a combination of a suicidal vector and 
counterselection with streptomycin (Sander et al 1995). Resistance to streptomycin in 
mycobacteria involves mutation within the rpsL gene coding for the ribosomal protein S12 
(Finken et al., 1993). Sensitivity to streptomycin is dominant over resistance in a merodiploid 
strain carrying a wildtype allele and a mutated allele (Kenney and Churchward, 1994; 
Lederberg, 1951). A suicidal vector in which a wildtype rpsL gene is cloned in proximity to a 
target gene (mutagenized by deletion of parts of the open reading frame) was used. In case of 
unmarked deletion mutagenesis, the deletion allele was flanked by a hyg cassette coding for 
resistance to hygromycin. In case of marked deletion mutagenesis, the respective resistance 
cassette was cloned into the deletion allele. The gene replacement vector was transformed into 
a streptomycin-resistant derivative of M. smegmatis or M. tuberculosis, with a mutated rpsL. 
The first selection for maintenance of cloned sequences was conferred by the positive 
selectable marker (e.g. the resistance cassette). Transformants were purified by streaking on 
selective agar containing the respective antibiotic. Individual clones were investigated by 
PCR and Southern blot analysis for integration by homologous recombination (single cross-
over). Single cross-over transformants were grown up in liquid broth and subsequently 
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subjected to a second selection step. For counterselection streptomycin was used to select 
against maintenance of plasmid sequences which contain the gene encoding the streptomycin-
sensitive allele of the rpsL gene (Figure 1). Putative knockout mutants which have undergone 
the counterselection procedure were colony purified and investigated by PCR and Southern 
blot analysis for allelic replacement recombinants. 
 
wt
suicide vector
kanR
CSM
wtkanR CSM
First crossing over
(intermolecular)
A
wtkanR CSM kanR
kanR
CSM
wt
B Second crossing over (intramolecular)  
Figure 1: Targeted allelic replacement strategy 
Shown is the strategy for marked deletion mutagenesis making use of a kanamycin resistance cassette (A) First 
crossing over. The suicide vector carries the counterselectable marker (CSM) rpsL and the mutated gene 
interrupted by a positive selectable marker (kanR); wt = wildtype target gene of the recipient. (B) Second 
crossing over leading to inactivation of the target gene.   
 
Cloning strategy for generation of knockout vectors 
Using genomic DNA, 1-1.5 kbp fragments upstream (5’) and downstream (3’) of the 
predicted open reading frame were amplified. The primers were constructed to contain 
restriction sites (Table 1). The PCR fragments were subcloned into pGEM®-T Easy Vector 
and the accuracy of the PCR product was controlled by sequencing with primers T7 and SP6. 
Subsequently, the PCR fragments were cloned into the suicide vector pMCS5-rpsL-hyg for 
unmarked knockouts (representative scheme see Figure 2), or into pMCS5-rpsL for marked 
knockouts.  
 
The resulting knockout vectors were controlled by sequencing. The mentioned cloning 
protocol was applied to the construction of all knockout vectors if not otherwise indicated.  
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Generation of M. smegmatis mutants 
 
Disruption of M smegmatis uvrD (unmarked) 
uvrD open reading frame: 562 5153 – 562 2802 (2352 bp) 
Cloned 5’ flanking region: 562 6132 – 562 4935 (1198 bp), amplified with primers 1f and 1r 
Cloned 3’ flanking region: 562 3114 – 562 1904 (1210 bp), amplified with primers 2f and 2r 
Deleted region: 562 4934 – 562 3115 (1821 bp) 
The suicide vector pMCS5-rpsL-hyg- uvrD (sm) was constructed according to the scheme 
shown in Figure 2 a. 
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Figure 2: Cloning of knockout vectors for the generation of unmarked mutants 
(A) Knockout vector for M. smegmatis uvrD (B) Knockout vector for M. smegmatis uvrB 
Using genomic DNA, 1-1.5 kbp fragments upstream (5’) and downstream (3’) of the predicted open reading 
frame were amplified. The primers were constructed to contain restriction sites (1). The PCR fragments were 
subcloned into pGEM®-T Easy vector (2). The 5’ PCR fragments were cloned into the suicide vector pMCS5-
rpsL-hyg to result in pMCS5-rpsL-hyg- uvrD 5’, and pMCS5-rpsL-hyg- uvrB 5’, respectively (3). The 3’ PCR 
fragments were added to result in the knockout vectors pMCS5-rpsL-hyg- uvrD (sm), and pMCS5-rpsL-hyg- 
uvrB (sm) (4). This strategy was also applied for generation of the knockout vector for M. tuberculosis uvrD2.  
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Disruption of M. smegmatis uvrB (unmarked) 
uvrB open reading frame: 388 7521 – 388 5361 (2160 bp) 
Cloned 5’ flanking region: 388 8458 – 388 7260 (1198 bp), amplified with primers 3f and 3r 
Cloned 3’ flanking region: 388 5632 – 388 4403 (1229 bp), amplified with primers 4f and 4r  
Deleted region: 388 7259 – 388 5633 (1628 bp) 
The suicide vector pMCS5-rpsL-hyg- uvrB (sm) was constructed according to the scheme 
shown in Figure 2 b. 
 
Generation of M. smegmatis uvrD / uvrB double mutant 
The uvrB knockout vector pMCS5-rpsL-hyg-uvrB (sm) was transformed into the 
M. smegmatis uvrD mutant. 
 
Disruption of M. smegmatis smc 
smc open reading frame: 1 2905 – 1 6492 (3587 bp) 
Cloned 5’ flanking region: 1 2569 – 1 3652 (1083 bp), amplified with primers 5f and 5r 
Cloned 3’ flanking region: 1 5565 – 1 6565 (1000 bp), amplified with primers 6f and 6r 
Deleted region: 1 3653 – 1 5564 (1911 bp) 
The suicide vector pMCS5-rpsL-hyg- smc (sm) was constructed according to the scheme 
shown in Figure 3. 
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Figure 3: Cloning of the knockout vector for the generation of an M. smegmatis smc mutant  
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Generation of M. tuberculosis mutants 
 
Disruption of M. tuberculosis uvrD 
A 5134 bp ApaI/EcoRV fragment comprising the uvrD gene was isolated from bacterial 
artificial clone (BAC) Rv103 (Brosch et al, 1998) and cloned into plasmid ptrpA-1-rpsL 
previously digested with ApaI/EcoRV resulting in puvrD-rpsL. For functional inactivation of 
uvrD a 1.4 kbp fragment (SalI-AatII) was deleted and substituted by a 3 kbp gentamicin 
resistance cassette originally derived from plasmid pML10 resulting in plasmid puvrD::gm-
rpsL (Figure 4a). This plasmid was transformed into the streptomycin resistant 
M. tuberculosis strain H37Rv #1424.  
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Figure 4: Cloning of vectors for the generation M. tuberculosis uvrD mutant (A) and complementation of 
M. tuberculosis uvrD mutant (B) 
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For complementation vector puvrD-rpsL was digested with NsiI/XhoI to obtain a 3319 bp 
fragment comprising the whole uvrD gene plus 362 bp upstream and 641 bp downstream 
sequences. This fragment was subcloned into vector pMCS5 and subsequently inserted into 
the HpaI site of integrative vector pMV361 (Figure 4b).  
 
uvrD open reading frame: 105 8260 - 106 0575 (2316 bp) 
Cloned region: 105 7112 - 106 2246 (5134 bp) 
Deleted region: 105 8559 - 105 9943 (1384 bp) 
Complementation: 105 7898 - 106 1216  
 
 
Disruption of M. tuberculosis uvrA 
A 5.9 kbp NotI fragment comprising the uvrA gene was isolated from BAC Rv401 (Brosch et 
al, 1998) and cloned into pBluescript KS (-) (Stratagene) previously digested with NotI 
resulting in pBluescript-uvrA. For functional inactivation of uvrA the resulting plasmid was 
digested with EcoNI and StuI (deletion of a 70 bp fragment and of a 1.2 kbp fragment).  
Subsequently, a 1.2 kbp fragment containing the kanamycin resistance cassette from plasmid 
pUC4K was inserted resulting in plasmid puvrA::aph. From this plasmid a 5.9 kbp NotI 
fragment comprising the inactivated uvrA gene was subcloned into plasmid pBluescript-rpsL 
(M.s.) previously digested with NotI resulting in plasmid puvrA::aph-rpsL (Figure 5). 
pBluescript-rpsL (M.s.) is a derivative of pBluescript carrying a 0.9 kbp fragment with the 
rpsL gene of M. smegmatis. 
 
uvrA open reading frame: 184 3741-184 6659  (2919 bp) 
Cloned region: 184 1810-184 7701 (5892 bp) 
Deleted region: 184 4659-184 6001 (1343 bp) 
 
Generation of M. tuberculosis uvrA / uvrD double mutant 
The uvrD  knockout vector was transformed into the M. tuberculosis uvrA mutant.  
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Figure 5: Cloning of the knockout vector for the generation of an M. tuberculosis uvrA mutant 
 
 
Disruption of M. tuberculosis uvrD2 (unmarked) 
uvrD2 open reading frame: 356 9109 - 357 1211 (2103 bp) 
Cloned 5’ flanking region: 356 8121 - 356 9346 (1225 bp), amplified with primers 7f and 7r 
Cloned 3’ flanking region: 357 0831 - 357 2148 (1317 bp), amplified with primers 8f and 8r 
Deleted region: 356 9347 - 357 0830 (1485 bp) 
Construction of the suicide vector pMCS5-rpsL-hyg-uvrD2 (tb) was similar to the 
construction shown in Figure 2. 
 
Generation of M. tuberculosis mutants with multiple deficiencies in DNA damage repair 
pathways 
To generate multiple knockout mutants, genes were inactivated consecutively. Towards this 
aim, the M. tuberculosis uvrD mutant strain and the double mutant strain uvrA / uvrD were 
transformed with knockout-vectors recA and uvrD2.  
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Disruption of M. tuberculosis smc 
smc open reading frame: 323 4189 - 323 7806 (3618 bp) 
Cloned 5’ flanking region: 323 4077 - 323 5133 (1056 bp), amplified with primers 9f and 9r 
Cloned 3’ flanking region: 323 7254 - 323 8138 (884 bp), amplified with primers 10f and 10r 
Deleted region: 323 5134 - 323 7253 (2121 bp) 
Construction of the suicide vector pMCS5-rpsL-hyg- smc (tb): see Figure 6. 
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Figure 6: Construction of the knockout vector for the generation of an M. tuberculosis smc mutant  
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3.11 
3.11.1 
3.11.2 
3.11.3 
Assays 
 
Spontaneous mutation frequencies 
Mutation frequencies were determined by fluctuation experiments. Briefly, at least six parallel 
cultures of each strain were grown until late log phase in 7H9 medium, with a viable cell 
number around 109/ml. Subsequently, cultures were diluted to 2 x 103 / ml and incubated for 2 
days at 37°C. 100 µl of each culture were plated on freshly prepared 7H10 agar plates 
containing rifampicin and serial dilutions were plated on non-selective medium. After 4 days 
of incubation at 37°C, colony forming units (CFU) were determined. The number of CFUs 
obtained on agar plates containing rifampicin was divided by the number of CFUs obtained 
on nonselective medium. For calculation of the mutation frequencies, the median of the ratio 
of cells that gained resistance against rifampicin was determined, as previously described (Lea 
and Coulson, 1949; Luria and Delbrück, 1943). 
 
MIC and MBC 
 
MICs were determined by E-test (AB BIODISK) according to the manufacturer’s 
instructions. Determination of minimal bactericidal concentrations (MBCs) was performed in 
a microtiter plate format as described before (Pfister et al., 2005). In brief, freshly grown 
cultures were diluted to an absorbance (A600) of 0.01 in 7H9 medium and incubated for 72 h 
at 37°C in the presence of 2-fold serial dilutions of rifampicin. The rifampicin stock solution 
(2 mg/ml) was made in DMSO. Aliquots from those wells that showed growth inhibition were 
plated on drug-free solid agar and incubated at 37°C for a further 72 h. The MBC is defined 
as the minimal drug concentration that kills >99.9 % of the bacterial inoculum. 
 
Survival after exposure to UV light 
UV sensitivity of strains was determined by plating dilutions (in triplicate) on solid medium 
and irradiation of open plates in a Stratalinker 2400 (Stratagene, 254nm) at 0–160 mJ/cm2. 
CFUs were determined after 3-4 days incubation at 37°C and compared to the untreated 
control. 
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3.11.4 
3.11.5 
3.11.6 
Survival after treatment with DNA damaging agents 
DNA damaging agents (final concentration) 
• Acidified sodium nitrite (pH 5.4, 3mM) 
• tert-butylhydroperoxide (250µM) 
• Mitomycin C (0.02 µg/ml) 
 
25 ml cultures of each strain were grown in 7H9 medium until early midlog phase and serial 
dilutions were plated on LB agar for CFU determination. For determination of susceptibility 
to NaNO2, cultures were centrifuged and resuspended in 7H9 medium acidified with HCl (pH 
5.4). Subsequently, cultures were split into six 3 ml aliquots. Freshly prepared compounds 
(tert-butylhydroperoxide 250 µM, NaNO2 3 mM, mitomycin C 0,02 µg/ml) were added to 
three aliquots, the remaining aliquots served as untreated control. After incubation for 24 h at 
37°C, serial dilutions were plated onto LB agar. CFUs were counted after 3 days growth at 
37°C. Survival was calculated by the ratio of CFUs of the treated cultures compared to the 
CFUs of the untreated controls.  
This protocol was also applied to M. tuberculosis strains, with the following modifications: 
Cultures were grown in 7H9 medium supplemented with OADC and exposed to the DNA 
damaging agent for 6 days. CFU were determined after 4-6 weeks growth at 37°C.  
 
Susceptibility to ionizing radiation 
Cultures were grown in 7H9 until early midlog phase. 1.5 ml of each strain were transferred 
into a 6 well cell culture titer plate and exposed to ionizing radiation (6.3 Gy/min.). 250 µl 
aliquots were taken after 10, 30 and 60 min of exposure. Serial dilutions were plated on LB 
agar plates. CFUs obtained after treatment were compared to the untreated control.  
 
Gene conversion frequencies 
M. smegmatis strains were transformed with an integrative vector carrying mutated rrnA gene 
fragments. The mutated rrnA gene fragments confer drug resistance (apramycin for the 16S 
rRNA 1491 mutation, clarithromycin for the 23S rRNA 2058/2059 mutation) upon 
recombination with the chromosomal wildtype rrnA gene (see section 4.3.5 and Table 3). For 
the positive selection of primary transformants, the vector encoded kanamycin resistance 
cassette was used. Following growth on medium containing kanamycin for three days, 
transformants were picked and grown in 4 ml 7H9 medium for another three days. Gene 
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conversion frequencies were assessed by fluctuation experiments. Briefly, for each construct 
and strain, at least ten independent transformants were picked and grown. Aliquots of these 
precultures were taken to inoculate 4 ml 7H9 medium with approximately 5x105 cells. After 
two days of growth, serial dilutions were plated on permissive medium and on selective 
medium containing either apramycin or clarithromycin. The relative marker integration 
frequencies were determined by the ratio of cells which gained antibiotic resistance compared 
to the number of cells obtained on permissive medium.  
 
 
3.12 Mice infection experiments 
 
BALB/c and nude mice (6 to 8 weeks old) were obtained from the breeding facility at the 
National Institute for Medical Research (Mill Hill, United Kingdom). M. tuberculosis strains 
were grown in Dubos broth. Logarithmically growing cultures were diluted in saline to an OD 
of 0.8; 0.2 ml (approximately 106 CFU) were injected into the tail vein. Mice were sacrificed 
according to ethical guidelines at various times (three mice per strain for each time point), and 
the spleens and lungs were removed, weighed, and homogenized. The suspensions were 
serially diluted in saline and plated on 7H10 agar supplemented with OADC. CFU were 
determined after 3 weeks incubation at 37°C and calculated as CFU per organ. These 
experiments were performed in collaboration with Elaine O. Davis (National Institute for 
Medical Research, London, UK). 
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4 Results 
  
 
 
4.1 
4.2 
NER in mycobacteria 
 
Genome analyses of M. tuberculosis and M. smegmatis indicate that both species have a full 
set of NER genes. The open reading frame MSMEG3816 has been annotated as excinuclease 
ABC subunit B (uvrB) in the genome of M. smegmatis. MSMEG3816 encodes a protein of 
719 amino acids. It displays a high degree of homology to M. tuberculosis uvrB (Rv1633). 
M. tuberculosis uvrB encodes a protein of 698 amino acids, with 83% identity (87% positives) 
to M. smegmatis uvrB. 
The open reading frame MSMEG5534 in the genome of M. smegmatis has been annotated as 
ATP-dependent DNA helicase and has been named pcrA in the TIGR genome data base. 
Since the encoded protein (783 amino acids) has a high degree of homology (80% identity / 
87% positives) to M. tuberculosis uvrD (Rv0949), we propose that MSMEG5534 represents 
the M. smegmatis uvrD homologue. In this context it is important to note that in other Gram-
positive bacteria like B. subtilis uvrD homologues are named pcrA as well.  
 
 
Generation of M. smegmatis NER mutants 
 
To study the role of the NER pathway in mycobacteria, M. smegmatis mutants deficient in 
uvrB and in uvrD were constructed. 
For targeted gene inactivation an unmarked deletion mutagenesis strategy employing a 
suicidal vector that harbours a counter-selectable marker was used as described in section 
3.10. Disruption of uvrD was verified by Southern blot analysis using a DNA probe specific 
for the 5’ flanking region of the uvrD open reading frame. This analysis revealed a 10.7 kbp 
hybridization signal in the mutant strain compared to a 2.0 kbp fragment in the parental strain. 
The difference in size is due to the loss of two restriction sites that are located in the deleted 
region (Figure 7 a). 
Disruption of uvrB was verified by Southern blot analysis using an uvrB-specific probe. This 
analysis revealed a 3.9 kbp hybridization signal in the mutant strain compared to a 5.6 kbp 
fragment in the parental strain. The difference in size is due to deletion of the genomic uvrB 
region (Figure 7 b). 
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Figure 7: Generation of M. smegmatis NER single mutants 
A Disruption of M. smegmatis uvrD Left: Southern blot analysis. Genomic DNA from M. smegmatis wildtype 
(lane 1), M. smegmatis uvrD mutant (lanes 2-3) and M. smegmatis uvrD sco (lane 4) was digested with BstXI 
and probed with a 653 bp MluI/BamHI DNA fragment containing 5’ flanking regions of the uvrD gene. The 
presence of a single 10.7 kbp fragment instead of a 2.0 kbp fragment as seen in the parental strain demonstrates 
successful deletion of uvrD coding sequences. Right: Schematic illustration of the uvrD locus and the Southern 
blot strategy. Shown are the genomic organisation of wildtype (wt), the knockout vector that contains the 
deletion allele (vector), the single cross-over genotype (sco) and the mutated genomic uvrD region in the 
knockout mutant (ko). Fragments detected by the probe specific for the 5’ flanking region are shown in bold 
letters. 
B Disruption of M. smegmatis uvrB Left: Southern blot analysis. Genomic DNA from M. smegmatis uvrB 
mutant (lane 1), M. smegmatis uvrB sco (lane 2) and M. smegmatis wildtype (lane 3) was digested with NcoI and 
probed with a 600 bp NdeI/BsmI uvrB gene fragment. The presence of a single 3.9 kbp fragment instead of a 5.6 
kbp fragment as seen in the parental strain demonstrates successful deletion of uvrB coding sequences. Right: 
Schematic illustration of the uvrB locus and the Southern blot strategy. Shown are the genomic organisation of 
wildtype (wt), the knockout vector that contains the deletion allele (vector), the single cross-over genotype (sco) 
and the mutated genomic uvrB region in the knockout mutant (ko). Fragments detected by the probe specific for 
the uvrB gene are shown in bold letters. 
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A M. smegmatis double mutant deficient in uvrB and uvrD was obtained after transformation 
of the uvrD mutant strain with the uvrB knockout vector. Disruption of uvrB was confirmed 
by Southern blot analyses using hybridization probes specific for uvrD or uvrB, respectively. 
(Figure 8). The schematic illustration of the uvrD and uvrB gene loci and the Southern blot 
strategies are given in Figure 7. 
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Figure 8: Generation of M. smegmatis uvrD/ uvrB double mutant 
(A) Genomic DNA from M. smegmatis  uvrD / uvrB double mutant (lane 1), M. smegmatis uvrD mutant / uvrB 
sco (lane 2) and M. smegmatis wildtype (lane 3) was digested with NcoI and probed with an oligonucleotide 
specific for uvrB. The presence of a single 3.9 kbp fragment instead of a 5.6 kbp fragment as seen in the parental 
strain demonstrates successful deletion of uvrB coding sequences. 
(B) Genomic DNA from M. smegmatis  uvrD / uvrB double mutant (lane 1), M. smegmatis uvrD mutant / uvrB 
sco (lane 2) and M. smegmatis wildtype (lane 3) was digested with BstXI and probed with an oligonucleotide 
specific for uvrD. The presence of a single 10.7 kbp fragment instead of a 2.0 kbp fragment as seen in the 
parental strain demonstrates successful deletion of uvrD coding sequences. 
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4.3 
4.3.1 
Characterisation of M. smegmatis NER mutant strains 
In vitro growth 
The in vitro growth characteristics of M. smegmatis wildtype and the NER mutants were 
assessed in 7H9 medium. For comparison, a M. smegmatis recA mutant (Frischkorn et al., 
1998) was included to the studies. Doubling times of the uvrB and uvrD mutant strains were 
indistinguishable from the parental strain. Growth of the uvrB / uvrD double mutant was 
considerably impaired, with a twofold increase in generation time compared to the wildtype 
(Figure 9). With respect to colony morphology, the mutants did not show any difference to 
the wildtype. When grown on solid media, the double mutant strain showed visible colonies 
about 20 hours later than the wildtype, confirming the general growth defect of the double 
mutant strain (data not shown).  
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Figure 9: Growth analysis of M. smegmatis strains 
Doubling times: wildtype 3.7 h +/- 0.1, uvrD mutant 3.5 h +/- 0.2, uvrB mutant 3.4 h +/- 0.2, uvrB / uvrD mutant 
7.6 h +/- 0.4, recA mutant 3.9 h +/- 0.2. 
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4.3.2 Spontaneous mutation frequencies 
Rifampicin has a single molecular target, the ß subunit of RNA polymerase encoded by the 
rpoB gene. Various point mutations in rpoB may confer high-level resistance. The frequency 
at which bacteria generate rifampicin-resistant mutants is widely used to assess the 
spontaneous mutation frequency. The calculation is based on the model for the distribution of 
mutant clones originally described by Luria and Delbrück (1943) and extended by Lea and 
Coulson (1949).  
The frequencies at which repair-deficient M. smegmatis mutants gain rifampicin resistance 
were investigated as described in section 3.11.1 and compared with those of the parental 
wildtype strain (Figure 10). The wildtype strain displayed a spontaneous mutation frequency 
of 3.8 x 10-8. In comparison, deletion of uvrD resulted in an approximately threefold 
increased mutation frequency (9.1 x 10-8, p < 0.05, n= 6, student’s t-test) and deletion of uvrB 
resulted in a fivefold increased mutation frequency (1.9 x 10-7, p < 0.01, n= 6, student’s t-
test). Inactivation of recA did not affect the mutation frequency (1.7 x 10-8 p > 0.05, n= 6, 
student’s t-test). The mutation frequency of the double mutant could not be assessed with this 
approach, as the uvrB / uvrD mutant strain was unable to grow on the selective plates used for 
recovery of the spontaneous drug resistant mutants (containing 175 µg/ml rifampicin). 
Considering the general growth defect of this strain, we assumed that the uvrB / uvrD mutant 
is incapable of acquiring high-level resistance against rifampicin. Determining the minimal 
inhibitory concentration (MIC) of rifampicin indicated that the uvrB / uvrD mutant displayed 
an eightfold decreased MIC (4 µg/ml compared to 32 µg/ml in the wildtype and the uvrB 
mutant strain and 16 µg/ml in the uvrD mutant strain, Table 4). Analysis of the minimal 
bactericidal concentration (MBC) revealed that no viable clones of the double mutant could 
be recovered following incubation at rifampicin concentrations higher than 130 µg /ml (for 
the wildtype strain and the uvrB and uvrD single mutant strains the MBC was 500 µg /ml, 
Table 4). Given the decreased MBC of rifampicin, we assessed the spontaneous mutation 
frequency of the uvrB / uvrD double mutant on plates containing 75 µg/ml rifampicin. Using 
this approach, the uvrB / uvrD double mutant strain was found to display an approximately 20 
fold increased spontaneous mutation frequency (7.2 x 10-7, p < 0.01, n= 6, student’s t-test) 
compared to the wildtype strain (Figure 10).  
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Figure 10: Spontaneous mutation frequencies of M. smegmatis wildtype (wt) and mutant strains 
Shown are the mean values (horizontal lines), 95% confidence interval (rectangular boxes) and outliers 
(vertical lines) of mutation frequencies calculated from the ratio of spontaneous rifampicin resistant cells 
obtained in six independent cultures of each strain. * Significant increase of mutation frequency compared to 
the wildtype statistically confirmed (student’s t-test p<0.05). Abbreviations: wt = M. smegmatis wildtype strain; 
uvrB, uvrD, uvrB/uvrD = M. smegmatis NER mutant strains, recA  = M. smegmatis recA mutant strain. 
 
 
 
Table 4: MIC and MBC to rifampicin of M. smegmatis NER mutant strains  
 
strain MIC (µg / ml) MBC (µg / ml) 
 
wildtype 
 
32 
 
500 
uvrB 32 500 
uvrD 16 500 
uvrB / uvrD 
 
4 130 
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4.3.3 Survival after treatment with DNA damaging agents  
To investigate whether absence of NER in M. smegmatis affects DNA repair proficiency, 
mutants were challenged with DNA-damaging agents in a survival assay. Different DNA 
damaging compounds were chosen to cover various types of DNA damage.  
i.) Tert-butyl-hydroperoxide (TBH) generates reactive oxygen intermediates (ROI) which can 
attack the bases and the sugar-phosphate backbone of the DNA, leading to strand breaks and 
base adducts (Halliwell and Aruoma, 1991). Treatment with TBH possibly also results in 
formation of alkoxyradicals and methylation reactions of the DNA, thus leading to alkylation 
damage (Hix et al., 1995). The M. smegmatis NER mutants were all significantly more 
susceptible towards TBH compared to the wildtype strain (Figure 11 a). The uvrB, uvrD and 
the uvrB / D double mutant displayed similar susceptibilities (student’s t-test: p > 0.1). TBH 
susceptibility of the M. smegmatis recA mutant was only slightly, yet significantly increased 
compared to the wildtype (42 % surviving cells of the recA mutant compared to 77% 
surviving cells of the wildtype; p < 0.05 student’s t-test). These findings indicate that NER is 
more important than recombinational repair in defence against ROI and alkylation damage in 
mycobacteria.  
ii.) Acidified sodium nitrite generates reactive nitrogen (RNI) intermediates, leading to 
oxidative damage of the DNA as well as inducing nitration, nitrosation and deamination 
reactions (Burney et al., 1999). The M. smegmatis recA mutant displayed a similar 
susceptibility to RNI as the wildtype (12% and 15 % surviving cells; p > 0.08 student’s t-test, 
Figure 11 b). As with ROI, the M. smegmatis NER mutants displayed significantly increased 
susceptibilities to acidified sodium nitrite. The uvrD and the uvrB / uvrD double mutant were 
considerably more susceptible than the uvrB single mutant (Figure 11 b), implying a further 
role of uvrD in the repair of RNI induced DNA damage. 
iii.) Exposure to mitomycin C (MMC) results in alkylation and interstrand crosslinks (Iyer 
and Szybalski, 1963; Kumar et al., 1992), which are mainly repaired by NER in E. coli (Van 
Houten et al., 2005). The M. smegmatis NER mutants diplayed different susceptibilities 
towards treatment with MMC. While susceptibilities of the recA and the uvrD mutants were 
substantially increased compared to the wildtype, the uvrB and the uvrB / D double mutants 
were extremely susceptible towards MMC (Figure 11 c). 
 
 
Results 44
0
20
40
60
80
wt uvrD uvrB uvrB/D recA
%
 su
rv
iv
al
A tert-butylhydroperoxide
0
5
10
15
20
%
 su
rv
iv
al
wt uvrD uvrB uvrB/D recA
B NaNO2, pH 5.4
Mitomycin C
0.00001
0.0001
0.001
0.01
0.1
1
10
wt uvrD uvrB uvrB /D recA
%
 su
rv
iv
al
C
100
%
 su
rv
iv
al
%
 su
rv
iv
al
%
 su
rv
iv
al
%
 su
rv
iv
al
%
 su
rv
iv
al
%
 su
rv
iv
al
%
 su
rv
iv
al
 
 
Figure 11: Survival of M. smegmatis strains following treatment with different DNA damaging agents  
(A) tert-butyl-hydroperoxide (250 µM); (B) acidified NaNO2 (pH 5.4, 3mM); (C) mitomycin C (0.02 µg/ml). 
Survival was calculated from the ratio of cells that survived treatment with the DNA damaging agent in 
proportion to CFU of the untreated control. Strains were incubated with the DNA damaging agent for 24 h. 
Shown are the mean values of one representative experiment performed with three independent cultures each. 
Standard deviations from the mean are given in the error bars. Abbreviations: wt = M. smegmatis wildtype 
strain; uvrB, uvrD, uvrB/D = M. smegmatis NER mutant strains, recA  = M. smegmatis recA mutant strain. 
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4.3.4 Survival after treatment with short wavelength UV light 
NER mutants in E. coli display an increased UV-susceptibility and NER is responsible for the 
repair of bulky adducts resulting from UV-light exposure. Hence, the impact of short 
wavelength UV light (UV-C) to survival of the M. smegmatis NER mutants was studied. 
Increasing UV-C doses from 0 mJ / cm2 to 160 mJ / cm2 were applied and M. smegmatis 
wildtype and mutant strains irradiated as described in section 3.11.2.  
The uvrB and uvrD mutant strains as well as the recA mutant strain were considerably more 
susceptible than the wildtype strain. Interestingly, combined deletion of uvrB and uvrD had an 
additive effect; cells were unable to survive doses in excess of 80 mJ / cm2 (Figure 12).  
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Figure 12: Survival of M. smegmatis strains following irradiation with UV-C. 
Survival was calculated from the ratio of cells that survived treatment with UV-C in proportion to the untreated 
control. Shown are the mean values of one representative experiment performed with three independent cultures 
each. Standard deviations of the means are given in the error bars. Ratio of treated to untreated cells is plotted in 
logarithmic scale. The uvrB / D mutant was unable to survive doses in excess of 80 mJ / cm2. 
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4.3.5 Gene conversion assays  
Base-base mispairing occurs in duplex DNA in the mode of purine-purine (G/G, A/A, G/A), 
purine-pyrimidine (G/T, A/C) or pyrimidine-pyrimidine (C/C, T/T, T/C) mismatches. With 
the exception of C/C, all base-base mispairings are subject to correction by the mismatch 
repair system (Marra and Schär, 1999). As mycobacteria are devoid of this otherwise highly 
conserved repair system, the effects of MMR deficiency and possible compensating roles of 
NER in postreplicative repair were examined. Towards this end, a plasmid transformation-
based assay was applied. Upon integration at the attB site of the mycobacterial genome, 
intermolecular recombination between the chromosomal M. smegmatis rrnA gene and the 
plasmid-borne rrnA gene fragment carrying a specific resistance mutation leads to antibiotic 
resistance. Intrachromosomal recombination occurs via an intermediate with a non-Watson-
Crick base pairing. In repair proficient cells, the intermediate is recognised and rejected, 
resulting in decreased gene conversion frequencies. In case of repair deficiency, the 
intermediate will not be recognised as abnormal, leading to mutation of the chromosomal 
rrnA operon following replication and postmitotic segregation in 50 % of the progeny, with 
consequent gain in resistance to the relevant antibiotic (Figure 13). The assay provided the 
opportunity to analyse recognition of different mismatches, e.g. purine-pyrimidine (G/T, A/C) 
or pyrimidine-pyrimidine (C/C, C/T, T/C) mismatches. The M. smegmatis wildtype 
chromosome harbours a second rrn operon (named rrnB) in addition to the rrnA operon, 
which precludes proper measurement of gene conversion frequencies using the assay 
described above. Hence, the NER mutants were constructed in a Δ rrnB background (Sander 
et al., 1996).  
M. smegmatis rrnB NER mutant strains were transformed with an integrative vector carrying 
a mutated rrnA gene fragment. The relative recombination frequencies using different rrnA 
fragments were analysed. Each of the rrnA fragments comprises a specific resistance 
conferring mutation which leads to a defined base-pairing error in the intermediate upon 
recombination (Table 5). The relative recombination frequency was assessed by calculating 
the ratio of cells which gained antibiotic resistance compared to the number of cells obtained 
on medium without antibiotic selection. The recombination frequencies were determined 
according to Lea and Coulson (1949) from fluctuation experiments with at least 10 
independent cultures for each strain and rrnA fragment.  
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Figure 13: Schematic overview of the assay applied in this study 
Upon integration of the vector at the chromosomal attachment site (attB), intrachromosomal recombination leads 
to an intermediate with a non-Watson-Crick base pairing. In case of mismatch repair deficiency, the intermediate 
is not rejected. After replication and postmitotic segregation, 50 % of the progeny gain resistance to an 
antibiotic. 
 
Table 5: Recombination substrates applied in this study 
 
 
For each of the different rrnA fragments, specific gene conversion frequencies were 
obtained. Comparison of marker integration frequencies observed in the wildtype revealed 
that the highest gene conversion frequencies (in the range of 10-4 to 10-5) were found with an 
A → C mutation leading to a C/T mismatch (Figure 14a). This mismatch was studied 
resistance position mutation 
resulting 
mismatch resistance 
   
23S rRNA 2058 A → C C/T Clarithromycin 
23S rRNA 2058 A → G G/T Clarithromycin 
23S rRNA 2059 A → C C/T Clarithromycin 
23S rRNA 2059 A → G G/T Clarithromycin 
16S rRNA 1491 G → A A/C Apramycin  
16S rRNA 1491 G → T T/C Apramycin  
16S rRNA 1491 G → C C/C Apramycin  
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making use of two different constructs with the A → C mutation located at 23S rRNA 
position 2058, or 2059, respectively. Deletion of uvrD resulted in significantly 
(approximately tenfold) increased gene conversion frequencies in comparison to the 
wildtype. In contrast, gene conversion frequencies in the uvrB mutant were virtually at 
wildtype control level (student’s t-test, n=10, p>0.05). Interestingly, combined deletion of 
uvrB and uvrD resulted in significantly elevated marker integration frequencies (about 5 fold 
[A → C mutation located at 23S rRNA position 2058] or 20 fold [A → C mutation located at 
23S rRNA position 2059]) compared to the frequencies obtained in the uvrD single mutant 
(Figure 14 a). Analysis of marker integration frequencies with an rrnA fragment carrying an 
A → G mutation which leads to a G/T mismatch, gave similar results (Figure 14 a). Again, 
two different constructs carrying the mutation at 23S rRNA position 2058, or 2059, were 
used. In general, marker integration frequencies were lower with the A → G mutation than 
with the A → C mutation, yielding frequencies in the range of 10-5 and 10-6 in the 
M. smegmatis wildtype. Gene conversion frequencies were considerably (about tenfold) 
elevated in the uvrD mutant, but only marginally (3 to 4 fold) increased in the uvrB mutant. 
A synergism of combined absence of uvrB and uvrD was observed, as the double mutant 
displayed marker integration frequencies about 20 fold higher than those of the uvrD single 
mutant (Figure 14 a).  
Recognition of A/C and C/C mismatches was determined with rrnA fragments carrying a 
G → A mutation or a G → C mutation at 16S rRNA position 1491. Gene conversion 
frequencies of the wildtype were in the range of 1 x 10 -6. Gene conversion frequencies of 
the uvrB mutant, the uvrD mutant and the uvrB / uvrD double mutant were only marginally 
(about fourfold) increased. Thus, no synergism of combined deletion of uvrB and uvrD was 
observed for A/C and C/C mismatch recognition (Figure 14 b). Analysis of marker 
integration frequencies using an rrnA fragment carrying a G → T mutation provided insights 
into recognition of T/C mismatches. The uvrD mutant strain and the uvrB / uvrD mutant 
strain yielded approximately tenfold increased gene conversion frequencies, whilst the uvrB 
mutant strain yielded fourfold increased frequencies (Figure 14 b).  
In summary, different gene conversion frequencies depending on the mismatch studied were 
observed. The NER mutants displayed higher marker integration frequencies compared to 
the wildtype. While the uvrB mutant showed only slightly increased gene conversion 
frequencies, high marker integration frequencies were observed with the uvrD mutant. The 
uvrB / uvrD mutant displayed the highest gene conversion frequencies, however, only with 
some of the mismatches studied. 
Results 49
A 
wt
uv
rB
uv
rD
uv
rB
 / u
vrD w
t
uv
rB
uv
rD
uv
rB
 / u
vrD w
t
uv
rB
uv
rD
uv
rB
 / u
vrD w
t
uv
rB
uv
rD
uv
rB
 / u
vrD
10-9
10-8
10-7
10-6
10-5
10-4
10-3
10-2
10-1
 2058 A → C 2059  A → C  2058 A → G 2059  A → G
Fr
eq
ue
nc
y
C/ T mismatch G/T mismatch
  *   *
  *
  *
  *
  *
  *
  *
  *
  * 
 
 
 
 
 
 
 
 
B 
wt
uv
rB
uv
rD
uv
rB
 / u
vrD w
t
uv
rB
uv
rD
uv
rB
 / u
vrD w
t
uv
rB
uv
rD
uv
rB
 / u
vrD
10-9
10-8
10-7
10-6
10-5
10-4
10-3
10-2
           1491 G → A        1491 G → C                   1491  G → T
Fr
eq
ue
nc
y
A/C mismatch C/C mismatch T/C mismatch
* * * * * *
*
*
*
 
 
 
 
 
 
 
 
 
 
Figure 14: Relative gene conversion frequencies obtained with rrnA fragments resulting in  C/T or G/ T 
mismatches (A) and rrnA fragments resulting in A/C, C/C or T/C mismatches (B) 
Shown are the median values (horizontal lines), 95% confidence interval (rectangular boxes) and outliers 
(vertical lines) of recombination frequencies calculated from the number of cells that gained antibiotic 
resistance in ten independent cultures of each strain. * Significant increase of gene conversion frequencies 
compared to the wildtype (student’s t-test, p<0.05). Abbreviations: wt = M. smegmatis wildtype strain; uvrB, 
uvrD, uvrB/uvrD = M. smegmatis NER mutant strains. 
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4.4 Disruption of NER DNA repair pathway in M. tuberculosis 
  
To assess the role of NER in the pathogenesis of Mycobacterium tuberculosis infection, 
mutants deficient in uvrA and in uvrD were generated, as well as a double mutant deficient in 
both proteins. The mutants were constructed by transformation with suicide plasmids using 
the rpsL counterselection strategy described in section 3.10.  
 
Disruption of uvrD was confirmed by Southern blot analysis making use of a probe 
comprising a 2411 bp HpaI / SacI uvrD gene fragment. This analysis revealed a hybridization 
signal in the mutant strain at 5.3 kbp compared to a signal at 3.7 kbp in the parental strain. 
The shift in fragment size in the uvrD knockout strain results from replacement of a 1.4 kbp 
uvrD gene fragment by a 3 kbp gentamicin resistance cassette. The mutant strain was 
complemented by introducing plasmid pMV361-uvrD expressing the wildtype uvrD allele, 
resulting in M. tuberculosis uvrD compl. (Figure 15). 
 
Disruption of uvrA was verified by Southern blot analysis using a probe specific for the 5’ 
flanking region of the uvrA open reading frame. This analysis revealed a 5.6 kbp 
hybridization signal in the mutant strain and a 4.3 kbp signal in the parental strain. The 
difference in size is due to loss of a restriction site after replacement of a 1.3 kbp uvrA gene 
fragment with a 1.2 kbp kanamycin resistance cassette (Figure 16). 
 
A M. tuberculosis double mutant deficient in uvrA and uvrD was obtained after 
transformation of the uvrA mutant strain with the uvrD knockout vector. Disruption of uvrD 
was verified by two Southern blot analyses using hybridization probes specific for uvrD and 
uvrA, respectively. The double mutant exhibited the hybridization patterns expected for 
disruption of uvrD and uvrA, respectively (Figure 15, Figure 16). Complementation of the 
double mutant is ongoing. 
 
 
 
 
 
 
 
 
 
Results 51
 
1     2     3     4    5    6      7
uvrD coding sequences
uvrD flanking sequences
vector sequences
genomic DNA
21
5.2
3.5
2.0
[kbp] wtuvrD
SacI SacI3.7 kb
sco
ko
vector
5.3 kb
GmR
uvrD
SacI SacI
GmR
SacI SacI SacI SacI6.2 kb
SacI SacI SacI
5.3 kbSacI
GmR
SacI SacI SacI
5.3 kbSacI
GmR
SacI SacI SacI
ko
compuvrD
complementation vector integrated at 
chromosomal attB site
2.4 kb
 
 
Figure 15: Generation of M. tuberculosis uvrD and uvrA/ D mutants  
Left panel: Southern blot hybridised with a uvrD-specific probe. Genomic DNA from M. tuberculosis uvrD sco 
(lane 1), uvrD mutant (lane 2), complemented uvrD mutant (lane 3), uvrA / uvrD mutant (lane 4), uvrA sco (lane 
5), uvrA mutant (lane 6) and wildtype (lane 7) was digested with SacI and probed with a 2411 bp HpaI / SacI 
uvrD gene fragment. The presence of a single 5.3 kbp fragment instead of a 3.7 kpb fragment demonstrates 
successful deletion of uvrD coding sequences. Complementation of uvrD is indicated by an additional 
hybridization signal at 2.4 kbp. The uvrA single cross-over (sco) and the uvrA mutant exhibit a hybridization 
pattern identical to the wildtype pattern.  
Right panel: Schematic illustration of the uvrD locus and the Southern blot strategy. Shown are the genomic 
organisation of wildtype (wt), the knockout vector that contains the deletion allele uvrD::gm (vector), the single 
cross-over genotype (sco), the mutated genomic uvrD region in the knockout mutant (ko) and its 
complementation at the attB site (ko comp). Fragments detected by the probe specific for the 5’ flanking region 
are shown in bold letters.  
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Figure 16: Generation of M. tuberculosis uvrA and uvrA/ D mutants 
Left panel: Southern blot hybridised with a probe specific for the upstream flanking regions of the uvrA gene. 
Genomic DNA from M. tuberculosis uvrA mutant (lane 1), uvrA sco (lane 2), uvrA / uvrD mutant (lane 3), uvrD 
sco (lane 4), uvrD mutant (lane 5) and wildtype (lane 6) was digested with Eco47III. The presence of a single 5.6 
kbp fragment instead of a 4.3 kbp fragment demonstrates successful deletion of uvrA coding sequences. The 
uvrD single cross-over (sco) and the uvrD mutant show a hybridization pattern identical to the wildtype pattern.  
Right panel: Schematic illustration of the uvrA locus and the Southern blot strategy. Shown are the genomic 
organisation of wildtype (wt), the knockout vector that contains the deletion allele uvrA::kan (vector), the single 
cross-over genotype (sco) and the mutated genomic uvrA region in the knockout mutant (ko). Fragments 
detected by the probe specific for the 5’ flanking region are shown in bold letters.  
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4.5 
4.5.1 
In vitro characterisation of M. tuberculosis NER mutant strains 
 
In vitro growth  
The NER mutants differed from the wildtype strain by remarkable changes in colony 
morphology as well as in colony size. The colonies of the NER mutant strains were 
significantly smaller than colonies of the wildtype strain. The most considerable decrease in 
colony size was found with the uvrA / uvrD mutant strain (Figure 17). 
To analyse the phenotype of the M. tuberculosis NER mutant strains in more detail, the in 
vitro growth in 7H9 broth supplemented with OADC was studied. Compared to the wildtype 
strain, the uvrA / uvrD mutant displayed considerable growth retardation. Deletion of uvrA 
had a slight effect on growth rate, whereas the uvrD mutant strain and the complemented 
uvrD mutant strain displayed growth rates virtually identical to the growth rate of the 
wildtype strain (Figure 18). 
 
 
wt uvrA uvrD uvrD / uvrA
 
 
Figure 17: Colony morphology of M. tuberculosis wildtype (wt) and NER mutant strains  
Colonies were grown on 7H10 agar for 40 days.  
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Figure 18: In vitro growth characteristics of M. tuberculosis NER mutants  
Cultures were grown in 7H9 medium supplemented with OADC. (A) Growth of wildtype strain, uvrD mutant 
and complemented uvrD mutant (B) Growth of wildtype strain and uvrA mutant. (C) Growth of wildtype strain 
and uvrA / uvrD double mutant. Generation times: wildtype 22.6 h +/- 1.9, uvrD mutant 20.8 h +/- 0.2, 
complemented uvrD mutant: 22.2 h +/- 0.2, uvrA mutant: 25.7 h +/- 2.2, , uvrA / uvrD mutant: 36.9 h +/- 0.6. 
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Long-time survival of M. tuberculosis uvrA / uvrD mutant 4.5.2 
In order to study survival of the M. tuberculosis uvrA / uvrD mutant in stationary phase, the 
M. tuberculosis wildtype and the uvrA / uvrD mutant were grown for 83 days and OD and 
CFU counts assessed at different time points. 
Both strains reached viable-cell counts at around 1 x 108 CFU/ml after growth for nine days. 
After 83 days of incubation, the cell counts of the wildtype strain dropped to 3 x 107 CFU/ml. 
In contrast, the CFUs of the uvrA / uvrD mutant decreased to 2 x 105 CFU/ml, indicating an 
inability to survive during long-term stationary phase (Figure 19). 
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Figure 19: Long-term survival of M. tuberculosis wildtype and uvrA / uvrD mutant strain 
OD values are plotted on the left axis, CFU counts are plotted on the right axis. All axes (including time on the 
x-axis) are plotted in logarithmic scale. Shown are the mean values of CFU counts of three independent cultures 
of each strain. Error bars: Standard deviation of the mean.  
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4.5.3 Susceptibility to DNA damaging agents 
To test the ability of the mutant strains to cope with different DNA damaging agents, strains 
were challenged with DNA-damaging agents in a survival assay as detailed for the 
M. smegmatis NER mutants (section 4.3.3). M. tuberculosis NER mutant strains were assayed 
for their susceptibilities towards tert-butylhydroperoxide (TBH) and mitomycin C (MMC). In 
brief, three independent cultures were treated with the DNA-damaging agent for six days and 
CFU counts were determined by plating serial dilutions on 7H10 agar supplemented with 
OADC. Survival was calculated from the ratio of cells that were able to survive treatment 
compared to the untreated control.  
TBH generates ROI and alkylating agents. The uvrA single and the uvrA / uvrD double 
mutant displayed a significant increase in susceptibility towards TBH compared to the 
wildtype strain. Susceptibility of the uvrD mutant strain was increased compared to the 
wildtype strain, although this was not found to be statistically significant (student’s t-test, p> 
0.05). Complementation of the uvrD mutant strain resulted in reconstitution of wildtype 
susceptibility (Figure 20 a).  
Treatment with mitomycin C (MMC) results in inter- and intrastrand crosslinks. The uvrA 
single and the uvrA / uvrD double mutant displayed a significant increase in susceptibility 
towards MMC compared to the wildtype strain. In contrast, the uvrD mutant strain, the 
complemented uvrD mutant strain and the wildtype strains displayed similar susceptibilities 
(Figure 20 b, student’s t-test, p> 0.05).  
In general, these findings agree with those made in M. smegmatis. NER inactivation in both 
species results in similar phenotypes: compared to inactivation of uvrB or uvrA, deletion of 
uvrD had a much smaller effect on susceptibilities towards TBH and MMC. The strong 
effects of disruption of M. smegmatis uvrB and M. tuberculosis uvrA on TBH and MMC 
susceptibilities indicate that these proteins presumably have equivalent roles in both species. 
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Figure 20: Susceptibility of M. tuberculosis NER mutants to DNA damaging agents 
(A) tert-butyl hydroperoxide (250 µM) (B) mitomycin C (0.02 µg/ ml) Survival was calculated from the ratio of 
cells that survived treatment with the DNA damaging agent in proportion to CFU of the untreated control. 
Strains were incubated with the DNA damaging agent for 6 days. Shown are the mean values of one 
representative experiment performed with three independent cultures each. Standard deviations from the mean 
are given in the error bars. Abbreviations: uvrA, uvrD, uvrA/uvrD = M. tuberculosis NER mutant strains, uvrD 
compl. = M. tuberculosis uvrD strain complemented with the wildtype uvrD allele. 
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In vivo characterisation of M. tuberculosis NER mutant strains in a 
mouse model of infection  
4.6 
 
To evaluate the in vivo effect of NER disruption, the ability of the NER mutants to cause 
progressive infection in an in vivo mouse model was studied as described in section 3.12. In 
brief, groups of BALB/c mice were infected intravenously with approximately 5 x 10 5 cells 
of each strain. Progress of infection was assessed by determining organ CFU counts at various 
time points. Infection with wildtype M. tuberculosis cells resulted in progressive 
multiplication of bacteria in lungs and spleens, with the number of CFU reaching a plateau 
after nine weeks post infection. The uvrA mutant exhibited the same characteristic pattern of 
in vivo growth with organ CFU counts nearly identical to wildtype (Figure 21 a). In contrast, 
the uvrD mutant showed reduced ability to persist since the number of bacteria in lungs and 
spleens significantly decreased after nine weeks post infection (Figure 21 b).  
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Figure 21: In vivo growth of M. tuberculosis wildtype strain, uvrA mutant strain (A) and uvrD mutant 
strain (B) in a mouse model of infection 
Shown are CFU counts of lungs (left) and spleens (right) of intravenously infected BALB/c mice over a period 
of 140 days. CFU were calculated from the mean of CFU counts obtained from the lungs and spleens of three 
mice per strain for each time point. Error bars: standard deviations of the mean.  
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4.7 
4.7.1 
Generation of M. tuberculosis mutants with multiple deficiencies in 
 DNA damage repair pathways 
 
Failure to generate uvrD2 knockout mutants 
Genome analyses indicate that M. tuberculosis possesses a second DNA repair helicase 
assumed to be involved in NER. This homologue of uvrD has been annotated as uvrD2. To 
study the functional role of uvrD2, e.g. to analyse whether uvrD2 is capable of compensating 
for the loss of uvrD function, we initiated the generation of a mutant deficient in uvrD2, as 
well as a mutant lacking both helicases. In parallel, we started the construction of a mutant 
deficient in uvrA and both helicases. Due to the limited number of selectable markers in 
M. tuberculosis, this strategy had to employ unmarked deletion mutagenesis. 
M. tuberculosis wildtype, uvrD mutant strain and uvrA / uvrD double mutant strain were 
transformed with the uvrD2 knockout vector. Transformants were isolated and amplified for 
genomic DNA preparation. Subsequently, DNA was subjected to Southern blot analysis 
making use of a probe specific for the upstream region of the uvrD2 open reading frame. In 
the wildtype the probe hybridises to a 9 kbp fragment. Integration of the knockout vector 
occurs as a consequence of a single recombination event, resulting in a tandem arrangement 
of the functional uvrD2 allele and the deletion allele. Vector integration can occur either 
upstream (5’) or downstream (3’) of the targeted gene and thus result in 5’ single cross-over 
transformants or 3’ single cross-over transformants, respectively. Expected fragments in 5’ 
single cross-over transformants (5’ sco) are 13.6 kbp and 3.9 kbp; in 3’ single cross-over 
transformants (3’ sco) 8.1 kpb and 9.4 kbp. Successful disruption of uvrD2 would result in a 
hybridization signal at 7.5 kbp (a representative Southern blot is shown in Figure 22). 
In M. tuberculosis wildtype transformants, we obtained 4 clones that displayed a pattern 
indicative of a single cross-over event (all 3’ sco). Analyses of clones derived from 
transformation of the M. tuberculosis uvrD mutant strain revealed that 4 clones had 
undergone a single recombination event (all 3’ sco). Transformation of the M. tuberculosis 
uvrA / uvrD mutant yielded two single cross-over transformants (1 x 5’sco and 1 x 3’ sco). To 
inactivate uvrD2, a second intramolecular recombination event has to occur in the single 
cross-over transformant. Single cross-over clones were grown for ten days in liquid medium 
to allow for homologous recombination. Subsequently, the bacteria were plated on selective 
7H10 agar containing streptomycin. This counterselection selects against maintenance of 
knockout vector sequences which contain the wildtype rpsL gene. Loss of this allele upon 
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intramolecular recombination renders cells resistant to streptomycin. In order to calculate 
recombination frequencies, serial dilutions were plated on permissive medium without 
streptomycin. Frequencies for vector integration by intermolecular single cross-over 
recombination in mycobacteria are in the range of 10-4 to 10-6 (Sander et al., 1995). Expected 
frequencies for the second intramolecular recombination are in the range of 10-3 to 10-4. 
Counterselections resulted in the expected ratios of streptomycin-resistant clones, as 
summarised in Table 6. Despite the presence of a high number of streptomycin-resistant 
clones, Southern blot analyses demonstrated that no second intramolecular recombination 
event has occurred in any clone analysed. As all clones displayed a hybridization signal 
pattern indicative of tandem arrangement of the functional uvrD2 allele and the deletion allele 
(i.e. single cross-over clones), the resistance to streptomycin was due to spontaneous point 
mutations in the rpsL gene or due to gene conversion of the vector encoded susceptible rpsL 
allele by the chromosomal resistant rpsL allele. In total, 144 clones were analysed for 
inactivation of uvrD2 in the wildtype strain, 72 clones were analysed for inactivation of 
uvrD2 in the uvrD mutant strain, 24 clones were analysed for uvrD2 loss in the uvrA / uvrD 
mutant strain. In none, an uvrD2 knockout mutant was obtained. 
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Figure 22: Failure to generate uvrD2 mutants in M. tuberculosis 
Left panel: Southern blot analysis. Genomic DNA of clones obtained after counterselection of uvrD2 single 
cross-over mutants (lane 1-4) and DNA of the wildtype strain (lane 5) were digested with SexAI and hybridised 
with a probe specific for the upstream region of uvrD2. The hybridization signals in lane 1-4 reveal a pattern 
indicative for single cross-over clones, i.e. no uvrD2 knockout mutant could be obtained after counterselection. 
Right panel: Schematic illustration of the uvrD2 locus and the Southern blot strategy. Shown are the genomic 
organisation of wildtype (wt), the knockout vector that contains the deletion allele (vector), the single cross-over 
genotype (sco) and the mutated genomic uvrD2 region in the knockout mutant (ko). Fragments detected by the 
probe specific for the 5’ flanking region are shown in bold letters.  
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Table 6: Ratios of streptomycin-resistant clones after counterselection for uvrD2 inactivation 
 
Parental 
strain 
Ratio of streptomycin resistant clones Tested clones /  
obtained knockouts 
wildtype 1st counterselection 2.1 x 10-4 48 / 0 
 2nd counterselection 1.4 x 10-4 48 / 0 
 3rd counterselection 3.1 x 10-4 48 / 0  
uvrD 1st counterselection 3.6 x 10-4 36 / 0 
 2nd counterselection 2.5 x 10-3 36 / 0 
uvrA / uvrD 1st counterselection 1.8 x 10-3 24 / 0 
 
 
4.7.2 Failure to generate M. tuberculosis NER mutants deficient in recA 
To study the impact of deficiency in more than one DNA repair pathway, we aimed to 
construct M. tuberculosis mutants that are devoid of the NER and homologous recombination 
repair pathway. Therefore, we transformed the recA knockout vector into the M. tuberculosis 
uvrD mutant strain and into the uvrA / uvrD mutant strain, respectively. RecA single cross-
over transformants were obtained and subjected to counterselection.  
Overall, 3 independent counterselections were performed, in total 102 clones were screened 
(table 7). Counterselection of recA single cross-over transformants did not result in successful 
disruption of recA. 
 
 
Table 7: Ratios of streptomycin-resistant clones after counterselection for recA inactivation 
 
Parental 
strain 
Ratio of streptomycin resistant clones Tested clones /  
obtained knockouts 
uvrD 1st counterselection 1.2 x 10-3 30 / 0  
 2nd counterselection 4.3 x 10-5 36 / 0 
 3rd counterselection 3.2 x 10-3 36 / 0 
uvrA / uvrD No sco obtained after transformation (22 clones tested) 
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4.8 SMC in mycobacteria 
 
Analyses of molecular databases indicate that all mycobacterial genomes contain an SMC 
homologue. It is even present in M. leprae, a bacterium that has lost various gene functions 
during reductive genomic evolution (Cole et al., 2001). Mycobacterial SMC proteins share all 
those structural motifs conserved in members of the SMC family as determined by in silico 
analyses (Clustal W 1.83 multiple sequence alignment and InterPro Scan protein motive 
search). Homologous sequences are restricted to the head, hinge and tail domains. The three 
domains are connected by two long heptad repeat regions predicted to form coiled-coils 
(Figure 23). 
 
Figure 23: Sequence alignments of the three conserved SMC regions 
 
The conceptual M. smegmatis SMC ORF encodes an 1195 amino-acid polypeptide with a 
calculated molecular mass of 129.7 kDa. Overall, M. smegmatis SMC shares 74% identity 
with the 1205 amino-acid M. tuberculosis SMC and 55 % identity with the 1186 amino-acid 
SMC sequence of B. subtilis. The SMC protein of M. tuberculosis has a calculated molecular 
mass of 130.6 kDa.  
Eukaryotic SMC proteins functionally interact with other proteins, and SMC of B. subtilis 
was found to function in concert with two proteins called ScpA and ScpB (Hirano and Hirano, 
2004). Both, M. tuberculosis and M. smegmatis, have homologues of these interacting 
proteins, suggesting that mycobacterial SMC is functional (ScpA homologues: 
Rv1709/MSMEG3748; ScpB homologues: Rv1710/MSMEG3749, data not shown). All 
sequences were obtained from the Institute for Genomic research (TIGR) website and 
TubercuList of Institute Pasteur respectively. 
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4.9 Generation of M. smegmatis smc mutants 
 
The M. smegmatis smc knockout mutant was constructed by allelic exchange mutagenesis 
making use of the dominant-negative selectable marker rpsL as described in section 3.10 
(Sander et al., 1995). Using genomic DNA as template, a 2 kb deletion allele was constructed 
by joining PCR products that contain parts of the open reading frame flanked by upstream and 
downstream sequences. The resulting deletion allele lacks basepairs 747 to 2660 of the 3588 
basepair open reading frame. To allow proper selection of gene deletion mutants, a 
hygromycin resistance cassette was inserted between the two fragments resulting in the 
deletion allele smc::hyg. One prominent phenotype of previously described smc null mutants 
is temperature sensitivity (Britton et al., 1998; Jensen and Shapiro, 1999; Volkov et al., 
2003). Therefore, transformation and counterselection procedures of M. smegmatis were 
performed at room temperature. All selection steps were set off with bacteria taken from 
frozen stocks to ensure that no suppressor mutations arise due to extensive passaging. 
Disruption of the smc gene was verified by Southern blot analysis (Figure 24). This analysis 
revealed a 3.8 kbp hybridization signal in the mutant strain compared to a 7.3 kbp fragment in 
the parental strain. The shift in fragment size in the smc mutant strain results from 
replacement of a 1914 bp smc gene fragment by a 1758 bp hygromycin cassette, which 
provides a further restriction site.  
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Figure 24: Generation of M. smegmatis smc mutant 
(A) Southern blot analysis. Genomic DNA from M. smegmatis wildtype (lane 1), smc mutant (lane 2) and the 
smc single cross-over mutant (lane 3) was digested with BamHI and probed with a 685 bp PvuII gene 
fragment containing the 5’ flanking region of the smc gene. The presence of a single 3.8 kbp fragment in the 
mutant strain instead of a 7.3 kbp fragment observed in the parental strain demonstrates successful deletion 
of smc coding sequences.  
(B) Schematic illustration of the smc locus and the Southern blot strategy. Shown are the genomic organisation 
of wildtype (wt), the knockout vector that contains the deletion allele smc::hyg (vector), the single cross-
over genotype (sco) and the mutated genomic smc region in the knockout mutant (ko). Fragments detected 
by the probe specific for the 5’ flanking region are shown in bold letters.  
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4.10 
4.10.1 
Characterisation of M. smegmatis smc mutant strain 
 
In vitro growth 
In order to analyse the phenotype of the smc mutant strain, the in vitro growth characteristics 
were determined in 7H9 broth and compared to the parental wildtype strain.  
One main feature of all smc null mutants that have been previously described is temperature 
sensitive growth. Therefore, besides characterising growth at standard incubation temperature 
(37°C), the growth rates at lower (30°C) and higher temperatures (42°C) were also assessed.  
In contrast to smc null mutant phenotypes reported for B. subtilis and C. crescentus, the 
growth rates of the mutant and the wildtype were similar in M. smegmatis (Figure 25). 
Doubling times in logarithmic phase were nearly identical indicating that smc deletion does 
not affect in vitro growth of M. smegmatis. Additionally, wildtype and mutant were 
indistinguishable with respect to colony morphology; when grown on 7H10 agar, both strains 
showed the typical features of mycobacterial colonies with rough dry surfaces and irregular 
edges (data not shown).  
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Figure 25: Growth of M. smegmatis wildtype strain and M. smegmatis smc mutant strain at various growth 
temperatures 
Doubling times: 30°C: wildtype 4.0 h +/- 0.3, smc mutant 4.0 h +/- 0.2; 37°C: wildtype 3.6 h +/- 0.05, smc 
mutant 3.5 h +/- 0.1; 42°C: wildtype 5.0 h +/- 0.6, smc mutant 5.4 h +/- 0.5. 
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4.10.2 
4.10.3 
4.10.4 
Spontaneous mutation frequencies 
To assess whether mutation in SMC leads to an increase of the spontaneous mutation 
frequency, the frequencies of mutation to rifampicin resistance were determined as described 
in section 3.11.1. 
Mutation frequencies were comparable in wildtype (3.1 x 10-8 ± 1.5 x 10-8) and mutant strain 
(3.8 x 10-8 ± 1.0 x 10-8; p = 0.68; n = 4; student’s t-test), indicating that SMC deficiency does 
not result in a mutator phenotype in M. smegmatis.  
 
Susceptibility to ofloxacin, a DNA gyrase inhibitor  
DNA gyrase, which generates negative supercoiling, and topoisomerase I, which prevents 
excessive negative supercoiling by DNA gyrase, are essential to maintain the optimal 
topological state of DNA in the cell (Champoux, 2001). Previous investigations indicate that 
SMC proteins mediate chromosome compaction by contributing to the introduction of 
negative supercoils into DNA (Tadesse and Graumann, 2006). This hypothesis is 
corroborated by the observation that SMC and MukB mutants are hypersusceptible to gyrase 
inhibitors (Sawitzke and Austin, 2000), while loss of MukB function can be partially 
compensated by reducing topoisomerase I activity (Tadesse and Graumann, 2006).  
To investigate if SMC also interferes with DNA supercoiling in M. smegmatis, the minimal 
inhibitory concentration (MIC) towards the gyrase inhibitor ofloxacin using E-test (AB 
BIODISK) was determined. In contrast to findings made in other organisms (Sawitzke and 
Austin, 2000), M. smegmatis wildtype and smc mutant displayed identical drug susceptibility 
to ofloxacin with a MIC of 0.19 μg/ml.  
 
Survival after treatment with mitomycin C 
To investigate whether the M. smegmatis smc mutant is impaired in DNA repair, 
susceptibility to mitomycin C was studied. This DNA damaging agent generates intrastrand 
crosslinks. No difference in susceptibility of the wildtype and the smc mutant strain was 
observed, implying that mycobacterial SMC has a minor role in DNA repair (data not shown).  
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Susceptibility to ionizing radiation 4.10.5 
Since SMC in other organisms is known to participate in the repair of double-strand breaks 
(Potts et al., 2006; Sjogren and Nasmyth, 2001), the ability of the SMC mutant strain to 
survive treatment with ionizing radiation was assessed. Midlog cultures were irradiated and 
CFU determined as described in section 3.11.5. We also included a recA deficient mutant 
strain in this experiment. RecA is involved in the repair of double-strand breaks by 
homologous recombination.  
In contrast to the recA mutant strain, no major difference in survival between wildtype strain 
and smc mutant strain was found (Figure 26).  
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Figure 26: Survival of M. smegmatis wildtype, smc and recA mutant strains following exposure to ionizing 
radiation 
Survival was calculated from the ratio of cells that survived treatment with ionizing radiation in proportion to the 
untreated control. Shown are the mean values of one representative experiment performed with three 
independent cultures each. Standard deviations of the means are given in the error bars.  
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Susceptibility to UV-C 4.10.6 
The eukaryotic SMC5/6 complex has been described to act in a second pathway for the 
postreplicative repair of UV-induced lesions, which is different from the standard nucleotide 
excision repair (NER) pathway (Lehmann et al., 1995). In order to analyse the function of 
mycobacterial SMC in the repair of UV-induced lesions, sensitivity of the smc mutant strain 
to UV light was studied. Three independent cultures of each strain were grown in 7H9 
medium until late log phase (OD 1-2). Serial dilutions of each strain were plated on LB agar. 
Subsequently, the plates were exposed to different UV doses (0 - 160 mJ/cm2, 254 nm) and 
the number of CFUs were determined. In contrast to the recA mutant strain which was 
severely impaired in survival, the wildtype and the smc mutant strain displayed similar 
susceptibilities to UV (Figure 27). 
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Figure 27: Survival of M. smegmatis wildtype, smc and recA mutant strains following exposure to UV 
Survival was calculated from the ratio of cells that survived treatment with UV-C in proportion to the untreated 
control. Shown are the mean values of one representative experiment performed with three independent cultures 
each. Standard deviations of the means are given in the error bars. Ratio of treated to untreated cells is plotted in 
logarithmic scale. 
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4.10.7 Survival in stationary phase 
Some genes are not essential for exponential growth but a prerequisite for remaining viable 
during prolonged periods of oxygen and nutritional deprivation. In order to gain insight into a 
possible role of SMC for survival of M. smegmatis in stationary phase, CFU counts of the 
M. smegmatis wildtype and smc mutant grown for 28 days in 7H9 broth were compared. 
Both strains reached viable cell counts in the vicinity of 1 x 109 CFU/ml after growth for two 
days. These counts dropped to approximately 5 x 108 CFU/ml upon further incubation and 
remained virtually unchanged for the next 28 days (Figure 28). 
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Figure 28: Long-term survival of M. smegmatis wildtype (solid lines) and smc mutant (dashed lines) strain.  
Shown are the mean values of CFU counts of three independent cultures of each strain.  
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Generation of M. tuberculosis smc mutants  4.11 
 
The M. tuberculosis smc knockout mutant was constructed by allelic exchange mutagenesis as 
described in section 3.10. A deletion allele lacking 2121 basepairs of the 3618 basepair smc 
open reading frame (the resulting mutant lacks basepairs 553-2674 of the ORF) was 
constructed by allelic replacement mutagenesis as outlined for M. smegmatis in section 4.9. 
Disruption of the smc gene was controlled by Southern blot analysis (Figure 29). This 
analysis revealed a 4.3 kbp hybridization signal in the mutant strain compared to an 11.1 kbp 
fragment in the parental strain. The difference in size is due to deletion of the genomic smc 
region and introduction of an additional BamHI restriction site provided in the hygromycin 
resistance cassette. 
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Figure 29: Generation of M. tuberculosis smc mutant 
Left panel: Genomic DNA from M. tuberculosis wildtype (lane 1), M. tuberculosis smc mutant (lane 2) and M. 
tuberculosis smc sco (lane 3) was digested with BamHI and probed with a 935 bp NdeI DNA fragment 
containing the 5’ flanking regions of the smc gene. The presence of a single 4.3 kbp fragment instead of a 11.1 
kbp fragment as seen in the parental strain demonstrates successful deletion of smc coding sequences.  
Right panel: Schematic illustration of the smc locus and the Southern blot strategy. Shown are the genomic 
organisation of wildtype (wt), the knockout vector that contains the deletion allele smc::hyg (vector), the single 
cross-over genotype (sco) and the mutated genomic smc region in the knockout mutant (ko). Fragments detected 
by the probe specific for the 5’ flanking region are shown in bold letters. 
 
 
Results 71
4.12 
4.12.1 
Characterisation of M. tuberculosis smc mutant strain 
In vitro growth 
In vitro growth characteristics of the M. tuberculosis smc mutant strain were analysed in 7H9 
broth supplemented with OADC at 37°C and compared to the parental wildtype strain. No 
difference in growth between the mutant and the wildtype was found. Doubling times in 
logarithmic phase were nearly identical indicating that interruption of smc does not affect in 
vitro growth of M. tuberculosis (Figure 30 a). Additionally, wildtype and mutant were 
indistinguishable with respect to colony morphology; when grown on 7H10 agar, both strains 
showed the typical features of mycobacterial colonies with rough dry surfaces and irregular 
edges (Figure 30 b). 
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Figure 30: Growth analysis of M. tuberculosis wildtype and smc mutant strain 
A Growth curve. Doubling times: wildtype 22.6 h +/- 0.9 h, smc mutant strain 23.4 h +/- 0.8. 
B Colony morphology. Colonies were grown on 7H10 agar for 40 days. 
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Survival in stationary phase 4.12.2 
In order to gain insight into a possible role of SMC for survival of M. tuberculosis in 
stationary phase, CFU counts of the M. tuberculosis wildtype and smc mutant grown for 90 
days in 7H9 broth supplemented with OADC were compared.  
Both strains reached viable-cell counts in the vicinity of 1 x 108 CFU/ml after growth for nine 
days. These counts remained virtually unchanged for the next 20 days. After 83 days of 
incubation, the CFUs of both strains dropped to approximately 3 x 107 CFU/ml (Figure 31). 
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Figure 31: Long-term survival of M. tuberculosis wildtype and smc mutant strain 
OD values are plotted on the left axis, CFU counts are plotted on the right axis. All axes (including time on the 
x-axis) are plotted in logarithmic scale. Shown are the mean values of three independent cultures of each strain. 
Error bars: standard deviation of the mean. 
Discussion 73
5 Discussion 
 
5.1 DNA repair in mycobacteria 
 
Annually, Mycobacterium tuberculosis is responsible for nearly two million deaths (data from 
“Tuberculosis facts- Handout 2007” published on www.who.int). Part of its success lies in its 
ability to survive and replicate in macrophages, but the molecular mechanisms allowing it to 
do so are not yet understood (Kaufmann, 2001).  
The production of reactive oxygen intermediates and reactive nitrogen intermediates by the 
macrophages, once activated, is regarded an effective defence mechanism against intracellular 
pathogens (Chan et al., 1992; Ding et al., 1988; Nathan and Shiloh, 2000). However, 
M. tuberculosis seems to be superbly adapted to these extremely unfavourable conditions 
which demand efficient mechanisms to ensure genome stability. Despite the necessity for 
repair of DNA damage, mycobacteria are devoid of the mutLS-based post-replicative 
mismatch repair (MMR) system (Mizrahi and Andersen, 1998). MMR systems are highly 
conserved throughout evolution and contribute to mutation avoidance by correcting 
replication errors resulting from nucleotide misincorporation and polymerase slippage 
(Kunkel and Erie, 2005; Schofield and Hsieh, 2003). In addition, MMR inhibits 
recombination between non-identical (homeologous) sequences and thus takes part in 
ensuring the fidelity of recombination (Matic et al., 1995; Rayssiguier et al., 1989; Worth et 
al., 1994). The only MMR homologue present in mycobacteria is a DNA-helicase named 
UvrD, which is also involved in NER. 
Previous studies provided evidence that absence of MMR in mycobacteria does not affect 
genome fidelity as they display spontaneous mutation rates comparable with those of MMR 
proficient species (Springer et al., 2004). Assuming that alternative DNA repair mechanisms 
compensate for the lack of MMR, the role of NER in mycobacteria was studied. Prokaryotic 
NER has been extensively analysed in E. coli (Sancar, 1996). This DNA repair pathway is 
accomplished by the products of the uvrABC and uvrD genes and is capable of repairing a 
wide range of damage types (Sancar, 1996). Analysis of NER in Bacillus subtilis (Sancar, 
1996), Streptococcus pneumoniae (Sicard et al., 1992), Mycoplasma genitalium (Sancar, 
1996) and Deinococcus radiodurans (Minton, 1994) suggest that the repair mechanism 
originally characterised in E. coli is highly conserved in prokaryotes. However, little is known 
about nucleotide excision repair in mycobacteria. In silico genome analyses provided 
evidence that mycobacteria have a full set of NER genes including uvrABC and uvrD 
(Mizrahi and Andersen, 1998).  
Discussion 74
5.2 M. smegmatis NER mutants  
 
To analyse the role of the NER system in mycobacteria, we constructed M. smegmatis 
mutants deficient in the NER components uvrD and uvrB, as well as a mutant deficient in 
both proteins. Analysis of susceptibilities towards DNA damaging agents revealed that 
disruption of NER in M. smegmatis results in an impairment of DNA repair. NER mutants in 
E. coli  are sensitive not only to irradiation with UV, but also to a wide range of chemical 
agents, including mitomycin C (Friedberg, 2005). Consistently, we found that mycobacterial 
NER mutants are sensitive to treatment with UV and mitomycin C. The M. smegmatis uvrB 
and uvrB /uvrD double mutant, but not the uvrD single mutant are extremely susceptible 
towards MMC, corroborating previous observations that E. coli uvrB mutants were 
significantly more susceptible towards MMC than other E. coli uvr mutants (Vidal et al., 
2006). The M. smegmatis NER mutants, but not the recA mutant, are hypersensitive to TBH, 
indicating a major role of mycobacterial NER in the repair of oxidative and alkylation 
damage. In contrast, repair of oxidative DNA damage is primarily accomplished by base 
excision repair (BER) and homologous recombinational repair in E. coli (Konola et al., 2000). 
NER is not involved in the repair of ROI induced lesions here, as E. coli uvrA, uvrB and uvrC 
mutants display wildtype susceptibility to hydroperoxide (Imlay and Linn, 1987); alkylation 
damage is mainly repaired by methyltransferases and BER in E. coli (Nowosielska et al., 
2006) - NER is, if at all, only moderately capable of repairing these lesions (Samson et al., 
1988; Van Houten et al., 2005). Our findings indicate that in contrast to the observations 
made in E. coli, NER is more important than homologous recombinational repair in defence 
against ROI and alkylation damage in mycobacteria. 
Repair of RNI induced DNA damage in E. coli is mainly accomplished by repair mechanisms 
other than NER, primarily by BER and homologous recombinational repair (Spek et al., 
2001), although a role for UvrA in resistance to acidified sodium nitrite has been reported 
(Sidorkina et al., 1997). The mycobacterial NER mutants are more susceptible than both the 
wildtype strain and the recA mutant to the RNI generating agent acidified sodium nitrite. The 
mild phenotype RNI/ROI phenotype of the recA mutant indicates a minor role for 
homologous recombinational repair in repairing ROI and RNI induced lesions. 
 
Taken together, our data provide evidence that NER in mycobacteria is functional and that 
UvrB and UvrD play important roles in DNA repair. This is corroborated by analyses of 
spontaneous mutation frequencies toward rifampicin resistance. M. smegmatis uvrD and uvrB 
mutants displayed elevated spontaneous mutation frequencies compared to the wildtype 
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strain, indicating that disruption of NER has an impact on genomic integrity. Our findings 
suggest that the substrate spectrum of mycobacterial NER may differ from that of the 
described model species E. coli.  
 
Combined deletions of uvrB and uvrD have not been analysed in other prokaryotes so far. 
Interestingly, loss of both proteins rendered M. smegmatis more sensitive to UV than deletion 
of uvrB or of uvrD alone. The additive effect implies an additional role for one of these 
proteins besides NER. This assumption is corroborated by the observation that the in vitro 
growth rate of the double mutant was significantly reduced, while growth of the uvrB and 
uvrD single mutants was barely affected. We found that no spontaneous resistant clones of the 
double mutant could be obtained on medium containing high concentrations of rifampicin and 
that the double mutant was significantly more susceptible to rifampicin as determined by MIC 
assays. Consequently, the spontaneous mutation frequency towards rifampicin resistance was 
analysed at lower drug concentrations. The spontaneous mutation frequency of the double 
mutant was found to be considerably elevated compared to the uvrB and uvrD single mutants, 
indicating that overall repair capability is significantly impaired. However, a statistically 
significant additive effect of combined lack of uvrB and uvrD was not observed when the 
strains were assayed for their sensitivity to mitomycin C, TBH and acidified sodium nitrite. 
Other repair pathways, like BER and recombinational repair, might have overlapping repair 
specificities for DNA damage generated by these compounds and thus may partially 
compensate for the lack of uvrB and uvrD under these conditions.  
 
To investigate mismatch recognition in the absence of a MMR system, we made use of gene 
conversion assays. The assay applied in this study allows M. smegmatis cells to acquire 
antibiotic resistance upon recombination between the chromosomal rrnA operon and a 
plasmid borne partial gene fragment carrying a specific resistance mutation. This assay 
provided the opportunity to analyse recognition of different mismatches. Quantification of the 
relative marker integration frequencies revealed that marker integration depends on the 
specific mismatch, corresponding to the observations formerly made in MMR proficient 
species. The efficiency of repair for different base-pairing errors varies and appears to depend 
on multiple factors such as the physical structure of the mismatch and the sequence context 
(Dohet et al., 1985; Jones et al., 1987; Marra and Schär, 1999). In E. coli, the correction of 
G/T, A/C, G/G and A/A mismatches by the MMR system is highly effective, while 
elimination of C/T, T/T and A/G mismatches occurs with decreased efficiency. For C/C 
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mispairing, no correction activity can be observed (Dohet et al., 1985; Kramer et al., 1984; 
Parker and Marinus, 1992). We found that the M. smegmatis uvrB mutant displayed elevated 
gene conversion frequencies for most of the mismatches analysed. As gene conversion is 
mediated by recombination and occurs as consequence of absent mismatch recognition, our 
results indicate that mycobacterial NER may be involved in limiting recombination and act in 
the repair of DNA mismatches. A complementary function of NER in recognition of 
mismatches is corroborated by studies in Schizosaccharomyces pombe. NER of S. pombe is 
capable of recognizing and repairing C/C mismatches, which are not substrates of MMR. In 
the absence of MMR, other mismatches are processed by NER as efficiently as C/C 
mismatches (Fleck et al., 1999; Kunz and Fleck, 2001). However, we found that marker 
integration is significantly more efficient in the M. smegmatis uvrD mutant than in the uvrB 
mutant. These findings imply that UvrD has a further role besides involvement in the NER 
pathway. The involvement of mycobacterial UvrD in mismatch recognition and limiting 
recombination is supported by previous findings made in other prokaryotes. Analysis of 
E. coli UvrD function (Washburn and Kushner, 1991) and more recent studies in H. pylori 
(Kang and Blaser, 2006) revealed that deficiency in UvrD results in a hyperrecombinogenic 
phenotype. These observations can be explained by two different models. The first model 
refers to the assumption that NER or MMR remains incomplete as a consequence of UvrD 
deficiency (Arthur and Lloyd, 1980). Thus, nicks in the DNA occur more frequently. 
Replication forks will be stalled at such nicks, subsequently leading to the formation of 
double-strand breaks which will be repaired by recombinational repair (Arthur and Lloyd, 
1980). In another model it was proposed that UvrD participates in degradation of toxic 
recombination intermediates by actively removing RecA proteins from DNA (Centore and 
Sandler, 2007). This model is based on observations made in yeast and E. coli. UvrD of E. 
coli (Centore and Sandler, 2007; Flores et al., 2004; Flores et al., 2005; Petit and Ehrlich, 
2002; Veaute et al., 2005) as well as the helicase Srs2 of yeast (Veaute et al., 2003) were 
found to act as anti-recombinases to prevent potentially deleterious recombination events. 
The uvrB / uvrD double mutant displayed significantly higher gene conversion frequencies 
than the single mutants. Hence, combined loss of UvrB and UvrD function results in a 
synergistic (i.e. greater than additive) effect in mycobacteria. The synergism of UvrB and 
UvrD function in gene conversion prevention was not observed for recognition of A/C or C/C 
mismatches. The single mutants and the double mutant strain displayed similar marker 
integration frequencies, which were only marginally elevated compared to the wildtype strain. 
In the wildtype strain, A/C and C/C gene conversion frequencies are lower than those 
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obtained with the other mismatches. These findings can be explained by the topological 
properties of the respective mismatches. A/C and C/C mismatches are the least stable 
mismatches and lead to significant distortions of the DNA double helix. Hence, due to the 
unstable nature of the mismatch, the mismatch is rejected irrespective of repair, which 
accounts for the low marker integration frequencies obtained in the assay. Consequently, only 
a minor proportion of mismatch intermediate rejection is caused by the anti-recombination 
function of UvrD. 
 
Taken together, our observations provide evidence that despite the lack of MMR, 
mycobacteria possess efficient DNA repair mechanisms. We found that mycobacterial NER is 
capable of repairing a wide range of DNA damage. Furthermore, our data suggest a 
complementary function of NER in the recognition of DNA mismatches. The helicase 
component UvrD was shown to limit marker integration frequencies. We propose that repair 
of DNA mismatches is accomplished differently in mycobacteria than in the described model 
species. Further investigations will provide insights into new mechanisms that govern genome 
stability in mycobacteria. 
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5.3  M. tuberculosis NER: implications for pathogenesis and persistence 
 
To analyse whether the observations in M. smegmatis could be transferred to the relevant 
pathogen, M. tuberculosis NER mutants were generated. In comparison to the wildtype, the 
M. tuberculosis uvrA mutant and the uvrA / uvrD double mutant were found to be more 
susceptible towards DNA damaging agents, indicating that NER in M. tuberculosis is 
functional. Consistent with the observations made in M. smegmatis, the uvrA / uvrD double 
mutant displayed a severe growth defect which was accompanied by a significant alteration in 
colony morphology. These findings point towards an additional role of one of these proteins 
besides involvement in NER.  
The uvrA /uvrD double mutant displayed an impaired survival in stationary phase in vitro and 
the uvrD mutant exhibited a reduced ability to persist in an in vivo mouse model of infection. 
These findings indicate that besides its function in maintaining genomic stability, NER may 
also have important roles in the pathogenesis of M. tuberculosis infection. In this context it is 
important to note that the ability to persist for long periods of time within the human host is 
thought to be the main determinant for the success of M. tuberculosis as a human pathogen 
(Gomez and McKinney, 2004). In fact, it is estimated that one-third of the world population is 
latently infected and it is assumed that the majority of the disease arises from reactivation of 
persisting bacteria (Flynn and Chan, 2001). During the latent state, M. tuberculosis shifts into 
a dormant state by shutdown of metabolic activities, including biosynthesis of all cell 
compounds and replication of the genome. This dormant state is reversible and 
M. tuberculosis cells are able to reactivate when the host immune response is compromised 
(Flynn and Chan, 2001). The underlying mechanisms to exit dormancy and recover the 
actively growing state still remain to be elucidated. We hypothesize that during latent 
infection, mutagenic DNA damage accumulates as the bacteria are under constant attack of 
DNA damaging agents. Efficient DNA repair systems should thus be a precondition for 
successful resuscitation of dormant cells. Our analysis of mycobacterial NER corroborates 
this hypothesis; the in vivo phenotype of the uvrA / uvrD double mutant remains to be 
determined. Taken together, these findings indicate that functional UvrD is essential for long-
term survival of M. tuberculosis in vivo and in vitro and might thus be critical for emergence 
from the dormant state during reactivation. 
The obtained results may have further implications: the M. tuberculosis NER mutants may 
provide a new avenue for the development of TB vaccines. To date, no vaccine providing 
efficient protection against tuberculosis in adults is available (Andersen, 2007). The current 
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tuberculosis vaccine is based on Mycobacterium bovis BCG, an attenuated derivative of the 
causative agent of bovine tuberculosis. However, this vaccine is only capable of protecting 
children against invasive TB and does not prevent establishment of latent TB or reactivation 
of pulmonary disease in adults (Arbelaez et al., 2000). With regard to the alerting global 
impact of tuberculosis, development of  novel effective vaccination strategies is of urgent 
importance. A promising approach for development of a new class of vaccines is based on 
NER mutants inactivated by photochemical treatment. This concept of so-called killed but 
metabolically active vaccines (KBMA) was studied using the intracellular pathogen Listeria 
monocytogenes as a model organism (Brockstedt et al., 2005). Deletion of uvrAB in L. 
monocytogenes rendered bacteria with increased sensitivity to photochemical inactivation. 
Thereby growth and the ability to cause disease are prevented. Gene expression, protein 
synthesis and protein secretion are still proceeding after photochemical inactivation, thus 
retaining the bacteria’s capacity to stimulate innate and adaptive immune responses in the 
host. As this vaccine is based on a modified form of the bacteria themselves, the authors 
suppose that this concept might be applied to diseases whose antigenic correlates of immune 
protection are poorly defined, such as tuberculosis (Brockstedt et al., 2005). This assumption 
is corroborated by our observations on mycobacterial NER: the uvrA and uvrD mutants 
display increased susceptibilities towards irradiation with UV, and functional UvrD is 
essential for long-term survival of M. tuberculosis in vitro and in vivo. As growth of the 
double mutant is severely impaired in vitro and presumably attenuated in vivo, the double 
mutant already displays some features of a KBMA, and photochemical inactivation might be 
not required. Hence, M. tuberculosis NER single mutants or the uvrA / uvrD double mutant in 
particular might provide a potential basis to develop a KBMA vaccine. Taken together our 
data provide evidence that the NER system and particularly UvrD play an important role in 
maintenance of genome stability in mycobacteria, as well as in persistence of M. tuberculosis.  
 
 
Discussion 80
5.4 UvrD2 is essential in mycobacteria  
 
The importance of uvrD in mycobacteria is corroborated by the existence of a homologue 
named uvrD2 which might partially compensate for the loss of uvrD. Other Gram-positive 
bacteria like Bacillus subtilis and Staphylococcus aureus harbour only one uvrD gene (named 
pcrA) which was shown to be essential (Iordanescu, 1993; Petit et al., 1998). In silico 
analyses suggest that mycobacteria and the closely related corynebacteria are the only 
prokaryotes harbouring a second uvrD homologue. In addition to uvrD2, mycobacteria 
possess a third gene (Rv3201c) with predicted helicase activity (data obtained by Blastp 
searches at the TubercuList website of Institute Pasteur). E. coli possesses a helicase named 
Rep in addition to UvrD. Individually, UvrD and Rep proteins are not essential, while the 
double mutant is not viable (Taucher-Scholz and Hoffmann-Berling, 1983). However, despite 
homology between UvrD and Rep, the proteins do not share a common activity. It was shown 
that UvrD directly prevents homologous recombination, whereas Rep acts in replication 
(Veaute et al., 2005). Moreover, recent studies indicate that uvrD defects in E. coli cannot be 
suppressed by Rep, corroborating that UvrD function in E. coli is indispensable (Lestini and 
Michel, 2007).  
In an attempt to analyse the function of the two uvrD homologues in mycobacteria, we set out 
to generate M. tuberculosis mutants deficient in uvrD2, with the aim to subsequently generate 
double mutants lacking both helicases. However, we were not successful in generating even 
an uvrD2 single mutant and therefore assume this homologue to be essential. The reason for 
lethality remains to be elucidated, as well as the particular function of this helicase. 
The identification of conserved essential genes required for growth offers an approach for the 
development of new antimycobacterial drugs. Thus, uvrD2 may be considered a promising 
target for drugs endowed with activity against tuberculosis. 
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5.5 Role of DNA binding proteins in mycobacteria 
 
Besides DNA repair, other mechanisms that ensure genome integrity are probably important 
for persistence and resuscitation from the dormant state. DNA binding proteins that establish 
chromosome architecture presumably contribute to the bacterium’s capability to stabilise its 
genome during persistence and to accomplish proper cell division during reactivation. 
We decided to study the role of SMC in mycobacteria as in other organisms this protein was 
shown to have a global role in maintenance of chromosome stability (Britton et al., 1998; 
Jensen and Shapiro, 1999; Volkov et al., 2003), as well as in the repair of double-strand 
breaks (Dervyn et al., 2004). It is assumed that during latency, M. tuberculosis experiences an 
accumulation of double-strand breaks. Functional SMC therefore may be a prerequisite for 
resuscitation of dormant bacteria. In silico analyses revealed that mycobacterial SMC proteins 
share all structural motifs conserved in members of the SMC family; homologous sequences 
are restricted to the head, hinge and tail domains and the three domains are connected by two 
long heptad repeat regions predicted to form coiled-coils.  
We successfully generated SMC mutant strains in M. smegmatis and M. tuberculosis. 
However, SMC deficiency did not result in an apparent phenotype. This is surprising given 
previous data obtained in Bacillus subtilis and other bacterial SMC mutants, where 
inactivation of smc had a detrimental effect on growth rate and resulted in temperature 
sensitivity (Britton et al., 1998; Jensen and Shapiro, 1999; Volkov et al., 2003). In contrast, 
growth of the M. smegmatis smc mutant strain was not impaired at any temperature examined. 
Susceptibility of the mutant to ofloxacin, an inhibitor of DNA gyrase, was comparable to the 
wildtype. Exposing the mutant to DNA damage caused by ionizing radiation, UV light or 
treatment with the DNA damaging agent mitomycin C, provided evidence that mycobacterial 
SMC has only a minor role, if at all, in DNA repair. Our data also indicate that SMC is not 
essential for resuscitation of dormant bacteria as disruption of SMC did not affect the ability 
of M. tuberculosis and M. smegmatis cells to persist in stationary phase.  
In addition to SMC, other DNA-binding proteins might participate in maintaining 
chromosome organisation in mycobacteria and thus compensate for the loss of SMC. Genome 
sequence analyses indicate that mycobacteria have homologues of many of the proteins found 
to be associated with the nucleoid in E. coli. These proteins include HU (also annotated as 
HupB, Mdp1 or Hlp1, respectively), integration host factor (IHF) and the histone-like 
nucleoid structuring protein (H-NS).  
Some approaches have been made to characterise the role of histone-like protein HU 
(Rv 2986c) in M. tuberculosis. This protein binds to DNA and is capable of suppression of 
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DNA synthesis, transcription and translation in vitro (Furugen et al., 2001). As the expression 
of HU is increased in stationary growth phase, it might be involved in maintaining genomic 
stability during persistence of M. tuberculosis. However, deletion of the HU homologue in 
M. smegmatis did not result in an apparent phenotype and was not essential for survival in 
stationary phase, which might be explained by the redundancy of nucleoid-associated proteins 
in mycobacteria (Lee et al., 1998). This hypothesis is corroborated by the observation that 
several nucleoid-associated proteins can functionally substitute for each other in E. coli 
(Yasuzawa et al., 1992). A DNA-binding protein named Dps (DNA binding Protein from 
Starved cells) is present in M. smegmatis, but no homologues have been annotated in 
M. tuberculosis. Dps function has been analysed in E. coli (Almiron et al., 1992), 
Deinococcus radiodurans (Frenkiel-Krispin et al., 2004), B. subtilis (Frenkiel-Krispin and 
Minsky, 2006), and M. smegmatis (Gupta et al., 2002; Gupta and Chatterji, 2003). The protein 
is upregulated under starvation conditions and binds DNA without apparent sequence 
specificity, forming extremely stable complexes. In stationary phase, abundant Dps proteins 
protect DNA through Dps–DNA co-crystallization (Wolf et al., 1999). This protein might be 
the main substitute for HU function in M. smegmatis. It remains to be shown whether the 
findings on HU obtained in the model organism M. smegmatis hold true for its pathogenic 
relative M. tuberculosis. 
Chromosome structure is also linked to the regulation of gene expression and many nucleoid- 
associated proteins have been found to act as transcription factors besides their function as 
structural proteins (Stavans and Oppenheim, 2006). Recent studies of the iniBAC genes that 
confer antibiotic tolerance in M. tuberculosis revealed that those genes are induced by a 
histone-like protein named lsr2 (Colangeli et al., 2007). These data indicate that nucleoid –
associated proteins might have an important role in the pathogenesis of M. tuberculosis.  
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5.6 Conclusions 
 
With this work we made important progress towards understanding the mechanisms involved 
in maintenance of genome integrity in mycobacteria. Analysis of mycobacterial NER 
provided new insights into mycobacterial DNA repair by pointing out that mycobacteria 
significantly differ in this regard from described model species. Our findings imply that UvrD 
has an important role in compensating for MMR deficiency and that UvrD is involved in 
M. tuberculosis persistence. 
While the M. tuberculosis NER mutants may offer a promising avenue for the development of 
a new class of TB vaccines, further analysis of the mechanisms that govern chromatin 
stability in M. tuberculosis may lead to the development of new drugs active against bacteria 
in the latent state. These antibiotics could be of general use both to shorten the time period 
required to treat active disease and to eradicate latent tuberculosis.  
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1 
Abstract 
In this study, we investigated the role of the nucleotide excision repair (NER) pathway in 
mycobacteria, microorganisms naturally devoid of the mismatch repair (MMR) system. 
Single knock-out mutants deficient in the excinuclease component uvrB and in the helicase 
uvrD and a double knock-out lacking both proteins were constructed in Mycobacterium 
smegmatis. Studying susceptibility to DNA damaging agents, we found that the mycobacterial 
NER system is involved in the repair of a wide range of mutagenic DNA lesions and that the 
mycobacterial NER system is an important defence mechanism against oxidative and 
nitrosative damage. In a gene conversion assay, recognition and subsequent rejection of base-
pairing errors was assessed. Inactivation of uvrB and uvrD increased marker integration 
frequencies, with in part – and dependent on the mismatch studied - synergistic effects in the 
combined uvrB / uvrD mutant. Our results imply that NER and particularly the helicase UvrD 
have important roles in maintaining genome integrity and contribute to compensating for the 
lack of MMR in mycobacteria.  
2 
Introduction 
Part of the success of the pathogen Mycobacterium tuberculosis lies in its ability to survive 
and replicate in macrophages, although the molecular mechanisms allowing it to do so are not 
well understood (Kaufmann, 2001). The production of reactive oxygen intermediates (ROI) 
and reactive nitrogen (RNI) intermediates by macrophages is considered an effective defence 
mechanism against intracellular pathogens (Chan et al., 1992; Ding et al., 1988; Nathan and 
Shiloh, 2000). Among other cellular targets, ROI and RNI attack the chemical compounds of 
the DNA, i.e. the sugar-phosphate backbone and the bases (Burney et al., 1999). 
M. tuberculosis seems to be superbly adapted to these unfavourable conditions which demand 
efficient mechanisms that ensure genome stability. Even though efforts have been made to 
gain insight into mycobacterial DNA repair processes (Curti et al., 2007; Durbach et al., 
2003; Sander et al., 2001; Springer et al., 2001), the mechanisms involved in maintenance of 
genomic fidelity remain ambiguous. In silico analyses of mycobacterial genomes, i.e. M. 
tuberculosis (Cole et al., 1998; Mizrahi and Andersen, 1998), M. leprae (Cole et al., 2001), 
M. bovis (Garnier et al., 2003), M. avium, M. paratuberculosis and M. smegmatis (The 
Institute for Genome Research; http://www.tigr.org) revealed the presence of genes coding for 
enzymes involved in damage reversal, nucleotide excision repair (NER), base excision repair 
(BER), recombinational repair, non-homologous end-joining (NHEJ) and SOS repair. 
However, mycobacteria are devoid of the mutLS-based postreplicative mismatch repair 
(MMR) system (Mizrahi and Andersen, 1998; Springer et al., 2004). The only MMR 
homologue present in mycobacteria is a DNA-helicase named UvrD, which is also part of the 
NER. The MMR system is highly conserved throughout evolution and contributes to mutation 
avoidance by correcting replication errors resulting from nucleotide misincorporation and 
polymerase slippage (Kunkel and Erie, 2005; Schofield and Hsieh, 2003). In addition, MMR 
inhibits recombination between non-identical (homeologous) sequences and thus takes part in 
ensuring the fidelity of recombination (Matic et al., 1995; Rayssiguier et al., 1989; Worth et 
al., 1994). 
The finding that mycobacteria exhibit a general mutation rate that is comparable to that of 
MMR proficient species, suggests that mycobacteria possess alternative or compensating 
strategies for mismatch recognition and repair (Springer et al., 2004). Candidates for 
compensating mechanisms are known DNA repair processes, e.g. NER. Prokaryotic NER has 
been extensively analysed in E. coli. The process of NER in bacteria is mediated by the 
UvrABC excinuclease enzyme complex and the helicase UvrD (Sancar, 1996). The nucleotide 
excision repair system displays a broad substrate specifity: NER recognizes all lesions that 
3 
generate bulky distortions in the conformation of the DNA double helix, e.g. UV-induced 
photolesions such as pyrimidine dimers, intrastrand-crosslinks and large chemical adducts in 
the DNA formed through exposure to genotoxic agents (Batty and Wood, 2000). Analyses of 
NER in Bacillus subtilis (Sancar, 1996), Streptococcus pneumoniae (Sicard et al., 1992), 
Mycoplasma genitalium (Sancar, 1996) and Deinococcus radiodurans (Minton, 1994) 
indicate that the repair mechanism originally characterised in E. coli is highly conserved in 
prokaryotes. Interestingly, an additional function of mycobacterial UvrD besides NER has 
been proposed recently; UvrD was shown to physically and functionally interact with Ku, a 
protein participating in the NHEJ pathway of DNA double strand break repair (Sinha et al., 
2007). 
To study whether the mycobacterial NER pathway contributes to compensating for the 
inherent lack of MMR, we here generated mutants deficient in the NER components uvrD and 
uvrB, as well as a mutant lacking both proteins. The NER mutants were assessed with regard 
to their susceptibilities to various DNA damaging agents. Using a plasmid-based assay we 
also studied a possible involvement of mycobacterial NER in DNA mismatch recognition. 
Our data demonstrate that NER in mycobacteria is functional and that UvrB and UvrD play 
important roles in DNA repair and mutation prevention. In addition, we propose an additional 
function of UvrD besides involvement in the NER system, namely restricting gene 
conversion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
Experimental procedures 
 
 
Bacterial strains, media and culture conditions 
E. coli strain XL1 blue (Stratagene) was used for cloning and propagation of plasmids. 
Bacterial cultures were grown in Luria Bertani (LB) medium at 37°C for 14-20 h. Cultures of 
M. smegmatis SMR5 rrnB (Sander et al., 1996), a derivative of M. smegmatis mc2 155, were 
grown in 7H9 medium at 37°C for 2-3 days. When appropriate, antibiotics were added at the 
following concentrations: ampicillin 100 µg/ml, hygromycin 100 µg/ml; kanamycin 50 
µg/ml; streptomycin 100 µg/ml; apramycin 20 µg/ml; clarithromycin 50 µg/ml; rifampicin 
175 µg/ml. 
 
Generation of mycobacterial NER mutant strains  
Allelic replacement techniques were used to generate M. smegmatis knockout mutants 
(Sander et al., 1995). Using genomic DNA, 1-1.5 kbp fragments upstream (5’) and 
downstream (3’) of the target genes were amplified by PCR and cloned into pMCS5-rpsL-hyg 
for generation of unmarked knock-outs. The following primers were used: uvrD-1 / uvrD-2 
for amplification of the uvrD upstream region; uvrD-3 / uvrD-4 for amplification of the uvrD 
downstream region; uvrB-1 / uvrB-2 for amplification of the uvrB upstream region and uvrB-
3 / uvrB-4 for amplification of the uvrB downstream region. The resulting deletion alleles lack 
basepairs 219 to 2040 of the 2352 basepair uvrD (MSMEG5534) ORF and basepairs 262 to 
1890 of the 2160 basepair uvrB (MSMEG3816) ORF. Primer sequences are given in table 1; 
cloning was verified by sequencing. Vectors were transformed into M. smegmatis SMR5 
rrnB, a derivative of M. smegmatis mc2 155 carrying a non-restrictive rpsL mutation 
conferring streptomycin resistance (Sander et al., 1996). Transformants were plated on 
medium containing hygromycin to select for integration of the knockout vector by 
homologous recombination into the genome. Clones that had undergone a single cross-over 
event were detected by Southern blot analyses and subjected to counterselection. In brief, 
single cross-over clones were grown for three days in liquid broth and subsequently plated on 
selective agar containing streptomycin. Putative knock-out mutants were colony purified and 
investigated by Southern blot analyses for disruption of uvrD and uvrB, respectively. For 
generation of the M. smegmatis uvrB / uvrD double mutant, the uvrB knock-out vector was 
transformed into the M. smegmatis uvrD mutant and selection procedures were applied as 
detailed above. Gene disruption was confirmed by Southern blot analyses. 
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Determination of spontaneous mutation frequencies 
Mutation frequencies were determined by fluctuation experiments. Briefly, at least six parallel 
cultures of each strain were grown until late log phase in 7H9 medium, with a viable cell 
number around 109/ml. Subsequently, cultures were diluted to 2x103/ml and incubated for 2 
days at 37°C. 100 μl of each culture were plated on freshly prepared 7H10 agar plates 
containing rifampicin and serial dilutions were plated on non-selective medium. After 4 days 
of incubation at 37°C, colony forming units (CFU) were determined. The number of CFUs 
obtained on agar plates containing rifampicin was divided by the number of CFUs obtained 
on nonselective medium. For calculation of mutation frequencies, the median of the ratio of 
cells that gained resistance against rifampicin was determined, as previously described (Lea 
and Coulson, 1949; Luria and Delbrück, 1943). 
 
Determination of MIC and MBC 
Minimal inhibitory concentrations (MIC) were determined by E-test (AB BIODISK) 
according to the manufacturer’s instructions. Determination of MBCs was performed in a 
microtiter plate format as described previously (Pfister et al., 2005). In brief, freshly grown 
cultures were diluted to an absorbance (A600) of 0.01 in 7H9 medium and incubated for 72 h 
at 37°C in the presence of 2-fold serial dilutions of rifampicin. The rifampicin stock solution 
(2 mg/ml) was made in DMSO. Aliquots from those wells that showed growth inhibition were 
plated on drug-free solid agar and incubated at 37°C for a further 72 h. The MBC is defined 
as the minimal drug concentration that kills > 99.9 % of the inoculum. 
 
Survival after exposure to UV light 
UV sensitivity of strains was determined by plating dilutions (in triplicate) on solid medium 
followed by irradiation of open plates in a Stratalinker 2400 (Stratagene, 254nm) at 0–160 
mJ/cm2 (approximately 0-5 seconds). CFUs were determined after 3-4 days incubation at 
37°C and compared to the untreated control. 
 
Survival after treatment with DNA damaging agents 
25 ml cultures of each strain were grown in 7H9 medium until early mid-log phase and serial 
dilutions were plated on LB agar for CFU determination. For determination of susceptibility 
to NaNO2, cultures were centrifuged and resuspended in 7H9 medium acidified with HCl (pH 
5.4). Subsequently, cultures were split into six 3 ml aliquots. Freshly prepared compounds 
(tert-butylhydroperoxide 250 µM, NaNO2 3 mM, mitomycin C 0.02 µg/ml) were added to 
6 
three aliquots, the remaining aliquots served as untreated control. After incubation for 24 h at 
37°C, serial dilutions were plated onto LB agar. CFUs were counted after 3 days growth at 
37°C. Survival was calculated by the ratio of CFUs of the treated cultures compared to the 
CFUs of the untreated controls.  
 
Determination of gene conversion frequencies 
M. smegmatis strains were transformed with an integrative vector carrying various versions of 
mutated rrnA gene fragments. The approximately 1.0 kb partial 16S rRNA gene fragment 
with a mutated 1491 position covered 16S rRNA position 907 to ITS 1 position 2367, the 
partial 23S rRNA gene fragment with a mutated 2058 or 2059 position covered 23S rRNA 
position 1426 to 2624. Upon recombination with the chromosomal wildtype rrnA gene, the 
vector-encoded mutated rrnA gene fragment confers drug resistance (apramycin for the 16S 
rRNA 1491 mutation, clarithromycin for the 23S rRNA 2058/2059 mutation, vectors listed in 
table 2). Gene conversion frequencies were assessed by fluctuation experiments. Briefly, for 
each construct and strain, at least ten independent transformants were picked and grown. 
Aliquots of these precultures were taken to inoculate 4 ml 7H9 medium with approximately 
5x105 cells. After two days of growth, serial dilutions were plated on permissive medium and 
on selective medium containing apramycin or clarithromycin. The relative marker integration 
frequency was determined by the ratio of cells which gained antibiotic resistance compared to 
the number of cells obtained on permissive medium.  
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Results  
To study the role of the NER pathway in mycobacteria, we generated M. smegmatis mutants 
deficient in uvrB and in uvrD. In addition, a double mutant deficient in both genes was 
constructed. Disruption was verified by Southern blot analysis (Figures 1a, 1b). For 
comparison, a M. smegmatis recA mutant (Frischkorn et al., 1998) was included in the 
studies. 
Growth characteristics. The in vitro growth characteristics of the uvrB and uvrD mutant 
strains in Middlebrook 7H9 medium were indistinguishable from that of the parental strain. 
Growth of the uvrB / uvrD double mutant was considerably impaired, with a twofold increase 
in generation time compared to the wildtype (Figure 2a). 
Survival after treatment with DNA damaging agents. To investigate whether absence of 
NER in M. smegmatis affects DNA repair proficiency, mutants were challenged with DNA-
damaging agents in survival assays. Different DNA damaging compounds were chosen to 
cover various types of DNA damage.  
i) NER is responsible for the repair of bulky adducts resulting from UV-light exposure in E. 
coli, prompting us to study the impact of short wavelength UV light (UV-C) on survival of M. 
smegmatis NER mutants. The uvrB and uvrD mutant strains as well as the recA mutant strain 
were considerably more susceptible than the wildtype strain. Interestingly, combined deletion 
of uvrB and uvrD had an additive effect on survival following treatment with UV; the double 
mutant was unable to survive doses in excess of 80 mJ / cm2 (Figure 2b). ii) Tert-butyl-
hydroperoxide (TBH) generates ROI which can attack the bases and the sugar-phosphate 
backbone of the DNA, leading to strand breaks and base adducts (Halliwell and Aruoma, 
1991). Treatment with TBH may also result in formation of alkoxyradicals and methylation 
reactions of the DNA, thus leading to alkylation damage (Hix et al., 1995). The M. smegmatis 
NER mutants were significantly more susceptible towards TBH compared to the wildtype 
strain (Figure 2c; p < 0.05, student’s t-test). The uvrB, uvrD and the uvrB / uvrD double 
mutant displayed similar susceptibilities (student’s t-test: p > 0.1). TBH susceptibility of the 
M. smegmatis recA mutant was only slightly, yet significantly increased compared to the 
wildtype (42 % surviving cells recA mutant compared to 77% surviving cells wildtype; p < 
0.05 student’s t-test). These findings indicate that NER is more important than homologous 
recombinational repair in defence against ROI and alkylation damage in mycobacteria. iii) 
Acidified sodium nitrite generates RNI, leading to oxidative damage of the DNA as well as 
inducing nitration, nitrosation and deamination reactions (Burney et al., 1999). The M. 
smegmatis recA mutant displayed a similar susceptibility to RNI as the wildtype (12% and 15 
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% surviving cells; p > 0.08 student’s t-test, Figure 2d), while the M. smegmatis NER mutants 
displayed significantly increased susceptibilities to acidified sodium nitrate (p < 0.05, 
student’s t-test). The uvrD and uvrB / uvrD mutants were considerably more susceptible than 
the uvrB mutant (Figure 2d), suggesting a further role of uvrD in the repair of RNI induced 
DNA damage. iv) Exposure to mitomycin C (MMC) results in alkylation and interstrand 
crosslinks (Iyer and Szybalski, 1963; Kumar et al., 1992), which are mainly repaired by NER 
in E. coli (Van Houten et al., 2005). The M. smegmatis NER mutants showed different 
susceptibilities towards treatment with MMC. While susceptibilities of the recA and the uvrD 
mutants were significantly increased compared to the wildtype, the uvrB and uvrB / uvrD 
mutants were highly susceptible towards MMC (Figure 2e).  
Spontaneous mutation frequencies. Rifampicin has a single molecular target, the ß subunit 
of RNA polymerase encoded by rpoB. Various point mutations in rpoB confer high-level drug 
resistance. The frequency at which bacteria generate rifampicin-resistant mutants is widely 
used to assess the general spontaneous mutation frequency. The calculation is based on the 
model for the distribution of mutant clones originally described by Luria and Delbrück (1943) 
and extended by Lea and Coulson (1949). The wildtype strain displayed a spontaneous 
mutation frequency of 3.8 x 10-8 (Figure 3). In comparison, deletion of uvrD resulted in an 
approximately threefold increased mutation frequency (9.1 x 10-8, p < 0.05, n= 6, students t-
test) and deletion of uvrB resulted in a fivefold increased mutation frequency (1.9 x 10-7, p < 
0.01, n= 6, students t-test). Inactivation of recA did not affect the mutation frequency (1.7 x 
10-8 p > 0.05, n= 6, students t-test). The mutation frequency of the double mutant could not be 
assessed with this approach, as the uvrB / uvrD mutant strain was unable to grow on plates 
containing 175 μg/ml rifampicin used for selection of spontaneous drug resistant mutants. 
Considering the general growth defect of this strain, we assumed that the uvrB / uvrD mutant 
is incapable of acquiring high-level resistance against rifampicin. Minimal inhibitory 
concentration (MIC) assays revealed that the uvrB / uvrD mutant displayed a decreased MIC - 
4 μg/ml rifampicin compared to 32 μg/ml (wildtype, uvrB mutant strain) and 16 μg/ml (uvrD 
mutant strain); the minimal bactericidal concentration (MBC) for the uvrB / uvrD double 
mutant were found to be 130 μg /ml compared to 500 μg /ml for the wildtype strain and the 
uvrB and uvrD single mutant strains. Given the decreased MBC of rifampicin, we assessed 
the spontaneous mutation frequency of the uvrB / uvrD double mutant on plates containing 75 
μg/ml rifampicin. Using this approach, the uvrB / uvrD double mutant strain was found to 
display an approximately 20 fold increased spontaneous mutation frequency (7.2 x 10-7, p < 
0.01, n= 6, students t-test) compared to the wildtype strain.  
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Involvement of NER in mismatch recognition. Base-base mispairing occurs in duplex DNA 
in the form of purine-purine (G/G, A/A, G/A), purine-pyrimidine (G/T, A/C) or pyrimidine-
pyrimidine (C/C, T/T, T/C) mismatches. With the exception of C/C, all base-base mispairings 
are subject to correction by the mismatch repair system (Marra and Schär, 1999). As 
mycobacteria are devoid of this otherwise highly conserved repair system, the effects of 
MMR deficiency and a possible compensating role of NER in postreplicative repair were 
investigated. Towards this end, a plasmid transformation-based assay was applied (Pfister et 
al., 2004). Following integration at the attB site of the mycobacterial genome, intramolecular 
recombination between the chromosomal M. smegmatis rrnA gene and a plasmid-borne rrnA 
gene fragment carrying a specific resistance mutation leads to antibiotic resistance. 
Intrachromosomal recombination occurs via an intermediate with a non-Watson-Crick base 
pairing. In repair proficient cells, the intermediate is recognized and rejected, resulting in 
decreased gene conversion frequencies. In case of repair deficiency, the intermediate will not 
be recognized as abnormal, leading to mutation of the chromosomal rrnA operon following 
replication and postmitotic segregation in 50 % of the progeny, with consequent gain in 
resistance to the relevant antibiotic. The assay provided the opportunity to analyse recognition 
of different mismatches, e.g. purine-pyrimidine (G/T, A/C) or pyrimidine-pyrimidine (C/C, 
C/T, T/C) mismatches. The M. smegmatis wildtype chromosome harbours a second rrn 
operon (named rrnB) in addition to the rrnA operon, which precludes proper measurement of 
gene conversion frequencies using the assay described above. Hence, the NER mutants were 
constructed in a Δ rrnB background (Sander et al., 1996).  
M. smegmatis rrnB NER mutant strains were transformed with an integrative vector carrying 
a mutated rrnA gene fragment. For each of the different rrnA fragments, specific gene 
conversion frequencies were obtained. Comparison of marker integration frequencies 
observed in the wildtype revealed that the highest gene conversion frequencies (in the range 
of 10-4 to 10-5) were found with an A → C mutation leading to a C/T mismatch (Figure 4a). 
This mismatch was analysed making use of two different constructs with the A → C mutation 
located at 23S rRNA position 2058, or 2059, respectively. Deletion of uvrD resulted in 
significantly (approximately tenfold) increased gene conversion frequencies in comparison to 
the wildtype. In contrast, gene conversion frequencies in the uvrB mutant were virtually at 
wildtype control level (student’s t-test, n=10, p>0.05). Interestingly, combined deletion of 
uvrB and uvrD resulted in significantly elevated marker integration frequencies (about 5 fold 
[A → C mutation located at 23S rRNA position 2058] or 20 fold [A → C mutation located at 
23S rRNA position 2059]) compared to the frequencies obtained in the uvrD single mutant 
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(Figure 4a). Analysis of marker integration frequencies with an rrnA fragment carrying an A 
→ G mutation which leads to a G/T mismatch, gave similar results (Figure 4a). Again, two 
different constructs carrying the mutation at 23S rRNA position 2058, or 2059, were used. In 
general, marker integration frequencies were lower with the A → G mutation than with the A 
→ C mutation, yielding frequencies in the range of 10-5 and 10-6 in M. smegmatis wildtype. 
Gene conversion frequencies were considerably (about tenfold) elevated in the uvrD mutant, 
but only marginally (3 to 4 fold) increased in the uvrB mutant. A synergism of combined 
absence of uvrB and uvrD was observed, as the double mutant displayed marker integration 
frequencies about 20 fold higher than those of the uvrD single mutant (Figure 4a). 
Recognition of A/C and C/C mismatches was determined with rrnA fragments carrying a G 
→ A mutation or a G → C mutation at 16S rRNA position 1491. Gene conversion frequencies 
of the wildtype were in the range of 1 x 10-6. Gene conversion frequencies of the uvrB mutant, 
and the uvrD mutant were only marginally (about fourfold) increased and no synergism of 
combined deletion of uvrB and uvrD was observed for A/C and C/C mismatch recognition 
(Figure 4b). Analysis of marker integration frequencies using an rrnA fragment carrying a G 
→ T mutation provided insights into recognition of T/C mismatches. The uvrD mutant strain 
and the uvrD / uvrB mutant strain yielded more than tenfold increased gene conversion 
frequencies, whilst the uvrB mutant strain yielded fourfold increased frequencies (Figure 4b). 
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Discussion 
In this study, M. smegmatis mutants deficient in NER were generated and characterised. NER 
mutants in E. coli  are sensitive not only to irradiation with UV, but also to a wide range of 
chemical agents, including MMC (Friedberg, 2005). Consistently, we found that M. 
smegmatis NER mutants are sensitive to treatment with UV and MMC. Compared to the 
mycobacterial uvrB mutant, the uvrD mutant is extremely susceptible towards MMC, 
corroborating the previous observation that E. coli uvrB mutants were significantly more 
susceptible towards MMC than E. coli uvrA, uvrC and uvrD  mutants (Vidal et al., 2006). The 
M. smegmatis NER mutants, but not the recA mutant, are hypersensitive to TBH, indicating a 
role of mycobacterial NER in the repair of oxidative and alkylation damage. In contrast, 
repair of oxidative DNA damage is primarily accomplished by homologous recombinational 
repair and base excision repair (BER) in E. coli (Konola et al., 2000). NER of E. coli is not 
involved in the repair of ROI induced lesions, as E. coli uvrA, uvrB and uvrC mutants show 
wild-type like sensitivity to hydrogen peroxide (Imlay and Linn, 1987). Alkylation damage is 
mainly repaired by methyltransferases and BER in E. coli (Nowosielska et al., 2006). NER is, 
if at all, only moderately capable of repairing these lesions (Samson et al., 1988; Van Houten 
et al., 2005). Our findings indicate that contrary to observations in E. coli, NER is more 
important than homologous recombinational repair in defence against ROI and alkylation 
damage in mycobacteria. Repair of RNI induced DNA damage in E. coli is mainly 
accomplished by repair mechanisms other than NER, primarily by BER and homologous 
recombinational repair (Spek et al., 2001), although a role for UvrA in resistance to acidified 
sodium nitrite has been reported (Sidorkina et al., 1997). The mycobacterial NER mutants are 
more susceptible than both the wildtype strain and the recA mutant to the RNI generating 
agent acidified sodium nitrite. The mild RNI / ROI phenotype of the recA mutant indicates a 
minor role for homologous recombinational repair in repairing ROI and RNI induced lesions. 
Taken together, our data provide evidence that NER in mycobacteria is functional and that 
UvrB and UvrD play important roles in DNA repair. This is corroborated by analyses of 
spontaneous mutation frequencies towards rifampicin resistance. M. smegmatis uvrD and 
uvrB mutants display elevated spontaneous mutation frequencies compared to the wildtype 
strain, indicating that disruption of NER has an impact on genomic integrity. Our findings 
suggest that the substrate spectrum of mycobacterial NER may differ from that of the 
described model species E. coli.  
Combined deletion of uvrB and uvrD has not been analysed in other prokaryotes so far. 
Interestingly, loss of both proteins rendered cells more sensitive to UV than the uvrB and 
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uvrD single mutants, implying an additional role for one of these proteins besides NER. This 
assumption is corroborated by the observation that the in vitro growth rate of the double 
mutant was significantly reduced, whereas growth of the uvrB and uvrD single mutants was 
similar to that of the wildtype. We were unable to select for spontaneous resistant clones of 
the uvrB / uvrD mutant on medium containing high concentrations of rifampicin and found 
that the double mutant is significantly more susceptible to rifampicin as determined by MIC 
and MBC assays. Hence, the spontaneous mutation frequency towards rifampicin resistance 
was analysed at lower drug concentrations. The spontaneous mutation frequency of the double 
mutant was found to be considerably elevated compared to the uvrB and uvrD single mutants, 
indicating that overall repair capability is significantly impaired. However, a statistically 
significant additive effect of combined lack of uvrB and uvrD was not observed when the 
strains were assayed for their sensitivity to MMC, TBH and acidified sodium nitrate. Other 
repair pathways, like BER and recombinational repair, may have overlapping repair 
specificities for DNA damage generated by these compounds and thus may partially 
compensate for the lack of uvrB and uvrD under these conditions.  
To investigate mismatch recognition in the absence of a MMR system, we made use of gene 
conversion assays. The assay applied in this study allows M. smegmatis cells to acquire 
antibiotic resistance upon recombination between the chromosomal rrnA operon and a 
plasmid borne partial gene fragment carrying a specific resistance mutation. This assay 
provided the opportunity to analyse recognition of different mismatches. Quantification of the 
relative marker integration frequencies revealed that marker integration depends on the 
specific mismatch, corresponding to observations formerly made in MMR proficient species. 
The efficiency of repair for different base-pairing errors varies and appears to depend on 
multiple factors such as the physical structure of the mismatch and the sequence context 
(Dohet et al., 1985; Jones et al., 1987; Marra and Schär, 1999). In E. coli, the correction of 
G/T, A/C, G/G and A/A mismatches by the MMR system is highly effective, while 
elimination of C/T, T/T and A/G mismatches occurs with decreased efficiency. For C/C 
mispairing, no correction activity can be observed (Dohet et al., 1985; Kramer et al., 1984; 
Parker and Marinus, 1992). We found that the M. smegmatis uvrB mutant displayed elevated 
gene conversion frequencies for most of the mismatches analysed. As gene conversion is 
mediated by recombination and occurs as consequence of absent mismatch recognition, our 
results indicate that mycobacterial NER may be involved in limiting recombination and act in 
the repair of DNA mismatches. A complementary function of NER in recognition of 
mismatches is corroborated by studies in Schizosaccharomyces pombe. NER of S. pombe is 
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capable of recognizing and repairing C/C mismatches, which are not substrates of MMR. In 
the absence of MMR, other mismatches are processed by NER as efficiently as C/C 
mismatches (Fleck et al., 1999; Kunz and Fleck, 2001). Marker integration frequencies 
obtained in the M. smegmatis uvrD mutant are significantly increased compared to those 
obtained in the uvrB mutant. These findings imply that UvrD has a further role besides 
involvement in the NER pathway. The involvement of mycobacterial UvrD in mismatch 
recognition and limiting recombination is supported by previous findings. Analysis of E. coli 
UvrD function (Washburn and Kushner, 1991) and more recent studies in H. pylori (Kang and 
Blaser, 2006) revealed that deficiency in UvrD results in a hyperrecombinogenic phenotype. 
These observations can be explained by two different models. The first model refers to the 
assumption that NER or MMR remains incomplete as a consequence of UvrD deficiency 
(Arthur and Lloyd, 1980). Thus, nicks in the DNA occur more frequently. Replication forks 
will be stalled at such nicks, subsequently leading to the formation of double strand breaks 
which will be repaired by recombinational repair (Arthur and Lloyd, 1980). In another model 
it was proposed that UvrD participates in degradation of toxic recombination intermediates by 
actively removing RecA proteins from DNA (Centore and Sandler, 2007; Lestini and Michel, 
2007). This model is based on observations made in yeast and E. coli. UvrD of E. coli 
(Centore and Sandler, 2007; Flores et al., 2004; Flores et al., 2005; Petit and Ehrlich, 2002; 
Veaute et al., 2005) as well as the helicase Srs2 of yeast (Veaute et al., 2003) were found to 
act as anti-recombinases to prevent potentially deleterious recombination events. 
The uvrB / uvrD double mutant displayed significantly higher gene conversion frequencies 
than the uvrB and uvrD single mutants. Hence, combined loss of UvrB and UvrD function 
results in a synergistic (i.e. greater than additive) effect in mycobacteria. In the absence of 
NER and the anti-recombination function of UvrD, the bacteria are devoid of two important 
mutation avoidance mechanisms, resulting in high gene conversion frequencies. The 
synergism of UvrB and UvrD function in gene conversion prevention was not observed for 
recognition of A/C or C/C mismatches. The single mutant and the double mutant strains 
displayed similar marker integration frequencies, which were only marginally elevated 
compared to the wildtype strain. In the wildtype strain, A/C and C/C gene conversion 
frequencies are lower than those obtained with the other mismatches. These findings can be 
explained by the topological properties of the respective mismatches. A/C and C/C 
mismatches are the least stable mismatches and lead to significant distortions of the DNA 
double helix. Hence, due to the unstable nature of the mismatch, the mismatch is rejected 
irrespective of repair, which accounts for the low marker integration frequencies obtained in 
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the assay. Consequently, only a minor proportion of mismatch intermediate rejection is 
caused by the anti-recombination function of UvrD. 
Taken together, our observations provide evidence that despite the lack of MMR, 
mycobacteria possess efficient DNA repair mechanisms. We found that mycobacterial NER is 
capable of repairing a wide range of DNA damage. Furthermore, our data suggest a 
complementary function of NER in the recognition of DNA mismatches. The helicase 
component UvrD was shown to limit marker integration frequencies. We propose that repair 
of DNA mismatches is accomplished differently in mycobacteria than in the described model 
species. Further investigations will provide insights into new mechanisms that govern genome 
stability in mycobacteria. 
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Table 1: Primers used for  gene cloning 
Primer name Sequence 
uvrD-1 
uvrD-2 
uvrD-3 
uvrD-4 
uvrB-1 
uvrB-2 
uvrB-3 
uvrB-4 
5’-GGAATTCCATATGGTGAGGACGCCTACGAC-3’  
5’-GGAAGATCTGGTGAACGTGATGGCCAG-3’ 
5’-GGAAGATCTGCAGGAACTCATCGACTGGCG-3’ 
5’-TGCATGCATGATCGCGTCGGGCACCTTC-3’ 
5’-GGAATTCCATATGGGCCGAGTACGGCCAGTC-3’ 
5’-GGAAGATCTGCGCCATCACGAGCGTG-3’ 
5’-GGAAGATCTGAGTCGGTCGAGATCGGTGG-3’ 
5’-TGCATGCATCGTCATGTGCGCCAGCCGC-3’ 
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Table 2: Recombination substrates containing a mutated rrnA fragment. All vectors harbour a mutated rrnA 
fragment which confers antibiotic resistance (corresponding antibiotic denoted in parentheses) upon 
recombination with the chromosomal wildtype rrnA gene. Numbers indicate the rrnA position of the mutated 
nucleotide. 
 
 
pMV361ΔKan-Gm-rRNA A 2059 C (Clarithromycin) 
pMV361ΔKan-Gm-rRNA A 2059 G (Clarithromycin) 
pMV361ΔKan-Gm-rRNA A 2058 C (Clarithromycin) 
pMV361ΔKan-Gm-rRNA A 2058 G (Clarithromycin) 
pMV361ΔKan-Gm-rRNA G 1491 A (Apramycin) 
pMV361ΔKan-Gm-rRNA G 1491 C (Apramycin) 
pMV361ΔKan-Gm-rRNA G 1491 T (Apramycin) 
 
 
(Pfister et al., 2004) 
(Pfister et al., 2004) 
(Pfister et al., 2004) 
(Pfister et al., 2004) 
(Pfister et al., 2005) 
(Pfister et al., 2005) 
(Pfister et al., 2005) 
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Figure legends  
 
Figure 1: Generation of M. smegmatis NER mutants  
A Disruption of M. smegmatis uvrD. Left: Southern blot analysis. Genomic DNA from M. smegmatis wildtype 
(lane 1), uvrD mutant (lane 2) and uvrD single cross-over mutant (lane 3) was digested with BstXI and probed 
with a 653bp MluI/BamHI DNA fragment containing 5’ flanking sequences of the uvrD gene. The presence of a 
single 10.7 kbp fragment instead of a 2.0 kbp fragment as seen in the parental strain demonstrates successful 
deletion of uvrD coding sequences. Right: Schematic illustration of the uvrD locus and Southern blot analysis. 
Shown are the genomic organization of the wild type (wt), the knockout vector that contains the uvrD deletion 
allele (vector), the single cross-over genotype (sco), and the mutated genomic uvrD region in the knockout 
mutant (ko). Fragments detected by the probe specific for the 5’ flanking region are indicated. 
B Disruption of M. smegmatis uvrB. Left: Southern blot analysis. Genomic DNA from M. smegmatis uvrB 
mutant (lane 1), uvrB single cross-over mutant (lane 2) and wildtype (lane 3) was digested with NcoI and probed 
with a 600bp NdeI/BsmI uvrB gene fragment. The presence of a single 3.9 kbp fragment instead of a 5.6 kbp 
fragment as seen in the parental strain demonstrates successful deletion of uvrB coding sequences. Right: 
Schematic illustration of the uvrB locus and Southern blot analysis. Shown are the genomic organization of the 
wild type (wt), the knockout vector that contains the uvrB deletion allele (vector), the single cross-over genotype 
(sco), and the mutated genomic uvrB region in the knockout mutant (ko). Fragments detected by the probe 
specific for the uvrB gene are indicated. 
 
 
Figure 2: In vitro growth analysis and survival of M. smegmatis strains following DNA damage  
A In vitro growth analysis of M. smegmatis strains. Strains were grown in 7H9 broth in shaking cultures for 2 
days at 37°C. Doubling times: wildtype 3.7 h +/- 0.1, uvrD mutant 3.5 h +/- 0.2, uvrB mutant 3.4 h +/- 0.2, uvrB 
/ uvrD mutant 7.6 h +/- 0.4, recA mutant 3.9 h +/- 0.2. 
B Survival following irradiation with UV-C. Survival was calculated from the ratio of cells that survived 
treatment with UV-C in comparison to the untreated control. Shown are the mean values of one representative 
experiment performed with three independent cultures each. Standard deviations of the means are given in the 
error bars. Ratio of treated to untreated cells is plotted in logarithmic scale. The uvrB / D mutant was unable to 
survive doses higher than 80 mJ / cm .2   
C-E Survival after treatment with different DNA damaging agents. C  tert-butyl-hydroperoxide (250 μM)   
D acidified NaNO2 (pH 5.4, 3mM); E Mitomycin C (0.02 μg/ml). Survival was calculated from the ratio of cells 
that survived treatment with the DNA damaging agent in comparison to the untreated control. Shown are the 
mean values of one representative experiment performed with three independent cultures each. Strains were 
incubated with the DNA damaging agent for 24 h. Standard deviations from the mean are given in the error bars. 
Abbreviations: wt = M. smegmatis wildtype strain; uvrB, uvrD, uvrB/D = M. smegmatis NER mutant strains, 
recA  = M. smegmatis recA mutant strain. 
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Figure 3: Frequencies of mutation to rifampicin resistance 
Shown are the median values (horizontal lines), 95% confidence interval (rectangular boxes) and outliers 
(vertical lines) of mutation frequencies calculated from the ratio of cells that gained rifampicin resistance in six 
independent cultures of each strain. * Significant increase of mutation frequency compared to the wildtype 
(student’s t-test p<0.05). Abbreviations: wt = M. smegmatis wildtype strain; uvrB, uvrD, uvrB/uvrD = M. 
smegmatis NER mutant strains, recA  = M. smegmatis recA mutant strain. 
 
 
 
Figure 4 Relative gene conversion frequencies obtained with rrnA fragments resulting in  C/T or G/ T 
mismatches (A) and rrnA fragments resulting in A/C, C/C or T/C mismatches (B) 
Shown are the median values (horizontal lines), 95% confidence intervals (rectangular boxes) and outliers 
(vertical lines) of gene conversion frequencies calculated from the number of cells that gained apramycin or 
clarithromycin resistance in ten independent cultures of each strain. * significant increase of gene conversion 
frequencies compared to the wildtype (student’s t-test, p<0.05). Abbreviations: wt = M. smegmatis wildtype 
strain; uvrB, uvrD, uvrB/uvrD = M. smegmatis NER mutant strains. 
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Figure 1 
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Figure 2 
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SMC (structural maintenance of chromosomes) proteins play fundamental roles in various aspects of
chromosome organization and dynamics, including repair of DNA damage. Mutant strains of Mycobacterium
smegmatis and Mycobacterium tuberculosis defective in SMC were constructed. Surprisingly, inactivation of smc
did not result in recognizable phenotypes in hallmark assays characteristic for the function of these genes. This
is in contrast to data for smc null mutants in other species.
Most bacterial cells contain a single circular chromosome
that is folded and compacted into a structure called the nucle-
oid (24). Diverse DNA binding proteins are associated with the
nucleoid and take part in chromosome organization to assist in
a variety of complex processes such as replication, recombina-
tion, repair, modification, and transcription (8). Among these
proteins are the SMC (structural maintenance of chromo-
somes) proteins that are conserved from prokaryotes to eu-
karyotes (4, 5, 28). The SMC family proteins are large proteins
in the range between 110 and 170 kDa and share common
principles in domain organization: globular N- and C-terminal
domains which are connected by two long coiled-coil domains,
separated by a globular hinge domain of approximately 150
amino acids in length (12).
Eukaryotes possess at least six distinct SMCs that participate
in chromosome condensation, sister chromatid cohesion, DNA
repair, and gene dosage compensation (16, 19). Pairs of SMC
proteins form antiparallel heterodimers which assemble with
accessory proteins into complexes, such as the condensin com-
plex (SMC2 and SMC4), which condenses the chromosomes
during mitosis, and the cohesin complex (SMC1 and SMC3),
which mediates sister chromatid cohesion. Another complex
composed of SMC5 and SMC6 is involved in the cellular re-
sponse to DNA damage. Genetic and biochemical evidence
suggests that cohesin and the SMC5/6 complex cooperate in
the recombinational repair of double-strand breaks (17). The
cohesin complex assists in homologous recombination by hold-
ing sister chromatids together in the vicinity of the double-
strand breaks (26). The function of the SMC5/6 complex was
first recognized by the increased sensitivity of Schizosaccharo-
myces pombe SMC6 mutants to UV light and ionizing radiation
(21). Recent investigations of the SMC5/6 complex in yeasts,
plants, and human cells have shown that deletion of compo-
nents of this complex leads to an increased sensitivity towards
DNA-damaging agents (22).
In contrast to the multiple SMC proteins present in eu-
karyotes, most bacteria possess only a single SMC (28). This
single SMC protein is proposed to carry out several of the
functions divided between specialized SMC complexes in eu-
karyotic cells. Bacterial SMC proteins form antiparallel ho-
modimers through interactions in the hinge region, resulting in
symmetric molecules where both ends contain an ATPase and
a DNA binding domain (10). The gammaproteobacteria (such
as Escherichia coli) possess the MukB protein instead of SMC.
MukB is distantly related to SMC with structural and func-
tional similarity (20). SMC from Bacillus subtilis or Caulobacter
crescentus functionally resembles eukaryotic SMCs. The pro-
teins are not essential, but null mutants of SMC generate
anucleate cells (“titan cells”) and display aberrant nucleoid
formation (decondensed chromosomes) (2, 15, 31). In addi-
tion, deletion of SMC results in increased susceptibility to
DNA-damaging agents (7).
Little is known about chromosome stability, organization,
and partitioning in mycobacteria. Mycobacterium tuberculosis
persists for decades in its host during latent infection (30). It is
thus of interest to investigate the mechanisms which contribute
to the capability of the bacterium to stabilize its genome during
persistence and ensure proper cell division following reactiva-
tion. Bioinformatic analyses indicated that all mycobacterial
genomes encode a single SMC homologue. A homologous
open reading frame (ORF) is also present in Mycobacterium
leprae, a bacterium that has lost various gene functions during
reductive genomic evolution (6).
Mycobacterium smegmatis smc (MSMEG2422) encodes an
1,195-amino-acid polypeptide with a calculated molecular
mass of 129.7 kDa. The protein shares all structural motifs
conserved in members of the SMC family as determined by
Clustal W multiple sequence alignments and InterPro Scan
protein motif searches. Homologous sequences are restricted
to the head, hinge, and tail domains. The three domains are
connected by two long heptad repeat regions predicted to form
coiled coils. Overall, M. smegmatis SMC shares 74% identity
with the 1,205-amino-acid SMC sequence of M. tuberculosis
and 55% identity with the 1,186-amino-acid SMC sequence of
B. subtilis. Eukaryotic SMC proteins functionally interact with
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other proteins, and SMC of B. subtilis was found to function in
concert with two proteins called ScpA and ScpB (11). Both M.
tuberculosis and M. smegmatis have homologues of these inter-
acting proteins, suggesting that mycobacterial SMC is func-
tional (ScpA homologues, Rv1709/MSMEG3748; ScpB homo-
logues, Rv1710/MSMEG3749; sequences were obtained from
The Institute for Genomic Research website and TubercuList
of Institut Pasteur, respectively).
To study the function of mycobacterial SMC, we generated
an smc-null mutant in Mycobacterium smegmatis, an estab-
lished model for genetic and biochemical studies in mycobac-
teria (1, 14). The mutant was constructed by allelic-exchange
mutagenesis (14, 23). Using genomic DNA as template, a 2-kb
deletion allele was constructed by joining PCR products that
contain parts of the ORF flanked by upstream and downstream
sequences. The resulting deletion allele lacks bp 747 to 2660
of the 3,588-bp ORF. To allow proper selection of gene
deletion mutants, a hygromycin resistance cassette was in-
serted between the two fragments, resulting in the deletion
allele smc::hyg. Transformation and counterselection proce-
dures for M. smegmatis were performed at room tempera-
ture. Transformants were plated on medium containing hy-
gromycin to select for homologous recombination of the
knockout vector into the genome. Southern blot analysis
revealed a clone that displayed a pattern indicative of a
single-crossover event, i.e., tandem arrangement of the de-
letion allele upstream of the functional smc allele (desig-
nated 5 sco). The single-crossover clone was grown for 5
days in liquid medium at room temperature. Subsequently,
the bacteria were plated on selective 7H10 agar containing
streptomycin and hygromycin to select against maintenance
of knockout vector sequences which contain the wild-type
rpsL gene. Southern blot analyses demonstrated that in 11 of
24 analyzed clones, the wild-type smc gene was replaced by
the deletion allele, resulting in smc knockout mutants (Fig.
1). All selection steps were set off with bacteria taken from
frozen stocks to ensure that no suppressor mutations arose
due to extensive passaging.
One prominent phenotype of previously described smc null
mutants is temperature sensitivity (2, 15, 31). As many SMC
mutants have distinctive growth defects at high growth rates
(2), we analyzed the in vitro growth characteristics in 7H9
broth in comparison to the parental wild-type strain. 7H9 me-
dium is known to support optimal in vitro growth of mycobac-
teria. In addition to growth at the standard incubation temper-
ature (37°C), we assessed the growth rate at lower (30°C) and
higher (42°C) temperatures. In contrast to smc null mutant
phenotypes reported for B. subtilis and C. crescentus, the
growth rates of the mutant and the wild type were similar in M.
smegmatis at the various temperatures investigated (Fig. 2A).
Doubling times in logarithmic phase were nearly identical,
indicating that smc deletion does not affect in vitro growth of
M. smegmatis. Additionally, the wild type and the mutant were
indistinguishable with respect to colony morphology; when
FIG. 1. Generation of M. smegmatis smc mutant. (A) Southern blot analysis. Genomic DNA from M. smegmatis wild type (lane 1), smc mutant
(lane 2), and the smc single-crossover mutant (lane 3) was digested with BamHI and probed with a 685-bp PvuII gene fragment containing the
5 flanking region of the smc gene. The presence of a single 3.8-kbp fragment in the mutant strain instead of a 7.3-kbp fragment observed in the
parental strain demonstrates successful deletion of smc coding sequences. (B) Schematic illustration of the smc locus and the Southern blot
strategy. Shown are the genomic organization of the wild type (wt), the knockout vector that contains the deletion allele smc::hyg (vector), the
single-crossover genotype (sco), and the mutated genomic smc region in the knockout mutant (ko). Fragments detected by the probe specific for
the 5 flanking region are shown in bold letters.
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grown on 7H10 agar, both strains showed the typical features
of mycobacterial colonies with rough dry surfaces and irregular
edges (data not shown).
To assess if SMC deficiency leads to an increase in mutation
frequency, the frequencies of spontaneous resistance to
rifampin were determined. Four independent cultures of the
parental wild-type strain and of the mutant strain were grown
in 7H9 broth to mid-log phase, and aliquots were plated on
7H10 plates containing rifampin (175 g/ml). To calculate the
spontaneous mutation frequency, CFU were determined in
parallel by plating serial dilutions on nonselective LB medium.
Mutation frequencies were comparable in wild-type (3.1 
108 1.5 108) and mutant (3.8 108 1.0 108; P
0.68; n  4; Student’s t test) strains, indicating that SMC
deficiency does not result in a mutator phenotype in M. smeg-
matis.
DNA gyrase, which generates negative supercoiling, and to-
poisomerase I, which prevents excessive negative supercoiling
by DNA gyrase, are essential to maintain the optimal topolog-
ical state of DNA in the cell (3). Previous investigations have
indicated that SMC proteins mediate chromosome compaction
by contributing to the introduction of negative supercoils into
DNA (29). This is corroborated by the observation that smc
and mukB mutants are hypersusceptible to gyrase inhibitors
(25), while loss of MukB function can be partially compensated
for by reducing topoisomerase I activity (29). To investigate if
SMC interferes with DNA supercoiling in M. smegmatis, we
determined MICs towards the gyrase inhibitor ofloxacin using
the E-test (AB Biodisk). In contrast to findings made in other
organisms (25), M. smegmatis wild-type and smc mutant strains
displayed identical drug susceptibilities to ofloxacin, with MICs
of 0.19 g/ml.
SMC is known to participate in the repair of DNA double-
strand breaks in various organisms (22, 27), prompting us to
examine the ability of the SMC mutant strain to survive
treatment with ionizing radiation. Mid-log-phase cultures
were irradiated (0 to 378 Gy), and CFU were determined.
As DNA double-strand breaks are also repaired by homol-
ogous recombination repair (13), we included a recA mutant
strain as a control. In contrast to the recA mutant strain, no
major difference in survival between the wild-type strain and
the smc mutant strain was found (Fig. 2B). The eukaryotic
SMC5/6 complex has been described to act in a second
pathway for postreplicative repair of UV-induced lesions,
which is different from the standard nucleotide excision
repair pathway (18). In order to assess a possible role of
mycobacterial SMC in repair of UV-induced lesions, we
investigated the sensitivity of the SMC mutant strain to UV
irradiation. Three independent cultures of each strain were
grown in 7H9 medium until late log phase (optical density,
1 to 2). Serial dilutions of each strain were plated on LB
agar. Subsequently, the plates were exposed to different UV
doses (0 to 160 mJ/cm2, 254 nm) and the number of CFU
were determined. Compared to the recA mutant strain,
which was impaired in survival, the wild-type strain and the
smc mutant strain displayed similar susceptibilities to UV
(Fig. 2C). Investigation of susceptibility to mitomycin C, a
compound that damages DNA by generating intrastrand
cross-links, revealed no difference between the smc mutant
strain and the wild-type strain (data not shown). In sum-
mary, our data provide evidence that mycobacterial SMC
has, if at all, a minor role in DNA repair.
Some genes are not essential for exponential growth but
are prerequisites for remaining viable during stationary
FIG. 2. Analysis of M. smegmatis smc mutant strain. (A) Growth of M. smegmatis wild-type strain (solid lines) and smc mutant strain (dashed
lines) at various temperatures. OD600, optical density at 600 nm. (B) Survival following exposure to ionizing radiation. (C) Survival following
exposure to UV.
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phase (9). In order to gain insight into a possible role of
SMC in long-term survival of M. smegmatis, we compared
CFU counts of the M. smegmatis wild type and the smc
mutant grown for 28 days in 7H9 broth. Viable counts of
stationary cultures were similar for the two strains (Fig. 3),
suggesting that SMC is not essential for long-term survival
during stationary phase.
To study whether the findings obtained in the model or-
ganism M. smegmatis hold true for its pathogenic relatives,
we generated an M. tuberculosis smc mutant. A deletion
allele lacking 2,121 bp of the 3,618-bp smc ORF (the result-
ing mutant lacks bp 553 to 2674 of the ORF) was con-
structed by allelic-replacement mutagenesis as outlined for
M. smegmatis above. Disruption of smc was verified by
Southern blot analysis (Fig. 4). Growth of the mutant at
37°C in 7H9 broth supplemented with oleic acid-albumin-
dextrose-catalase was not impaired, indicating that interrup-
tion of smc does not affect in vitro growth (data not shown).
Survival in stationary phase was determined by comparing
CFU counts of the M. tuberculosis wild-type and smc mutant
strains grown for 83 days in 7H9 broth supplemented with
oleic acid-albumin-dextrose-catalase. Both strains reach vi-
able cell counts of about 1  108 CFU/ml after growth for 9
days, which for both strains dropped to approximately 3 
107 CFU/ml after 83 days of incubation, suggesting that
SMC is not required for long-term survival of M. tuberculosis
(data not shown).
In this study smc mutant strains of M. smegmatis and M.
tuberculosis were constructed. In contrast to previous data
obtained from other bacterial smc null mutants, SMC defi-
ciency did not result in apparent phenotypes. This is sur-
prising given the crucial role of SMC proteins in chromo-
some dynamics and DNA repair in all organisms analyzed so
far (12, 17, 19). Construction and analysis of scpA and scpB
knockout mutants will be subjects of future investigations.
These mutants eventually corroborate the results obtained
with the smc mutants or reveal a possible additional, SMC-
independent involvement of these proteins in mycobacterial
chromosome organization.
Taken together, our observations suggest that mainte-
nance of mycobacterial chromosome organization differs
from that of previously described models. Further investi-
gations of mycobacteria are likely to provide insights into
new mechanisms which maintain genome integrity and en-
sure persistence.
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Abstract 
Background: Microbial pathogens frequently evade host defense mechanisms by stochastically 
varying phenotypic traits. One major source of this variability are hypermutable simple sequence 
repeats in the genomes of these pathogens. However, such unstable sequences also come at a cost, as 
mutations are often deleterious. Here, we analyzed how these opposing forces shaped genome stability 
in the human pathogen Mycobacterium tuberculosis. M. tuberculosis lacks a mismatch repair system, 
and this renders simple sequence repeats particularly unstable.  
Results: We found that protein coding genes of M. tuberculosis do not contain long mono-, di- 
nucleotide repeats that could be interpreted as mutational hotspots. Rather, proteins are encoded by 
using codons in a way that prevents the emergence of these unstable sequences. This context-
dependent codon choice leads to a strong decrease in the estimated frame-shift mutation rate and thus 
to an increase in genome stability.  
Conclusions: These results indicate that a context-specific codon choice helps to maintain genome 
integrity in this mismatch repair deficient pathogen. 
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Background 
M .tuberculosis is the causative agent of tuberculosis. It is one of the most harmful pathogens causing 
10 million new infections and 1.6 million deaths every year [1]. There is a considerable interest in 
understanding the genome evolution of this pathogen, as this can further our understanding of 
pathogenicity and contribute to the development of new vaccines [2-5]. Here we focus on one aspect 
of genome evolution that plays a pivotal role in the infection biology of many pathogens: structural 
properties of the DNA sequence that determine the local mutation rate. 
 
The rate at which a stretch of DNA mutates is influenced by the nucleotide sequence itself. Certain 
sequences are inherently prone to errors during replication and gene expression, while other sequences 
are more stable. Particularly unstable are simple sequence repeats, which consist of short motifs of up 
to six nucleotides that are repeated several times [6]. Simple sequence repeats are prone to length 
variation during replication because of DNA-polymerase slippage [7]. The mutation rate in simple 
sequence repeats is much higher than in non-repeated sequences [8, 9], and increases with the number 
of repeats [7, 10-13]. If simple sequence repeats are located in coding regions, and if they consist of 
motifs whose length is not a multiple of three, then a change in the number of repeats leads to a frame-
shift mutation, and thereby to a complete loss of the amino acid sequence information. 
 
Some organisms, and particularly microbial pathogens, contain conspicuously long simple sequence 
repeats in coding regions [14]. For example, the bacteria Haemophilus influenzae [15], Neisseria 
meningitidis [16], and Campylobacter jejuni [17] contain mononucleotide, dinucleotide and 
tetranucleotide repeats in genes that are involved in interactions with the host. The most plausible 
biological function of these repeats is that they promote phenotypic variation among otherwise clonal 
cells by altering protein expression profiles at a high rate [18]. This phenotypic variation might allow 
pathogens to evade the immune system, as well as to increase the probability that a fraction of a clonal 
population survives changing conditions [19].  
 
However, unstable nucleotide sequences also come at a cost, as many mutational changes are 
detrimental. Recent studies suggested that simple sequence repeats are avoided in genomes of non-
pathogenic organisms [20-22]. It is thus currently not clear whether unstable nucleotide sequences are 
ubiquitous among microbial pathogens, or whether selection for stability usually also prevails in these 
genomes and leads to a bias against simple sequence repeats. Given the significance of M. tuberculosis 
as pathogen, it is important to investigate whether the genome of this microorganism is biased towards 
stability or instability.  
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Mycobacteria are especially prone to polymerase slippage in simple sequence repeats, for two reasons. 
First, their high G+C content (65.6% in M. tuberculosis; [2]) makes the emergence of repeats more 
likely. Second, they lack a mismatch repair system (MMR) [23] or other orthologous repair systems 
that could compensate for this deficiency [2, 24, 25]. MMR deficiency leads to a high mutation rate in 
simple sequence repeats, and especially in mononucleotide repeats [26], and it has been shown 
experimentally that in mycobacteria, the frame-shift rate in mononucleotide repeats is particularly high 
[23]. 
 
Here, we analyzed whether proteins in M. tuberculosis are encoded in a way that prevents or promotes 
the emergence of unstable sequences. A recent study has analyzed the distribution of simple sequence 
repeats in mycobacterial genomes, and reported that long repeats were less frequent than expected if 
nucleotides were randomly distributed [27]. We investigated here the causes and consequences of this 
under-representation. Focusing on short nucleotide repeats, which are a particularly important 
determinant of stability, we found that a context-dependent codon choice in the genome of  M. 
tuberculosis leads to a bias against these unstable sequences, and that this leads to a strong increase in 
estimates of genetic stability. 
 
Results and Discussion 
Comparing frequencies of mononucleotide repeats in coding regions 
and intergenic regions. 
A first insight into the distribution of short nucleotide repeats can be gained from the comparison of 
coding and intergenic regions. The frequency of repeats in a particular region of the genome is 
determined by the combination of mutational processes and selection. Mutational processes are 
expected to be similar in coding and intergenic regions (except for transcription-mediated mutations 
and repair [28]). In contrast, selection is generally stronger on coding regions than on intergenic 
regions. If selection leads to a bias for or against repeats, one would expect this bias to be stronger in 
coding regions than in intergenic regions. We tested this by comparing observed and expected 
occurrences of repeats in these two regions. We focused on mononucleotide repeats, because they are 
particularly unstable and more frequent than other types of repeats. 
 
 We first determined the number of mononucleotide repeats that would be expected if nucleotides were 
randomly distributed within each region, and then compared this number to the actually observed 
frequencies of repeats. We found that repeats of three nucleotides and more are less frequent than 
expected in both coding and intergenic regions (Figure 1). The bias increases with increasing repeat 
length, and is stronger in coding than in intergenic regions  (at p<0.0001 for repeats of length 3 to 7; 
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chi-square test). The latter finding suggests that the bias against repeats might be a consequence of 
selection against unstable sequences. 
 
Context-dependent codon choice in M. tuberculosis limits the emergence 
nucleotide repeats. 
In this first comparison, we calculated the expected frequencies of mononucleotide repeats under the 
assumption that nucleotides are randomly distributed. This null-model is appropriate for comparisons 
involving intergenic regions. In coding regions, however, a null-model that preserves the amino acid 
sequence and gene-specific codon frequencies is more adequate [22]. Such a modified null-model 
accounts for constraints on the DNA sequence imposed by the need to encode a particular protein, and 
it accounts for regional variation in GC-content and codon usage. We thus re-analyzed coding regions 
by using this modified null-model. For each gene, we determined the codon frequencies, and then re-
arranged the codons while preserving the amino acid sequence. Such a re-arrangement is possible 
because the genetic code is degenerate; as most amino acids are encoded for by more than one codon, 
a given amino acid sequence can be encoded for by different nucleotide sequences. For each gene, we 
generated 100 randomized sequences. Then we asked whether the observed nucleotide sequence 
differs from the random sequences in the frequency of short nucleotide repeats, and thus in terms of 
stability.  
 
We again first focused on mononucleotide repeats, and found that these repeats are strongly under-
represented in coding regions of M. tuberculosis (Figure 2). The under-representation increases with 
increasing repeat length. Furthermore, the bias is stronger against runs of cytosine and guanine than 
against runs of adenine and thymine. This pattern can be explained by the fact that mononucleotide 
repeats of cytosine and guanine have a higher mutation rate than repeats of adenine and thymine [22, 
29, 30]. 
 
Importantly, the bias against mononucleotide repeats depicted in Figure 2 is not a consequence of an 
avoidance of certain codons; the randomized sequences have the same codon frequencies as the 
observed sequence. Rather, the bias results from a context-dependent codon choice. For example, the 
amino acid proline can be encoded by CCA, CCC, CCG and CCT. The codon CCC is used often (at 
34%) at positions that are not followed by a cytosine. At positions followed by one cytosine, the 
frequency of CCC drops to 16%. With every additional cytosine following, the frequency decreased 
further (Figure 3). This decrease is statistically significant (p<0.0001, logistic regression). This same 
pattern holds for the codons AAA and GGG (and is also significant at p<0.0001; logistic regression). 
For TTT, the pattern is slightly different; the relative frequency of TTT first increases at positions 
followed by one thymidine, and then decreases at positions followed by more than one thymidine.  
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Quantifying the stabilizing effect of context-dependent codon choice 
As nucleotide repeats are prone to frame-shift mutations, the under-representation of mononucleotide 
repeats in the genome of M. tuberculosis is expected to lead to a decrease in the mutation rate. We 
sought to quantify the magnitude of this effect. First, we estimated the frame-shift mutation rate in 
mononucleotide repeats in coding regions of the M. tuberculosis genome. This estimate was based on 
published measurements of the frame-shift mutation rate in mononucleotide repeats in Mycobacteria 
and other bacteria (see Methods). Then, we estimated the frame-shift mutation rate that would be 
expected if codons were used at random, irrespective of the local context. To do so, we analyzed the 
randomized genomes, where codons were used in a context-independent manner. The ratio between 
estimated frame-shift mutation rates in the real and in the randomized genomes gave us an estimate for 
the magnitude of the stabilizing effect of context-dependent codon choice in the genome of M. 
tuberculosis.  
 
This ratio was sensitive to the mutation rate parameters retrieved from the literature, and we thus 
carried out the analysis for a range of parameter values. This analysis showed that the stabilizing effect 
of context-dependent codon choice was surprisingly strong: for a plausible range of biological 
parameters, the estimated frame-shift mutation rate in mononucleotide repeats in the randomized 
sequences was between 10 and 100 times higher than in the real sequence (Figure 4). For the 
parameter values that we considered most plausible (see Methods), the randomized genomes had an 
estimated frame-shift mutation rate that was about 20 times higher than the estimate for the real 
genome.  
 
In fact, without context dependent codon choice, one would expect that frame-shift mutations in 
mononucleotide repeats would be the most frequent type of mutations in the M. tuberculosis genome. 
For the most plausible parameter values, we estimated that in the absence of context-dependent codon 
choice, the probability to acquire a frame-shift mutation in a mononucleotide repeat in a protein-
coding gene would be 3% per replication (see Additional File 2). This value is about ten times higher 
than the total number of mutations expected per genome and replication in DNA-based microbes [31]. 
This means without bias against mononucleotide repeats, frame-shift mutations would happen very 
frequently, and they would constitute a very large fraction of all mutations that occur. This indicates 
that context-dependent codon choice has a substantial impact on genome stability of M. tuberculosis.  
 
We carried out the same analysis for the genome of the non-pathogenic Escherichia coli strain K12. 
Previous studies reported a bias against mononucleotide repeats for this organism, and attributed this 
bias to selection for stability (see [22]). Interestingly, the estimated stabilizing effect of context-
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dependent codon choice was much smaller for E. coli than for M. tuberculosis (Fig. 4). For the 
combination of parameters that we considered most plausible for M. tuberculosis, the estimated 
mutation rates for the real and the randomized genomes of E. coli differed by less than a factor of three 
(compared to a factor of 20 for M. tuberculosis). One possible explanation for this difference is that in 
the mismatch-deficient M. tuberculosis, selection against unstable sequences is stronger than in E. 
coli, and that this results in a stronger stabilization of the genome by context-dependent codon choice.  
 
Observed and expected frequencies of dinucleotide and tetranucleotide 
repeats  
In addition to mononucleotide repeats, di- and tetranucleotide repeats are other important determinants 
of the local mutation rate; they are also involved in phase variation in a number of pathogenic bacteria 
[32]. It is thus important to investigate whether context-dependent codon choice also leads to a bias 
against these two other types of repeats. To determine the expected frequencies of di- and 
tetranucleotide repeats, we again used a null model that conserved the amino acid sequence and the 
gene-specific codon frequencies. Then, we compared these expected frequencies of di- and 
tetranucleotide repeats to the actually observed frequencies.  
 
Dinucleotide repeats are generally rare in the genome of M. tuberculosis, and the observed numbers 
are close to expected. There are twelve different types of dinucleotides (discounting AA, CC, GG and 
TT, which are also mononucleotide repeats). The longest observed dinucleotide repeats are of length 
five; there is total of 41 occurrences of AC5, CA5, CG5 and GC5. By analyzing all dinucleotide repeats 
of length three and longer, we detected 15 cases where the observed number is significantly different 
from the expectation; in 11 of these 15 cases, the expected number exceeds the observed number. In 
the remaining four cases, the expected number is lower than the observed number (see Additional File 
1). 
 
The results for tetranucleotide repeats are similar. There are 240 tetranucleotides that are not also 
mono- or dinucleotide repeats. The longest observed tetranucleotide repeats are of length four (two 
occurrences of GGCC4). There are only 88 cases where the observed frequency of tetranucleotide 
repeats (of length two and longer) is significantly different from the expectation, and in 51 of those the 
expected number exceeds the observed number (see Additional File 1). These results indicate that 
context-dependent codon choice leads to some bias against di- and tetranucleotide repeats, but this 
bias is small compared to mononucleotide repeats. This might be because mononucleotide repeats tend 
to have higher frame-shift mutation rates than other repeats, and tend to be more de-stabilized by the 
absence of a mismatch repair system [33]. 
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Selection or a neutral process? 
The under-representation of short nucleotide repeats in the genome of M. tuberculosis could either 
result from selection for stable nucleotide sequences, or it could result from a neutral process [34]. A 
candidate for a neutral process is a deletion bias in nucleotide repeats. If deletions in short nucleotide 
repeats are more frequent than insertions, then repeats would decrease in size over the course of 
generations, and long repeats would become rare. However, in mono-, di- and tetranucleotide repeats, 
most deletions result in frame-shift mutation, which are usually deleterious; only deletions of a 
multiple of three units retain the reading frame. As most mutations in nucleotide repeats involve only 
one or two units [33], a deletion bias might not be a likely explanation for the under-representation of 
repeats observed here. 
 
Another observation is consistent with the idea that the observed pattern is a consequence of selection: 
the bias against repeats is more pronounced in coding than in non-coding regions, as would be 
expected if it resulted from selection against targets of frame-shift mutations. There was also evidence 
for the action of selection in a previous study with other organisms that investigated statistical 
associations between the occurrence of repeats and the expression level and essentiality of genes [22].  
 
However, the two types of explanations are not mutually exclusive, and they might both be involved in 
the observed pattern. And both explanations have the same final consequences: they lead to a genome 
that has fewer short nucleotide repeats and that is thus more stable. Interestingly, one would expect 
both types of processes to operate more strongly in organisms that lack an efficient mismatch repair 
system; in such organisms, selection for stable sequences would be stronger, and deletion biases would 
operate more quickly, thereby eliminating targets for frame-shift mutations. As a consequence, the 
lack of a mismatch repair system might, over evolutionary times, lead to genomes that partially 
compensate for this lack by an increased structural stability.  
Conclusions 
In the present study we introduced the concept that a context-dependent codon choice can be an 
alternative to a mismatch repair system for attaining genetic stability. We showed that in the 
pathogenic, MMR-deficient M. tuberculosis, codons are used in a context-specific way that limits the 
emergence of short nucleotide repeats, and therefore reduces the number of targets for frameshift 
mutations. Context-dependent codon choice leads to a strong decrease in the estimated frame-shift 
mutation rate. This structural stability in M. tuberculosis is more pronounced than in the mismatch 
repair-proficient bacterium E. coli. This is consistent the idea that a deficiency in enzymatic DNA 
repair increases the selection for inherently stable genomes.  
It is interesting to note that M. tuberculosis is an obligate pathogen, while E. coli is free-living. 
Genomes of bacterial pathogens often contain long mononucleotide repeats in genes involved in 
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interactions with the host [14]. However, the strong bias against short nucleotide repeats in M. 
tuberculosis is in line with the idea that in all organisms there is a core set of genes that are under 
selection for fulfilling their function in a stable and ordered manner [32], and suggest that in M. 
tuberculosis a dominant fraction of genes belongs to this group. 
Methods 
Origin of data 
Sequence data of the whole genome and intergenic regions of M. tuberculosis H37Rv (genebank 
number AL123456) were retrieved from http://tigr.org. Sequence data of E. coli K12 were retrieved 
from NCBI (accession no. 000913). 
Comparing mononucleotide repeats in coding and intergenic regions 
with a null-model that assumes random distribution of nucleotides  
To compare the distribution of mononucleotide repeats in coding and intergenic regions, we used a 
null-model based on a random distribution of nucleotides within each compartment. We first 
determined the observed distribution of mononucleotide repeats for each nucleotide, as well as the 
frequency of each nucleotide in both compartments. Then we calculated the expected distribution of 
mononucleotide repeats in both compartments with a permutation model. For example: the expected 
number of G6 repeats is determined by the probability of finding exactly 6 consecutive Gs by chance. 
As long as a compartment is reasonably large, this is very closely approximated by ((N-
G)
2
/N
2
) x (G
6
/N
6
)N, where G is the number of Gs and N is the total number of all nucleotides within 
this compartment. 
For each combination of nucleotide and repeat length, we then tested whether the proportions of 
expected and observed numbers differed between coding and intergenic regions. Observed and 
expected numbers in coding and intergenic regions were regarded as entries in a 2*2 contingency 
table, and a chi-square test was used to test for an association between the values for 
observed/expected and coding/noncoding. 
Comparing observed and expected numbers of mononucleotide repeats 
in coding regions with a null-model that preserves the amino acid 
sequence and the codon frequencies 
The expected distribution of mononucleotide repeats in coding regions was calculated with a null-
model that preserved the amino acid sequence and the ORF-specific codon frequencies. For each ORF, 
we first determined the codon frequencies and the amino acid sequence. Then, we generated 1000 
random nucleotide sequences that preserved these two features. In these randomized sequences, the 
number and length of all mononucleotide repeats was determined.  This data was used to calculate the 
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average expected number of repeats, as well as the distribution around this average, for every 
combination of nucleotide and length. We also determined the percentile range of 2.5–97.5 of this 
distribution. If the observed number of mononucleotide repeats fell outside this range, we concluded 
that this observation was not consistent with the null-model; this indicated that repeats of this 
nucleotide and this particular length were significantly over- or underrepresented. For Fig. 2, the 
observed number of repeats as well as the 2.5–97.5 percentile range was standardized by dividing by 
the average of the expected number (for details see [22]). 
Determining the context-dependent usage of homogenous codons 
In all ORFs we determined the occurrences of the four amino acids that can be encoded by a 
homogeneous codon (i.e., a codon that consists of three identical nucleotides) as well as one or more 
non-homogeneous codons (codons that do not consist of three identical nucleotides). These are 
phenylalanine (TTT and TTC), proline (CCA, CCC, CCG, and CCT), lysine (AAA and AAC), and 
glycine (GGA, GGC, GGG, and GGT). For each occurrence of one of these amino acids, we 
determined whether the codon was homogeneous or non-homogeneous, and whether it was followed 
by one or more of the nucleotides that constitute the homogeneous codon. This data was used to 
determine how the usage of homogeneous codons changed at positions immediately followed by one 
or more nucleotides of the same type. We used logistic regression to test whether the probability for a 
homogeneous codon changed with the number of nucleotides of the same type following. The program 
Jmp (version 6, SAS Institute Inc.) was used for logistic regression. 
Estimating the frameshift mutation rate 
To estimate the frameshift mutation rates in mononucleotide repeats composed of different nucleotides 
and of different length, we used estimates of biological parameters from the literature. The first 
assumption was that the frame-shift mutation rate in a C6 repeat in Mycobacteria is about 3*10
7
 [23]. 
The second assumption was that in bacteria, the frame-shift mutation rate in repeats of C and G is 
about five times higher than in repeats of A and T of the same length [35]. The third assumption was 
that in MMR deficient bacteria, the mutation rate in mononucleotide repeats increases by about a 
factor three with each additional nucleotide that is added to the repeat [36]. A further assumption was 
that the frame-shift mutation rate in mononucleotide ‘repeats’ of length two and three (for example, 
CC and CCC) is negligible, and that only repeats of length four and longer have a significant frame-
shift mutation rate.  
 
The estimate of the genome-wide frame-shift mutation rate was particularly sensitive to the last two 
assumptions. For this reason, we varied these assumptions to obtain estimates of the frame-shift 
mutation rate for a whole range of parameter values (Figure 4). This lead to the following equations 
for estimated frame-shift mutation rates UFS(n) in a mononucleotide repeat of length n ! i (where i is 
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the minimal length that has a significant frame-shift mutation rate; mononucleotide repeats with a 
length smaller than i were assumed to have a frame-shift mutation rate of zero): 
UFS(n) = 3*10
-7
/b*c
n-6  
where b, a parameter that accounts for differences in the mutation rate between repeats of A and T 
versus repeats of C and G, is equal to five for the nucleotides A and T and equal to one for C and G, 
and c is the factor by which the mutation rate increases with each additional nucleotide. The factor 
3*10
-7
 is based on the estimated frame-shift mutation rate in C6 repeats of Mycobacteria [23].  This 
equation was used to calculate the estimated frame-shift mutation rate for every mononucleotide repeat 
in the real genome. We then added those rates to obtain the estimate of the total frame-shift mutation 
rate per genome. We used the same method to determine the estimated frame-shift mutation rate in the 
randomized genomes. Based on published data (see above), we concluded that the parameter values 
c=3 and i=4 are most plausible. For Figure 4, the parameter c was varied from 2 to 4, and the 
parameter i was varied from 4 to 6.  
Comparing observed and expected numbers of di- and tetranucleotide 
repeats in coding regions with a null-model that preserves the amino 
acid sequence and the codon frequencies 
To determine expected frequencies of di- and tetranucleotide repeats, we used the same null-model as 
for mononucleotide repeats. We generated 100 random nucleotide sequences of the coding regions that 
preserved the amino acid sequence of each ORF and the ORF-specific codon frequencies. In these 
randomized sequences, the number and length of all di-and tetranucleotide repeats was determined.  
This data was used to calculate the average expected number of repeats, as well as the percentile range 
of 2.5–97.5, for every combination of nucleotide and length.  
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Figure Legends 
Figure 1: Mononucleotide repeats are less frequent in coding regions than in intergenic regions in the 
genome of M. tuberculosis. The figure shows the ratio between total number of observed and expected 
mononucleotide repeats in coding (filled circles and solid line) and intergenic regions (open circles 
and dashed line). The expected values have been calculated under the null model that nucleotides are 
randomly distributed in each of these two compartments, and occur at the frequencies observed in each 
compartment. For repeats of length three to six nucleotides, the under-representation of 
mononucleotide repeats is significantly stronger in coding regions than in intergenic regions (at p < 
0.0001, chi square test). 
 
Figure 2: Proteins of M. tuberculosis are encoded in a way that minimizes the emergence of 
mononucleotide repeats. The lines depict the ratio between the observed and expected number of 
mononucleotide repeats (summed over all genes in the genome) as a function of their length. The 
expected numbers were calculated with a null-model that conserved the amino acid sequence and the 
gene-specific codon frequencies. The areas comprise 95% of the data from the randomized genomes. 
For repeats of three (for A, C and G) or six (for T) nucleotides and longer, the lines lie below this area, 
indicating that such repeats are significantly under-represented.  
 
Figure 3: The under-representation of long mononucleotide repeats in coding regions of M. 
tuberculosis is a consequence of a context-dependent codon choice. Codons consisting of three 
identical nucleotides (‘homogeneous codons’) are avoided at positions followed by one or more 
nucleotides of the same type. The under-representation increases with increasing number of identical 
nucleotides following.  
 
Figure 4: Context-dependent codon choice leads to a strong decrease in the estimated frame-shift 
mutation rate in mononucleotide repeats in protein-coding genes in M. tuberculosis (upper area, light 
colors), and to a weaker decrease in E. coli (lower area, dark colors). We estimated the frame-shift 
mutation rate in the real genomes, and in randomized genomes without context-dependent codon 
choice. The ratio between these two values is a measure for the degree by which context-dependent 
codon choice stabilizes the genome, and is displayed on the z-axis. This ratio was calculated for 
different combinations of two biological parameters – the increase in the frame-shift mutation rate per 
nucleotide added to a mononucleotide repeat (parameter c, x-axis), and the minimal length for a 
mononucleotide repeat to exhibit a significant frame-shift mutation rate (parameter i, y-axis; see 
Methods). Published data suggest that in MMR-deficient bacteria c is close to 3 and i is about 4. For 
this combination, context-dependent codon choice leads to a decrease in the frame-shift mutation rate 
in mononucleotide repeats of a factor of about 20 in M. tuberculosis and of a factor of 3 in E. coli. 
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Additional Files 
Additional File 1: Tables with observed and expected numbers of mono-, di- and tetranucleotide 
repeats in protein-coding genes in the genome of M. tuberculosis.  
 
Additional File 2: Tables with estimated frame-shift mutation rates in mononucleotide repeats in 
protein coding genes of M. tuberculosis and E. coli. Estimates are given for the real genomes as well 
as for randomized genomes that preserve the amino acid sequence and the gene-specific codon 
frequencies.  
 
 
110
0.1
0.01
1 3 4
coding
intergenic
5 6 7 8 9 102
Length of nucleotide repeat
Figure 1
O
b
se
rv
e
d
/e
xp
e
ct
e
d
 
n
u
m
b
e
r 
o
f 
re
p
e
a
ts
Figure 1
A C
TG
0
1
1 3 4 5 6 7 8 9 102
0
1
1 3 4 5 6 7 8 9 102
0
1
1 3 4 5 6 7 8 9 102
0
1
1 3 4 5 6 7 8 9 102
Length of nucleotide repeat
Figure 2
O
b
se
rv
e
d
/e
xp
e
ct
e
d
 n
u
m
b
e
r 
o
f 
re
p
e
a
ts
Figure 2
01
10 3 4 5 62
Length of homogeneous run
following focal position
R
e
la
ti
v
e
 p
ro
p
o
rt
io
n
 o
f 
h
o
m
o
g
-
e
n
e
o
u
s 
co
d
o
n
 a
t 
fo
ca
l p
o
si
ti
o
n
Figure 3
A
C
G
T
Figure 3
2.5
2
3
3.5
Increase in 
the frame-s
hift mutatio
n rate 
per nucleot
ide added (
parameter c
)
M
in
im
al len
g
th
(p
aram
eter i)
D
e
cr
e
as
e
 in
 e
st
im
at
e
d
 f
ra
m
e
-s
h
if
t
 m
u
ta
ti
o
n
 r
at
e
  t
h
ro
u
g
h
 c
o
n
te
xt
-
d
e
p
e
n
d
e
n
t 
co
d
o
n
 c
h
o
ic
e
4
4
5
6
1
10
100
1000
10000
Figure 4
Additional files provided with this submission:
Additional file 1: additional file 1.pdf, 186K
http://www.biomedcentral.com/imedia/2021514890178502/supp1.pdf
Additional file 2: additional file 2.pdf, 52K
http://www.biomedcentral.com/imedia/8672393317850217/supp2.pdf
